
<html lang="en"     class="pb-page"  data-request-id="8c107086-4926-4ab1-9acd-cb55b80e12dc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-8;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00071;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV" /></meta><meta name="dc.Creator" content="Richard L.  Mackman" /></meta><meta name="dc.Creator" content="Hon C.  Hui" /></meta><meta name="dc.Creator" content="Michel  Perron" /></meta><meta name="dc.Creator" content="Eisuke  Murakami" /></meta><meta name="dc.Creator" content="Christopher  Palmiotti" /></meta><meta name="dc.Creator" content="Gary  Lee" /></meta><meta name="dc.Creator" content="Kirsten  Stray" /></meta><meta name="dc.Creator" content="Lijun  Zhang" /></meta><meta name="dc.Creator" content="Bindu  Goyal" /></meta><meta name="dc.Creator" content="Kwon  Chun" /></meta><meta name="dc.Creator" content="Daniel  Byun" /></meta><meta name="dc.Creator" content="Dustin  Siegel" /></meta><meta name="dc.Creator" content="Scott  Simonovich" /></meta><meta name="dc.Creator" content="Venice  Du Pont" /></meta><meta name="dc.Creator" content="Jared  Pitts" /></meta><meta name="dc.Creator" content="Darius  Babusis" /></meta><meta name="dc.Creator" content="Arya  Vijjapurapu" /></meta><meta name="dc.Creator" content="Xianghan  Lu" /></meta><meta name="dc.Creator" content="Cynthia  Kim" /></meta><meta name="dc.Creator" content="Xiaofeng  Zhao" /></meta><meta name="dc.Creator" content="Julie  Chan" /></meta><meta name="dc.Creator" content="Bin  Ma" /></meta><meta name="dc.Creator" content="Diane  Lye" /></meta><meta name="dc.Creator" content="Adelle  Vandersteen" /></meta><meta name="dc.Creator" content="Sarah  Wortman" /></meta><meta name="dc.Creator" content="Kimberly T.  Barrett" /></meta><meta name="dc.Creator" content="Maria  Toteva" /></meta><meta name="dc.Creator" content="Robert  Jordan" /></meta><meta name="dc.Creator" content="Raju  Subramanian" /></meta><meta name="dc.Creator" content="John P.  Bilello" /></meta><meta name="dc.Creator" content="Tomas  Cihlar" /></meta><meta name="dc.Description" content="A discovery program targeting respiratory syncytial virus (RSV) identified C-nucleoside 4 (RSV A2 EC50 = 530 nM) as a phenotypic screening lead targeting the RSV RNA-dependent RNA polymerase (RdRp)..." /></meta><meta name="Description" content="A discovery program targeting respiratory syncytial virus (RSV) identified C-nucleoside 4 (RSV A2 EC50 = 530 nM) as a phenotypic screening lead targeting the RSV RNA-dependent RNA polymerase (RdRp)..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 9, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00071" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00071" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00071" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00071" /></link>
        
    
    

<title>Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00071" /></meta><meta property="og:title" content="Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0013.jpeg" /></meta><meta property="og:description" content="A discovery program targeting respiratory syncytial virus (RSV) identified C-nucleoside 4 (RSV A2 EC50 = 530 nM) as a phenotypic screening lead targeting the RSV RNA-dependent RNA polymerase (RdRp). Prodrug exploration resulted in the discovery of remdesivir (1, GS-5734) that is &gt;30-fold more potent than 4 against RSV in HEp-2 and NHBE cells. Metabolism studies in vitro confirmed the rapid formation of the active triphosphate metabolite, 1-NTP, and in vivo studies in cynomolgus and African Green monkeys demonstrated a &gt;10-fold higher lung tissue concentration of 1-NTP following molar normalized IV dosing of 1 compared to that of 4. A once daily 10 mg/kg IV administration of 1 in an African Green monkey RSV model demonstrated a &gt;2-log10 reduction in the peak lung viral load. These early data following the discovery of 1 supported its potential as a novel treatment for RSV prior to its development for Ebola and approval for COVID-19 treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00071"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00071">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00071&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00071&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00071&amp;href=/doi/10.1021/acs.jmedchem.1c00071" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 5001-5017</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00058" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00114" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Richard L. Mackman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard L. Mackman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a0f2c9c3c8c1d2c48eedc1c3cbcdc1cee0c7c9ccc5c1c48ec3cfcd"><span class="__cf_email__" data-cfemail="3e6c575d565f4c5a10735f5d55535f507e5957525b5f5a105d5153">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+L.++Mackman">Richard L. Mackman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hon C. Hui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hon C. Hui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hon+C.++Hui">Hon C. Hui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Perron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Perron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Perron">Michel Perron</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eisuke Murakami</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eisuke Murakami</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eisuke++Murakami">Eisuke Murakami</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Palmiotti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Palmiotti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Palmiotti">Christopher Palmiotti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Lee">Gary Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kirsten Stray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirsten Stray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirsten++Stray">Kirsten Stray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lijun Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lijun Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lijun++Zhang">Lijun Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bindu Goyal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bindu Goyal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bindu++Goyal">Bindu Goyal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwon Chun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwon Chun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwon++Chun">Kwon Chun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Byun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Byun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Byun">Daniel Byun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dustin Siegel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dustin Siegel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dustin++Siegel">Dustin Siegel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Scott Simonovich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott Simonovich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Simonovich">Scott Simonovich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Venice Du Pont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Venice Du Pont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Venice++Du+Pont">Venice Du Pont</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jared Pitts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jared Pitts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jared++Pitts">Jared Pitts</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Darius Babusis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darius Babusis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darius++Babusis">Darius Babusis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arya Vijjapurapu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arya Vijjapurapu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arya++Vijjapurapu">Arya Vijjapurapu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xianghan Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xianghan Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xianghan++Lu">Xianghan Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cynthia Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cynthia Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia++Kim">Cynthia Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaofeng Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaofeng Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaofeng++Zhao">Xiaofeng Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julie Chan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julie Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Chan">Julie Chan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bin Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bin Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Ma">Bin Ma</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7549-2658" title="Orcid link">http://orcid.org/0000-0002-7549-2658</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diane Lye</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diane Lye</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diane++Lye">Diane Lye</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adelle Vandersteen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adelle Vandersteen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adelle++Vandersteen">Adelle Vandersteen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah Wortman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah Wortman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Wortman">Sarah Wortman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kimberly T. Barrett</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly T. Barrett</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+T.++Barrett">Kimberly T. Barrett</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Toteva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Toteva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Toteva">Maria Toteva</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Jordan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Jordan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Jordan">Robert Jordan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raju Subramanian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raju Subramanian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raju++Subramanian">Raju Subramanian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John P. Bilello</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John P. Bilello</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Bilello">John P. Bilello</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Tomas Cihlar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomas Cihlar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomas++Cihlar">Tomas Cihlar</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00071&amp;href=/doi/10.1021%2Facs.jmedchem.1c00071" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 5001–5017</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 9, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 January 2021</li><li><span class="item_label"><b>Published</b> online</span>9 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00071</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5001%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRichard%2BL.%2BMackman%252C%2BHon%2BC.%2BHui%252C%2BMichel%2BPerron%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D8%26contentID%3Dacs.jmedchem.1c00071%26title%3DProdrugs%2Bof%2Ba%2B1%25E2%2580%25B2-CN-4-Aza-7%252C9-dideazaadenosine%2BC-Nucleoside%2BLeading%2Bto%2Bthe%2BDiscovery%2Bof%2BRemdesivir%2B%2528GS-5734%2529%2Bas%2Ba%2BPotent%2BInhibitor%2Bof%2BRespiratory%2BSyncytial%2BVirus%2Bwith%2BEfficacy%2Bin%2Bthe%2BAfrican%2BGreen%2BMonkey%2BModel%2Bof%2BRSV%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5017%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00071"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1178</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00071" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;L. Mackman&quot;},{&quot;first_name&quot;:&quot;Hon&quot;,&quot;last_name&quot;:&quot;C. Hui&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Perron&quot;},{&quot;first_name&quot;:&quot;Eisuke&quot;,&quot;last_name&quot;:&quot;Murakami&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Palmiotti&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Kirsten&quot;,&quot;last_name&quot;:&quot;Stray&quot;},{&quot;first_name&quot;:&quot;Lijun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Bindu&quot;,&quot;last_name&quot;:&quot;Goyal&quot;},{&quot;first_name&quot;:&quot;Kwon&quot;,&quot;last_name&quot;:&quot;Chun&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Byun&quot;},{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;Siegel&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Simonovich&quot;},{&quot;first_name&quot;:&quot;Venice&quot;,&quot;last_name&quot;:&quot;Du Pont&quot;},{&quot;first_name&quot;:&quot;Jared&quot;,&quot;last_name&quot;:&quot;Pitts&quot;},{&quot;first_name&quot;:&quot;Darius&quot;,&quot;last_name&quot;:&quot;Babusis&quot;},{&quot;first_name&quot;:&quot;Arya&quot;,&quot;last_name&quot;:&quot;Vijjapurapu&quot;},{&quot;first_name&quot;:&quot;Xianghan&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Xiaofeng&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;Lye&quot;},{&quot;first_name&quot;:&quot;Adelle&quot;,&quot;last_name&quot;:&quot;Vandersteen&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Wortman&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;T. Barrett&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Toteva&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Jordan&quot;},{&quot;first_name&quot;:&quot;Raju&quot;,&quot;last_name&quot;:&quot;Subramanian&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Bilello&quot;},{&quot;first_name&quot;:&quot;Tomas&quot;,&quot;last_name&quot;:&quot;Cihlar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5001-5017&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00071&quot;},&quot;abstract&quot;:&quot;A discovery program targeting respiratory syncytial virus (RSV) identified C-nucleoside 4 (RSV A2 EC50 = 530 nM) as a phenotypic screening lead targeting the RSV RNA-dependent RNA polymerase (RdRp). Prodrug exploration resulted in the discovery of remdesivir (1, GS-5734) that is &gt;30-fold more potent than 4 against RSV in HEp-2 and NHBE cells. Metabolism studies in vitro confirmed the rapid formation of the active triphosphate metabolite, 1-NTP, and in vivo studies in cynomolgus and African Green monkeys demonstrated a &gt;10-fold higher lung tissue concentration of 1-NTP following molar normalized IV dosing of 1 compared to that of 4. A once daily 10 mg/kg IV administration of 1 in an African Green monkey RSV model demonstrated a &gt;2-log10 reduction in the peak lung viral load. These early data following the discovery of 1 supported its potential as a novel treatment for RSV prior to its development for Ebola and approval for COVID-19 treatment.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00071" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00071&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00071" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00071&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00071" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00071&amp;href=/doi/10.1021/acs.jmedchem.1c00071" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00071" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00071" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00071%26sid%3Dliteratum%253Aachs%26pmid%3D33835812%26genre%3Darticle%26aulast%3DMackman%26date%3D2021%26atitle%3DProdrugs%2Bof%2Ba%2B1%25E2%2580%25B2-CN-4-Aza-7%252C9-dideazaadenosine%2BC-Nucleoside%2BLeading%2Bto%2Bthe%2BDiscovery%2Bof%2BRemdesivir%2B%2528GS-5734%2529%2Bas%2Ba%2BPotent%2BInhibitor%2Bof%2BRespiratory%2BSyncytial%2BVirus%2Bwith%2BEfficacy%2Bin%2Bthe%2BAfrican%2BGreen%2BMonkey%2BModel%2Bof%2BRSV%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D8%26spage%3D5001%26epage%3D5017%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/jmcmar.2021.64.issue-8/20210422/jmcmar.2021.64.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A discovery program targeting respiratory syncytial virus (RSV) identified <i>C</i>-nucleoside <b>4</b> (RSV A2 EC<sub>50</sub> = 530 nM) as a phenotypic screening lead targeting the RSV RNA-dependent RNA polymerase (RdRp). Prodrug exploration resulted in the discovery of remdesivir (<b>1</b>, GS-5734) that is >30-fold more potent than <b>4</b> against RSV in HEp-2 and NHBE cells. Metabolism studies in vitro confirmed the rapid formation of the active triphosphate metabolite, <b>1</b>-<b>NTP</b>, and in vivo studies in cynomolgus and African Green monkeys demonstrated a >10-fold higher lung tissue concentration of <b>1-NTP</b> following molar normalized IV dosing of <b>1</b> compared to that of <b>4</b>. A once daily 10 mg/kg IV administration of <b>1</b> in an African Green monkey RSV model demonstrated a >2-log<sub>10</sub> reduction in the peak lung viral load. These early data following the discovery of <b>1</b> supported its potential as a novel treatment for RSV prior to its development for Ebola and approval for COVID-19 treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acute respiratory viruses such as respiratory syncytial virus (RSV), influenza, and rhinovirus are significant global health problems. Year round, these viruses circulate in the global population and are most prevalent during the winter months in each hemisphere.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In vulnerable patient populations, they can have lethal consequences and the economic burden is considerable, with estimated costs in the United States exceeding $40B for rhinovirus and $87B for influenza. Some influenza viruses that have efficient human-to-human transmission also carry the additional risk of evolving into pandemics. Notable historical examples include the 1918 Spanish Flu and the more recent 2009 H1N1 swine flu pandemic.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The emergence of the coronavirus SARS-CoV-2 in late 2019 has resulted in the most recent global pandemic and has once again thrown respiratory viruses to the forefront of public awareness. A short 9 months after the WHO designated COVID-19 a pandemic, there are upwards of 100M confirmed infections and more than 2.3M recorded deaths worldwide.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Research into the prevention and treatment of acute respiratory viruses is therefore of critical importance.</div><div class="NLM_p">Remdesivir (<b>1</b>, GS-5734, Veklury) is the first agent to be approved as a treatment for hospitalized COVID-19 patients (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The rapid approval of <b>1</b> for COVID-19 was enabled by extensive research conducted since its initial discovery as part of a program to identify new treatments for RSV.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Following the identification of potent anti-Ebola virus activity of <b>1</b> in vitro and in vivo at the start of the West Africa Ebola outbreak, it was selected for clinical development as a potential treatment option for Ebola.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The development of <b>1</b> provided a platform of clinical experience and drug supply from which to rapidly launch clinical studies investigating its efficacy for COVID-19 leading to its regulatory approval.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of RSV and HCV RdRp nucleoside inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">RSV infection, despite its efficient human-to-human transmission, generally results in mild disease that resolves without complications in most immunocompetent patients. However, progression to the lower respiratory tract can lead to airway inflammation, symptoms of bronchiolitis, pneumonia, and, in some cases, respiratory failure. These outcomes are commonly associated with vulnerable patient populations including infants, the elderly with underlying comorbidities, and immunocompromised individuals.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(11−18)</a> In infants less than 1 year of age, RSV is associated with significantly more deaths than influenza and a greater risk for the long-term development of recurrent wheezing and asthma in children.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Elderly individuals with chronic obstructive pulmonary disorder, asthma, and diabetes mellitus are also a known high-risk population for severe RSV infection.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14−17)</a> Another patient population susceptible to RSV infection is post-transplant patients, in which severe lower respiratory tract infection leads to greater morbidity and mortality.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The only treatment options for RSV are palivizumab, approved for prophylaxis in infants, and the broad-spectrum antiviral ribavirin (<b>2</b>) that has limited efficacy and carries significant safety concerns for caregivers.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a></div><div class="NLM_p">RSV is a negative-sense, single-stranded RNA virus from the pneumoviridae family.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The antisense positive-strand RNA encodes for 11 viral proteins, and in recent years, significant progress has been made to demonstrate clinical proof-of-concept for targeting some of these viral proteins. The fusion inhibitors presatovir, rilematovir, and sisunatovir, in addition to a next-generation RSV nucleocapsid inhibitor EDP-938 and the nucleoside analogue lumicitabine (<b>3</b>), have all demonstrated efficacy in human RSV challenge studies.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23−27)</a> Nucleoside <b>3</b> targets the RSV RNA-dependent RNA polymerase (RdRp), which is a large 250 kDa protein that functions within a complex with other RSV proteins, e.g., P and M2-1.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The RdRp has the critical function of copying the viral RNA, and like many other viral RdRp, its function can be inhibited by nucleoside analogues that mimic the natural RNA substrates.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Our interest in RSV has been long-standing given the unmet medical need for safer and more effective treatments for RSV. In 2008, we initiated a program aimed at discovering novel treatments for RSV infection. The leads for our discovery program were identified through phenotypic screening campaigns, the first, a high-throughput screen of small-molecule library comprising ∼400 K compounds and the second, a medium-throughput screen of riboside nucleosides and nucleotides. The phenotypic screen assessed the inhibition of RSV A2-induced cytopathic effects in the cervical adenocarcinoma HEp-2 cell line. In the ∼400 k compound screen, a submicromolar RSV fusion lead was identified, which was subsequently optimized into the clinical fusion inhibitor presatovir, GS-5806.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The nucleoside screen identified <b>4</b>, which targets the RSV RdRp and therefore has an orthogonal mechanism of action to the fusion inhibitor. Fusion inhibitors prevent the spread of RSV by blocking viral entry into uninfected cells, whereas the nucleoside analogues inhibit the viral RNA replication process in cells that harbor the virus. Given the difference in mechanisms of action, we elected to optimize <b>4</b> in parallel to the fusion leads.</div><div class="NLM_p">Nucleoside <b>4</b> was first prepared in a HCV RdRp program that led to the clinical candidate <b>5</b>.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> Indeed, the expansive collections of HCV RdRp nucleoside inhibitors within the broader research community also resulted in other groups discovering RSV inhibitors based on leads from their HCV programs, e.g., <b>3</b>.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Despite the significant efforts toward identifying HCV RdRp inhibitors across many research groups, <b>6</b> was the only FDA-approved nucleoside analogue that emerged, illustrating that the successful development of potent and selective nucleoside inhibitors for HCV RdRp was very challenging.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Aside from <b>2</b>, all of the clinically advanced RdRp inhibitors in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> retain the 3′-OH and either a 2′-OH or 2′-F group to satisfy a key recognition element for viral RNA polymerase binding. Their nucleoside triphosphates (NTPs), e.g., <b>1</b>-<b>NTP</b>, are generated inside infected cells and compete with the natural nucleotides as substrates for incorporation by the viral polymerase into nascent viral RNA strands. Once incorporated, the modified nucleoside can result in immediate or delayed chain termination of viral RNA strand synthesis due to the structural modifications around the ribose core, e.g., 1′-CN, 2′-C-Me, or 4′-CH<sub>2</sub>Cl.<a onclick="showRef(event, 'ref7 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref7 ref36 ref37 ref38">(7,36−38)</a> For example, the 1′-CN modification following incorporation allows several additional nucleotides to be incorporated before halting the RNA synthesis, potentially as a result of steric factors hindering the polymerase motion along the RNA or subtle changes in the tertiary structure of the double-strand RNA.<a onclick="showRef(event, 'ref7 ref38'); return false;" href="javascript:void(0);" class="ref ref7 ref38">(7,38)</a> Another structural feature of several compounds in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> is the application of ester prodrugs to mask one or more of the hydroxyl groups and/or 5′-phosphoramidate prodrugs that can more efficiently generate the intermediate monophosphate metabolite precursor of the NTP inside cells.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p last">Here, we describe in detail the follow-up efforts on RSV screening lead <b>4</b>, including the SAR of 1′-modifications that established that the 1′-CN group was optimal for RSV potency and viral polymerase selectivity. Prodrugs were designed to either improve oral absorption or optimize cellular potency, which led to the discovery of the 5′-2-ethylbutylalanine monophenol phosphoramidate, <b>1</b>, as a more potent RSV inhibitor with efficacy in the African Green monkey RSV model. In recent years, the broad-spectrum in vitro and in vivo antiviral efficacies of <b>1</b> toward multiple respiratory virus pathogens including, Nipah, MERS, SARS-CoV, and, more recently, SARS-CoV-2 have been demonstrated.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40−44)</a> The early data reported here on the discovery of <b>1</b> for RSV supports the continued investigation of <b>1</b> beyond its approval for SARS-CoV-2 treatment toward other respiratory viruses, including RSV.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the 1′-CN <i>C</i>-nucleoside analogue <b>4</b> has been described previously.<a onclick="showRef(event, 'ref7 ref31'); return false;" href="javascript:void(0);" class="ref ref7 ref31">(7,31)</a> Analogues <b>7–10</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) that are structurally close to <b>4</b> were also assessed from the library to evaluate the SAR around the 1′-modification. The synthesis of <b>7–10</b> has been previously reported, along with the synthesis of their respective NTPs.<a onclick="showRef(event, 'ref6 ref8 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref30 ref31 ref32">(6,8,30−32)</a> The submicromolar RSV potency of nucleoside <b>4</b> in the initial HEp-2 screening assay was striking since it was 8-fold more potent toward RSV than toward the HCV 1b replicon (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Earlier work had shown that the SAR for the 1′-modifications toward HCV was narrow, declining precipitously with larger substituents.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A similar trend was observed for RSV, indicating that this trajectory has limited substitution scope for RSV.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Ester Prodrugs on <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC), 4-dimethylaminopyridine (DMAP), <i>N</i>,<i>N</i>-dimethylformamide (DMF), acetic acid (86%), propionic acid (95%), <i>iso</i>-butyric acid (95%); (ii), DIC, Et<sub>3</sub>N, BOC-valine; and (iii) 20% TFA in CH<sub>2</sub>Cl<sub>2</sub>, 24% over two steps.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. RSV and HCV Antiviral Activities of 1′-Modified <i>C</i>-Nucleoside Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd.</th><th class="colsep0 rowsep0" align="center">1′</th><th class="colsep0 rowsep0" align="center">2′</th><th class="colsep0 rowsep0" align="center">RSV RNP<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HCV RdRp<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">RSV A2 HEp-2 EC<sub>50</sub>/CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HCV 1b Huh-7 EC<sub>50</sub>/CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">MT-4 CC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.1<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">5.6<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.53/>100</td><td class="colsep0 rowsep0" align="left">4.1/>89</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50/0.036</td><td class="colsep0 rowsep0" align="left">0.0035/0.15</td><td class="colsep0 rowsep0" align="left"><0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5.5/93</td><td class="colsep0 rowsep0" align="left">39/>45</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">C≡CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">232</td><td class="colsep0 rowsep0" align="left">34/>100</td><td class="colsep0 rowsep0" align="left">>89/>89</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">38<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">>100/>100</td><td class="colsep0 rowsep0" align="left">>89/>89</td><td class="colsep0 rowsep0" align="left">>200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are determined using the NTP analogue in a cell-free RSV ribonucleoprotein (RNP) complex assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are determined using the NTP analogue in a cell-free HCV RdRp assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><b>1</b> and <b>4</b> generate the same metabolite, <b>1-NTP</b>.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>n</i> = 1 data.  All data are <i>n</i> ≥ 2 replicates unless noted.</p></div></div></div><div class="NLM_p">To establish that the antiviral activity was driven by the respective triphosphate metabolite, the RSV ribonucleoprotein (RNP) complex containing the RdRp was isolated from RSV-infected cell extracts and a biochemical assay was established.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Triphosphate <b>1-NTP</b> was found to be 5-fold more potent toward the RSV RNP complex than recombinant HCV RdRp.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Screening of the 1′-methyl <b>8</b>, 1′-ethynyl <b>9</b>, and the 1′-CN, 2′-C-Me <b>10</b><i>C</i>-nucleosides resulted in a progressively reduced anti-RSV activity that was consistent with the decreased inhibition of their respective NTPs toward the RSV RNP complex. The same trend of decreasing antiviral potency was observed for <b>8</b> and <b>9</b> toward HCV, which was also in line with the decreased inhibition of the triphosphates toward HCV RdRp. However, the 1′-CN, 2′-C-Me analogue <b>10</b> was an exception since despite lacking HCV activity in cells, its triphosphate was 15-fold more potent toward the HCV RdRp than <b>1</b>-<b>NTP</b>. It was known that the 2′-C-Me modification is a potency driver toward HCV RdRp and is present in many of the most effective HCV RdRp inhibitors, as exemplified by <b>5</b> and <b>6</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Structural modeling of the RSV and HCV RdRp active sites suggested that the reduced potency of <b>10</b> toward RSV RdRp was likely due to residue E778 that occludes the RSV active site in the proximity of the 2′-β position of the ribose.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In HCV RdRp, this region is occupied by the smaller and more accommodating S282 residue. The 1′-unsubstituted <i>C</i>-nucleoside analogue <b>7</b> was found to be cytotoxic across multiple cell lines, including the rapidly proliferating MT-4 human T-cells. Taken together, these data established that the 1′-CN group was optimal among several 1′-modifications on the adenine <i>C</i>-nucleoside for RSV potency and selectivity. Inspired by <b>4</b>, the SAR was later expanded beyond the 1′-modifications leading to the first report of potent 4′-modified <i>C</i>-nucleosides toward RSV.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro and In Vivo Profiles of Esters <b>11–14</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd.</th><th class="colsep0 rowsep0" align="center">5′-ester</th><th class="colsep0 rowsep0" align="center">2′, 3′-esters</th><th class="colsep0 rowsep0" align="center">RSV HEp-2 EC<sub>50</sub>/CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">log <i>D</i></th><th class="colsep0 rowsep0" align="center">Caco-2 AB/BA (10 × 10<sup>–6</sup> cm<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">F%<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> rat/dog/cyno</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.53/>100</td><td class="colsep0 rowsep0" align="left"><0.3</td><td class="colsep0 rowsep0" align="left">0.17/2.1</td><td class="colsep0 rowsep0" align="left">12/89/3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">acetyl</td><td class="colsep0 rowsep0" align="left">acetyl</td><td class="colsep0 rowsep0" align="left">0.82/>100</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">0.9/1.9</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">propionyl</td><td class="colsep0 rowsep0" align="left">propionyl</td><td class="colsep0 rowsep0" align="left">0.43/>100</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left"><0.1/0.26<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><i>iso</i>-butyryl</td><td class="colsep0 rowsep0" align="left"><i>iso</i>-butyryl</td><td class="colsep0 rowsep0" align="left">0.26/81</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">2.1/1.5</td><td class="colsep0 rowsep0" align="left">57<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>/-/28<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">valine</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.11/>100</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.55/0.45</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 animals.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Caco-2 compound recovery is low.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">F% of compound <b>4</b> based on the mg equivalent of <b>4</b> administered as the prodrug, standard deviation ±3% for rat and ±9% for cyno. All in vitro data are <i>n</i> ≥ 2 replicates unless noted.</p></div></div></div><div class="NLM_p">Compound <b>4</b> has a low log <i>D</i> and demonstrated low cell permeability in the Caco-2 assay with an efflux ratio (BA/AB) of 12 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). It was therefore not surprising that the oral bioavailability was low in cynomolgus monkey and rat. In dogs, the oral bioavailability was high, which is thought to be due to the larger pore size and greater pore frequency in the paracellular pathway of the dog and potentially the role of nucleoside transporters specific to the dog.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Riboside inhibitors frequently employ ester prodrugs to mask one or more of the ribose hydroxyl groups and improve oral bioavailability. For example, the <i>iso-</i>butyryl esters masking both free hydroxyls in <b>3</b> were reported to improve the oral bioavailability of the parent nucleoside in cynomolgus monkeys from 3 to 44%.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A similar tactic was attempted on <b>4</b> through the preparation of ester prodrugs <b>11–14</b> that would be expected to provide the greatest absorption benefit by masking all of the polar ribose hydroxyls or by leveraging peptide transporters, e.g., <b>14</b>, modeled after oral valganciclovir.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The ester analogues were readily prepared using a straightforward carbodiimide coupling followed by deprotection of the amino acid protecting group in example <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The most effective ester prodrug was the highly lipophilic tri-<i>iso</i>-butyryl ester <b>13</b>, which demonstrated 2-fold improved potency, a higher log <i>D</i>, and the greatest improvement in Caco-2 permeability with no efflux (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Following oral dosing of <b>13</b>, no ester prodrug was detected in the plasma due to rapid pre-systemic cleavage of the esters, but the systemic exposure of <b>4</b> was increased by ∼5- and ∼8-fold in rat and cynomolgus monkey, respectively, suggesting that this may be a promising approach to increase the oral delivery of <b>4</b>. Recently, a deutero analogue of <b>13</b> has been reported to have a 57% oral bioavailability in rats consistent with these data.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Despite these results, the modest improvement in antiviral activity for <b>13</b> implied that permeability was not limiting the antiviral potency of <b>4</b> in cell culture.</div><div class="NLM_p">The first step in intracellular anabolism of a nucleoside analogue to the corresponding monophosphate can be rate-limiting leading to reduced potency in cellular assays. To avoid this limitation, monophosphate prodrugs, e.g., <b>5</b> and <b>6</b>, are frequently employed to bypass this anabolism step and deliver higher concentrations of the monophosphate species inside cells.<a onclick="showRef(event, 'ref32 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref35">(32,35)</a> A variety of 5′-monophosphate prodrugs were designed on <b>4</b> to assess whether more potent inhibition of RSV in cell culture could be obtained. Phosphate prodrugs screened included the thioester prodrug <b>15</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> phosphordiamide esters <b>16a−b</b>, and monoalanine phosphoramidate esters <b>18a–k</b> and <b>19</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Phosphate Prodrugs on <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) PO(OMe)<sub>3</sub>, 1<i>H-</i>tetrazole, (<i>i</i>-Pr)<sub>2</sub>NP(OCH<sub>2</sub>CH<sub>2</sub>SC(═O)C(CH<sub>3</sub>)<sub>3</sub>) (ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>); (ii) MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, DMF, cyclopropylmethyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, 50 °C, <b>18c</b> (38%); (iii) MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, tetrahydrofuran (THF), cyclooctyl((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, 50 °C 81%; and (iv) HCl, 0 °C, over two steps <b>18h</b> (42%), <b>18k</b> (62%).</p></p></figure><div class="NLM_p">The thioester prodrug <b>15</b> was prepared using the phosphorane reagent described by Lefebvre et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The syntheses of prodrugs <b>16a−b</b>, <b>18a–k</b>, and <b>19</b> have been described previously except <b>18c</b>, <b>18h</b>, and <b>18k</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Monoamidate <b>18c</b> was prepared in moderate yield by direct coupling of the amidate reagent in the presence of MgCl<sub>2</sub> to nucleoside <b>4</b>. A higher yielding and more robust procedure that coupled the desired amidate reagent to the 2′,3′-acetonide protected nucleoside <b>17</b>, followed by removal of the acetonide, was also developed.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For example, monoamidate <b>18k</b> was prepared in a 62% overall yield from the protected nucleoside <b>17</b>. The diastereomeric monoamidate mixture <b>18j</b> was separated by chiral chromatography to afford <b>1</b> and <b>1-</b><i><b>R</b></i><sub><b>p</b></sub>. Later, a stereospecific synthesis was developed and the two diastereoisomers were assigned by determination of the small-molecule X-ray structure of the more potent isomer <b>1</b>.<a onclick="showRef(event, 'ref8 ref51'); return false;" href="javascript:void(0);" class="ref ref8 ref51">(8,51)</a></div><div class="NLM_p">More substantial potency gains were realized with 5′-phosphate prodrugs that bypass the first phosphorylation step in the conversion of <b>4</b> to its intermediate 5′-monophosphate in cells and thereby enhance the formation of <b>1</b>-<b>NTP</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The dithioester phosphate prodrug <b>15</b> was earlier found to improve the activity of <b>4</b> toward HCV in hepatic Huh-7 cells, confirming that, at least in hepatic cells, there is evidence for inefficient metabolism of <b>4</b> to its monophosphate.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, in the HEp-2 cell RSV assay, <b>15</b> demonstrated only a small improvement in RSV potency and a relatively low selectivity index. The prodrug following thioester cleavage releases an episulfide, which may be the root cause for the reduced selectivity.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Phosphoramidate-based prodrugs were also evaluated including the phosphordiamide esters <b>16a−b</b> and monoalanine phosphoramidate esters <b>18a–k</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The potency advance was achieved using the monoalanine phosphoramidate ester prodrug approach, which generates the monophosphate in cells via the mechanism described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.<a onclick="showRef(event, 'ref39 ref53'); return false;" href="javascript:void(0);" class="ref ref39 ref53">(39,53)</a> Initial cleavage of the alanine ester by intracellular esterases, e.g., carboxyesterase 1, carboxyesterase 2, or cathepsin A, is followed by intramolecular cyclization and ejection of the phenol-leaving group. The cyclic intermediate is then hydrolyzed to the intermediate alanine monophosphate (alanine metabolite) followed by the P–N bond cleavage by histidine triad enzymes, e.g., Hint1. This process leads to the intracellular generation of the monophosphate metabolite, effectively bypassing the slow first phosphorylation step in the intracellular metabolism of <b>4</b> and ultimately formation of <b>1-NTP</b>.</div><div class="NLM_p">The diastereomeric isopropylmonoamidate ester mixture (<b>18b</b> mixture) was prepared given the precedence for the <i>S</i>p isomer of this amidate prodrug in tenofovir alafenamide. The mixture demonstrated no improvement in activity over <b>4</b> (data not shown), and the single <i>S</i>p diastereomer <b>18b</b> provided a modest improvement over <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). It was hypothesized that the moderately high polarity (log <i>D</i> = 1.1) of the iso-propyl amidate prodrug may limit cell permeability and disfavor binding in the esterase cleavage pocket, similar to the commonly accepted relationship observed for polar compounds disfavoring binding to P450 metabolic enzymes. The more lipophilic 2-ethylbutyl ester <b>18j</b> was subsequently prepared to increase the log <i>D</i> while avoiding the introduction of additional stereochemistry or steric hinderance from α-carbon branching. We were delighted to find a 20-fold improvement in RSV potency for <b>18j</b> relative to <b>4</b>. Moreover, the same prodrug on the 1′-ethynyl nucleoside, <b>19</b>, also substantially improved the antiviral activity by >30-fold compared to parent <b>9</b>, implying that the 1′-modified <i>C</i>-nucleosides, in general, have inefficient metabolism to the monophosphate precursor. Encouraged by the potency improvement of <b>18j</b>, the prodrug ester SAR was explored across a range of lipophilicity to identify the optimal ester prodrug. Ethyl ester <b>18a</b>, which also has a low log <i>D</i> but lacks α-branching, was less potent than <b>18j</b>, suggesting that the increased lipophilicity of the 2-ethylbutyl ester, as opposed to the lack of α-branching, was the main driver for the improved potency. In general, for esters that lacked α-branching, as lipophilicity was increased, e.g., <b>18c</b>, <b>18h</b>, <b>18i</b>, and <b>18j</b>, the RSV HEp-2 potency was improved by more than 10-fold compared to <b>4</b>. When α-branching was present, higher lipophilicity or strained small rings were required to improve the potency, e.g., cyclooctyl <b>18k</b> and cyclobutyl <b>18e</b>. Following the chiral separation of the <b>18j</b> isomers, the <i>S</i>p isomer <b>1</b> was found to be more potent than <b>1-</b><i><b>R</b></i><b>p</b>, resulting in an overall 35-fold improvement in potency relative to the parent <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The assignment of <i>S</i>p stereochemistry in <b>1</b> was later determined by solving the single-crystal X-ray structure and is consistent with the stereochemistry for tenofovir alafenamide and sofosbuvir <b>6</b>.<a onclick="showRef(event, 'ref7 ref35 ref51 ref54'); return false;" href="javascript:void(0);" class="ref ref7 ref35 ref51 ref54">(7,35,51,54)</a> The judicious choice of the ester moiety in generating optimal potency in the phosphoramidate analogues strongly suggests that the rate-limiting step in the prodrug breakdown is the initial ester cleavage, as described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Phosphordiamide prodrugs were also evaluated, e.g., <b>16a,b</b>, and found to be less potent than <b>1</b>. It is presumed that the metabolic process for the phosphordiamide prodrugs is analogous to the monoamidates, with initial ester cleavage of one amino acid ester, followed by cyclization onto the phosphorus and ejection of the other amino acid moiety (essentially acting as a surrogate of the phenol). Lipophilicity appeared equally important for optimal potency in the phosphordiamide analogues since the 2-ethylbutylalanine phosphordiamide <b>16b</b> was more potent than the corresponding ethyl ester analogue <b>16a</b>. This suggests that the intracellular esterases that initiate the prodrug breakdown may be the same for both the monoamidate and phosphordiamide prodrugs of <b>4</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Phosphate Prodrug Antiviral Activity in HEp-2 and NHBE Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd.</th><th class="colsep0 rowsep0" align="center">1′</th><th class="colsep0 rowsep0" align="center">alanine ester</th><th class="colsep0 rowsep0" align="center">RSV HEp-2 EC<sub>50</sub>/CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HEp-2 SI<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">RSV NHBE EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">log <i>D</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.53/>100</td><td class="colsep0 rowsep0" align="left">>189</td><td class="colsep0 rowsep0" align="left">1.85</td><td class="colsep0 rowsep0" align="left"><0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.15/8.7<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">6.48/>100<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>15</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">2-ethylbutyl</td><td class="colsep0 rowsep0" align="left">0.31/36</td><td class="colsep0 rowsep0" align="left">116</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">0.30/>73</td><td class="colsep0 rowsep0" align="left">>243</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><i>iso</i>-propyl (<i>S</i><sub>p</sub>)</td><td class="colsep0 rowsep0" align="left">0.36/>100</td><td class="colsep0 rowsep0" align="left">>277</td><td class="colsep0 rowsep0" align="left">2.50</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>cpropyl</td><td class="colsep0 rowsep0" align="left">0.044/50</td><td class="colsep0 rowsep0" align="left">1136</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left"><i>t</i>-butyl</td><td class="colsep0 rowsep0" align="left">4.50/>100</td><td class="colsep0 rowsep0" align="left">>22</td><td class="colsep0 rowsep0" align="left">>5.0</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18e</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">cbutyl</td><td class="colsep0 rowsep0" align="left">0.075/34</td><td class="colsep0 rowsep0" align="left">453</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18f</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">cpentyl</td><td class="colsep0 rowsep0" align="left">0.17/>80</td><td class="colsep0 rowsep0" align="left">471</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18g</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">3-pentyl</td><td class="colsep0 rowsep0" align="left">0.31/>100</td><td class="colsep0 rowsep0" align="left">323</td><td class="colsep0 rowsep0" align="left">>5.0</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18h</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>cbutyl</td><td class="colsep0 rowsep0" align="left">0.024/23</td><td class="colsep0 rowsep0" align="left">958</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18i</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">neopentyl</td><td class="colsep0 rowsep0" align="left">0.050/11</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18j</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">2-ethylbutyl</td><td class="colsep0 rowsep0" align="left">0.027/9.2</td><td class="colsep0 rowsep0" align="left">341</td><td class="colsep0 rowsep0" align="left">0.069</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">2-ethylbutyl (<i>S</i><sub>p</sub>)</td><td class="colsep0 rowsep0" align="left">0.015/6.1</td><td class="colsep0 rowsep0" align="left">407</td><td class="colsep0 rowsep0" align="left">0.049</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1-</b><i><b>R</b></i><sub><b>p</b></sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">2-ethylbutyl (<i>R</i><sub>p</sub>)</td><td class="colsep0 rowsep0" align="left">0.028/26</td><td class="colsep0 rowsep0" align="left">929</td><td class="colsep0 rowsep0" align="left">0.065</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18k</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">coctyl</td><td class="colsep0 rowsep0" align="left">0.028/48</td><td class="colsep0 rowsep0" align="left">1714</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">C≡CH</td><td class="colsep0 rowsep0" align="left">2-ethylbutyl</td><td class="colsep0 rowsep0" align="left">0.75/>100</td><td class="colsep0 rowsep0" align="left">>133</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">SI, selectivity index (CC<sub>50</sub>/EC<sub>50</sub>).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">96-well assay format.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Single undefined isomer. All data <i>n</i> ≥ 2 unless noted. All compounds are mixtures of <i>S</i><sub>p</sub> and <i>R</i><sub>p</sub> isomers unless noted otherwise. c, cyclo.</p></div></div></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed intracellular metabolism pathway of <b>1</b>. The prodrug is broken down via carboxyl ester hydrolysis, phenol ejection, and Hint1-mediated phosphorus–nitrogen bond cleavage to release the monophosphate metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With RSV as the target virus of interest, it was important to also ensure in vitro potency of the optimized prodrugs against RSV in a primary human lung epithelial cell line. To this end, RSV assays were developed in normal human bronchial epithelial cells (NHBEs) and human airway epithelial (HAE) cell cultures derived from human lung donor tissue.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Screening of the prodrugs in the NHBE cells established that the SAR trends were generally similar and the 2-ethylbutylalanine ester <b>1</b> was the most potent with 38-fold improved activity over parent <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Detection of secreted RSV in HAE culture supernatant further demonstrated that an ∼40-fold increase in the concentration of <b>4</b> is required to achieve a similar viral load drop as <b>1</b> and its diastereoisomer <b>1-</b><i><b>R</b></i><b>p</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The reduction in RSV levels in the HAE culture supernatants is comparable at all concentrations of <b>1</b> and <b>1-</b><i><b>R</b></i><b>p</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf" class="ext-link">Supporting Information</a>). Incubation of <b>1</b> and <b>1-</b><i><b>R</b></i><b>p</b>, at 0.25 μM in the HAE cells, resulted in a median viral load drop of 2.50 and 3.84 log<sub>10</sub>, respectively, when compared to that of <b>4</b>. The cumulative data in NHBE and HAE cells supported the potential of the phosphoramidate prodrug <b>1</b> to effectively inhibit RSV in lung cells in vivo.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. RSV viral loads in HAE cultures following a 3 day basolateral compartment treatment with <b>4</b>, <b>1</b>, <b>1-</b><i><b>R</b></i><b>p</b>, or the dimethyl sulfoxide (DMSO) control. A representative of two experiments is displayed. Presented are box and whisker plots of the median and interquartile ranges of six technical replicates for each treatment. <i>p</i> values were determined by the Mann–Whitney Student <i>t</i> test (unpaired nonparametric). LOQ is the limit of quantitation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vitro metabolism studies were conducted to assess intracellular <b>1</b>-<b>NTP</b> formation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) in HEp-2 cells, NHBE cells, and HAE cultures to confirm that the antiviral potency was correlated with <b>1-NTP</b> formation. In HEp-2 cells, the <b>1</b>-<b>NTP</b> levels increased in proportion with the increase in the incubation concentration from 1 to 10 μM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, panel A). The single diastereoisomer <b>1</b> and its isomeric mixture <b>18j</b> yielded similar levels of <b>1</b>-<b>NTP</b>, although it was marginally lower for <b>18j</b> at the elevated incubation concentration. The <i>iso</i>-propyl prodrug <b>18b</b> was also tested at the high concentration in HEp-2 cells and found to generate low levels of <b>1-NTP</b> consistent with its weaker antiviral activity (data not shown). The average <b>1</b>-<b>NTP</b> levels from continuous incubations of <b>1</b> and parent <b>4</b> at 1 μM over 48 h (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, panels A–C) were calculated for each cell type and are shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. In all cases, higher concentrations of <b>1</b>-<b>NTP</b> were generated from <b>1</b> consistent with its improved antiviral activity in these cells relative to <b>4</b>. Taken together, these data confirm that <b>4</b> has slow and inefficient metabolism in a variety of human cell types, including primary lung epithelial cells, and the phosphoramidate prodrug <b>1</b> effectively bypasses this metabolic limitation to generate high concentrations of <b>1</b>-<b>NTP</b> and improve potency.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Intracellular metabolism of <b>4</b> (red), <b>1</b> (black), and diastereomeric mixture <b>18j</b> (blue) to the active metabolite <b>1-NTP</b>. (A) HEp-2 cells with continuous incubation at 1 and 10 μM. (B) NHBE cells with continuous incubation and a 2 h pulse incubation at 1 μM. (C) HAE culture, two donors with continuous incubation at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro RSV Antiviral Activity and Metabolism</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>cpd</b>.</th><th class="colsep0 rowsep0" align="center"><b>cell</b></th><th class="colsep0 rowsep0" align="center" char="."><b>RSV EC</b><sub><b>50</b></sub><b>(μM)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>avg. [1-NTP]</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><b>pmol/10</b><sup><b>6</b></sup><b>cells</b></th><th class="colsep0 rowsep0" align="center" char="."><b>intracellular IC</b><sub><b>50</b></sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><b>(μM)</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">HEp-2</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">22.0</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NHBE</td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="char" char=".">20.5</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HAE</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6.54</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">HEp-2</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NHBE</td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HAE</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Average <b>1</b>-<b>NTP</b> concentrations following a continuous 1 μM incubation over 48 h.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Estimated <b>1-NTP</b> concentrations in cells at EC<sub>50</sub> concentrations (intracellular IC<sub>50</sub>) calculated using average cell volumes of 3 pL/cell (HEp-2) and 7 pL/cell (NHBE).</p></div></div></div><div class="NLM_p">The intracellular <b>1</b>-<b>NTP</b> assessment can also be used to estimate the average intracellular concentration of <b>1</b>-<b>NTP</b> that is present in cells when 50% of the virus replication is inhibited (intracellular IC<sub>50</sub>) effectively mirroring the biochemical IC<sub>50</sub> experiment. The calculated intracellular IC<sub>50</sub> from the average concentration of <b>1</b>-<b>NTP</b> is reported in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and results in an RSV RdRp intracellular IC<sub>50</sub> ranging from 0.11 to 0.35 μM, several fold more potent than the biochemical assay IC<sub>50</sub> reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> but within a comparable range.</div><div class="NLM_p">In vivo, <b>1</b> was expected to be rapidly cleared from systemic circulation due to the abundance of hepatic esterases that would result in rapid hepatic clearance. The human pharmacokinetics for <b>1</b> following intravenous injection have since confirmed a rapid clearance of the prodrug.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The plasma <i>C</i><sub>max</sub> of <b>1</b> following the 75 mg human dose delivered by IV over 30 min was approximately 5 μM and fell rapidly, in the first 1 h, to below 1 μM. To reflect the reduced exposure of <b>1</b> in vivo, a 2 h pulse incubation (drug-containing media replaced with fresh incubation media) was conducted in NHBE cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Following media replacement, concentrations of <b>1</b>-<b>NTP</b> derived from <b>1</b> remained higher than those from <b>4</b> over the 48 hour incubation due to the long intracellular half-life of the <b>1</b>-<b>NTP</b> metabolite. High antiviral potency coupled with the in vitro metabolism data in primary lung cells supported the progression of <b>1</b> into in vivo studies.</div><div class="NLM_p">To the best of our knowledge, at the time of these studies, no data existed that demonstrated the ability of phosphoramidate nucleoside prodrugs to effectively produce nucleoside triphosphate within lung tissues from exposure in the central compartment. The mechanism of breakdown for the phosphoramidate prodrug described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> is proposed to begin with an esterase cleavage mediated by cathepsin A or carboxyesterases. This metabolic process is very efficient in hepatocytes due to the high expression of esterases, and therefore the application of the phosphoramidate approach for distributing the compound to HCV-infected hepatocytes is well aligned for the HCV phosphoramidates <b>5</b> and <b>6</b>. In contrast, the in vivo distribution of the nucleoside triphosphate <b>1-NTP</b> into lung tissues would presumably depend upon the rate of absorption and metabolism in lung cells compared to those in hepatocytes and other tissues. To assess the metabolism and distribution of <b>1</b> into lung cells from the central compartment, nonhuman primates were used as the model since the plasma half-life of <b>1</b> in rodents is very short (<1 min) due to abundant plasma carboxylesterases. Oral dosing of <b>1</b> in cynomolgus monkey demonstrated a low oral bioavailability (<1%) due to high intestinal and first-pass hepatic extraction of <b>1</b> (data not shown). Therefore, we dosed <b>1</b> by intravenous (IV) administration to demonstrate that <b>1</b> could (i) generate the active anabolite <b>1-NTP</b> in lung tissue from exposure in the central compartment; (ii) deliver higher concentrations of <b>1</b>-<b>NTP</b> in lungs than that of parent <b>4</b>, and (iii) confer antiviral efficacy in vivo toward RSV to confirm active metabolite formation in epithelial cells that harbor replicating RSV virus. The plasma pharmacokinetics in cynomolgus and AGM following a 30 min IV dosing of 10 mg/kg of <b>1</b> and 20 mg/kg of <b>4</b> (cynomolgus only) are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. The plasma <i>C</i><sub>max</sub> and exposure of <b>1</b> in both AGM and cynomolgus monkey were comparable, and the plasma half-life was less than 1 h in both species consistent with the human pharmacokinetics.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The breakdown of prodrug <b>1</b> in the plasma and tissue also resulted in plasma exposures of parent <b>4</b> that were comparable in both species.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo plasma and lung pharmacokinetics of <b>1</b> and <b>4</b> following a 30 min IV infusion administration at 10 and 20 mg/kg, respectively. (A) African Green monkey and Cynomolgus monkey plasma pharmacokinetics. (B) Respiratory tissue <b>1</b>-<b>NTP</b> concentrations at 24 h post initiation of IV infusion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Plasma and Tissue Pharmacokinetics in Nonhuman Primates Following 30 min IV Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">AGM</th><th class="colsep0 rowsep0" align="center">cyno</th><th class="colsep0 rowsep0" align="center">cyno</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">compound</td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">IV dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Prodrug 1</td><td class="colsep0 rowsep0" align="left">CL (L/h/kg)</td><td class="colsep0 rowsep0" align="left">2.13</td><td class="colsep0 rowsep0" align="left">1.92</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">22.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub> (μM·h)</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Parent 4</td><td class="colsep0 rowsep0" align="left">CL (L/h/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">79.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub> (μM·h)</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1-NTP<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (nmol/g)</td><td class="colsep0 rowsep0" align="left">PBMC (μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">7.54</td><td class="colsep0 rowsep0" align="left">32.2</td><td class="colsep0 rowsep0" align="left">8.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">1.39</td><td class="colsep0 rowsep0" align="left">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">lower bronchi</td><td class="colsep0 rowsep0" align="left">1.12</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mainstem bronchi</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">trachea</td><td class="colsep0 rowsep0" align="left">0.54</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">all metabolites<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> (nmol/g)</td><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">17.3</td><td class="colsep0 rowsep0" align="left">18.4</td><td class="colsep0 rowsep0" align="left">2.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">39.8</td><td class="colsep0 rowsep0" align="left">65.7</td><td class="colsep0 rowsep0" align="left">3.44</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last"><b>1-NTP</b> levels in PBMC and respiratory tissues (lung, bronchi, trachea) collected at 24 h following initiation of intravenous infusion, reported as nmol/g of tissues.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">PBMC intracellular concentration of <b>1-NTP</b> reported using a 0.2 pL/cell volume conversion.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Total nucleos(t)ide metabolite levels in liver and kidney tissues collected at 24 h represent the sum of <b>4</b>, mono- and diphosphates of <b>4</b>, and <b>1-NTP</b> species for each tissue. Parameters: clearance (CL; L/h/kg); volume of distribution at steady state (<i>V</i><sub>ss</sub>; L/kg); terminal half-life (<i>T</i><sub>1/2</sub>; h); maximum concentration (<i>C</i><sub>max</sub>; μM); and area under the concentration–time curve from time 0 to infinity (AUC<sub>inf</sub>; μM·h).</p></div></div></div><div class="NLM_p">Tissues from different parts of the lower respiratory tract, including the trachea, mainstem bronchus, lower bronchi, and lung, were collected at 24 h following dosing and analyzed for the <b>1</b>-<b>NTP</b> content (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). In cynomolgus monkey, the <b>1</b>-<b>NTP</b> levels generated from prodrug <b>1</b>, relative to parent <b>4</b>, were several fold higher in the lung and trachea and comparable in the bronchi tissues, despite the lower dose. Normalizing the molar doses of <b>1</b> and <b>4</b> resulted in prodrug <b>1</b> delivering <b>1-NTP</b> 15-fold more efficiently into the lung tissue of cynomolgus monkey than <b>4</b> and 4-fold more efficiently in the lower bronchi. An estimate of the <b>1</b>-<b>NTP</b> lung tissue concentration at 24 h post infusion is ∼3 μM, approximately 10-fold higher than the estimated intracellular IC<sub>50</sub> against RSV, suggesting that a 10 mg/kg daily IV infusion in nonhuman primate models of RSV has the potential to be efficacious. In AGM, the <b>1-NTP</b> levels following dosing of <b>1</b> were slightly lower in the lungs leading to an estimated 11-fold improved efficiency compared to <b>4</b> (using the cynomolgus monkey data for <b>4</b>) and comparable or superior in other respiratory tissues. Taken together, these data suggest that over a 24 h dosing interval, the prodrug <b>1</b> can more effectively generate <b>1-NTP</b> in the lower respiratory tract tissues than <b>4</b> despite its relatively short plasma half-life and that a broad distribution of <b>1-NTP</b> across different sections of the lower lung is maintained.</div><div class="NLM_p">Reliable methods to measure the anabolite <b>1-NTP</b> levels within specific cell types of the collected lung tissues are currently unavailable and hampered by the potential for <b>1</b>-<b>NTP</b> to decompose during sample preparation. Therefore, to indirectly demonstrate the effective loading of <b>1</b>-<b>NTP</b> into cells where the RSV virus predominantly replicates (e.g., ciliated cells and alveolar pneumocytes), we chose to examine the effect of <b>1</b> in an AGM model of RSV. Nucleoside <b>3</b> was reported to have efficacy in this model when administered prophylactically and later also demonstrated efficacy in a human challenge treatment study confirming the translational value of this model for human RSV infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> A similar experiment to that reported for <b>3</b> was conducted using IV administration of 10 mg/kg <b>1</b>, initiated 4 h prior to RSV infection, with additional doses delivered daily at 24, 48, 72, 96, and 120 h post infection (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Bronchoalveolar lavage (BAL) samples and nasopharyngeal swabs were collected every other day beginning at day 1 post infection until day 15. On the days when the active drug was administered, the BAL and nasal sampling were performed prior to dosing and viral loads were assessed by RT-qPCR. Relative to vehicle control, a significant drop of >2-log in BAL peak viral load was observed in the treatment animals during the dosing period. A rebound in the BAL viral load was observed in the 4–5 days following cessation of dosing, and then the virus was cleared through day 15 in both the vehicle and treatment arms at a similar rate. In the nasopharyngeal swab samples, a similar decrease in nasal viral load was observed. These results demonstrated that <b>1</b> significantly reduces RSV replication in the lung lavage samples (>99%) and the upper airway supporting the generation of <b>1</b>-<b>NTP</b> in the ciliated and alveolar lung cells where RSV replicates.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy in RSV A2-infected African Green monkeys following 30 min IV infusion of <b>1</b> (green crosses) compared to vehicle (black circles) beginning at −4 h relative to RSV challenge, followed by daily dosing initiated at 24 h post inoculation for five doses. (A) Study outline. (B) Viral load assessed by the real-time quantitative polymerase chain reaction (RT-qPCR) RT-qPCR in bronchoalveolar (BAL) fluid samples. (C) Viral load assessed by RT-qPCR in nasopharyngeal (NP) swabs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Intravenous dosing was a suitable delivery method of <b>1</b> for Ebola treatment in the clinic due to the gastrointestinal complications in Ebola patients and their inpatient status. For respiratory infections, a more convenient route of delivery is highly desirable, especially for treatment in the outpatient setting. In parallel to the clinical program investigating IV administration of <b>1</b> for COVID-19 treatment, research into subcutaneous injection and inhaled administration of <b>1</b> has led to the clinical development of an inhaled product. The potent anti-RSV activity of <b>1</b>, together with the different formulation options, will allow for the future clinical investigation of <b>1</b> toward RSV infection and other respiratory viruses in vulnerable patient populations.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Phenotypic screening efforts toward RSV resulted in the identification of lead <b>4</b>, a 1′-CN adenine <i>C</i>-nucleoside as a submicromolar inhibitor of RSV. SAR studies evaluating the RSV activity of alternative 1′-modifications confirmed that the 1′-CN modification was optimal for potency and selectivity toward RSV leading to a prodrug campaign aimed at improving the cell-based potency and drug-like properties of <b>4</b>. The phosphoramidate prodrug <b>1</b> was discovered to have a 35-fold improved potency toward RSV in HEp-2 cells and 32- to 40-fold improved potency in NHBE and HAE cultures compared to <b>4</b>, suggesting that the parent has slow and inefficient metabolism in primary human lung cells. Intracellular metabolism analyses across primary human lung cell lines established the rapid generation of high concentrations of the active anabolite <b>1</b>-<b>NTP</b> from prodrug <b>1</b>, relative to incubation with <b>4</b>. In AGM and cynomolgus monkeys, despite the short plasma half-life of <b>1</b>, the active <b>1</b>-<b>NTP</b> was generated in lung tissues 11- and 15-fold more efficiently than from the administration of <b>4</b>, respectively. Generation of <b>1</b>-<b>NTP</b> in virally infected lung cells was then demonstrated indirectly in an AGM model of RSV where prophylactic IV administration of <b>1</b> resulted in the inhibition of virus replication in the lung and nasal tissues. These early data were later supported by additional animal studies demonstrating the effectiveness of IV administration of <b>1</b> in models of Nipah and coronaviruses including SARS-CoV-2 using prophylactic- and treatment-based regimens.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40−44)</a> It has therefore been well established that phosphoramidate prodrugs can effectively produce monophosphate nucleotide metabolites within lung tissues, which can then be metabolized to the NTPs to generate antiviral responses. Prodrug <b>1</b>, discovered for the respiratory pathogen RSV, and approved for the treatment of SARS-CoV-2 in hospitalized patients, illustrates the importance of continued research into nucleotide respiratory antivirals in the fight against known and emerging respiratory viruses.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All organic compounds were synthesized at Gilead Sciences, Inc. (Foster City, CA) unless otherwise noted. Commercially available solvents and reagents were used as received without further purification. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 300 MHz or Varian Mercury Plus 400 MHz at room temperature (rt), with tetramethylsilane as an internal standard. Proton nuclear magnetic resonance spectra are reported in parts per million (ppm) on the δ scale and are referenced from the residual protium in the NMR solvent (CHCl<sub>3</sub>-<i>d</i><sub>1</sub>: δ 7.26, MeOH-<i>d</i><sub>4</sub>: δ 3.31, DMSO-<i>d</i><sub>6</sub>: δ 2.50, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>: δ 1.93). Data is reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sep = septet, m = multiplet, br = broad, app = apparent)], coupling constants (<i>J</i>) in Hertz, integration. Phosphorus-31 nuclear magnetic resonance spectra are reported in parts per million on the δ scale. Data is reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), integration. No special nomenclature is used for equivalent phosphorus resonances. LCMS (A) was conducted on a Thermo Finnigan MSQ Std. using electrospray positive and negative [M + 1]<sup>+</sup> and [M – 1]<sup>−</sup> with a Dionex Summit HPLC System (model: P680A HPG) equipped with a Gemini 5 μ C18 110 Å column (30 mm × 4.60 mm), eluting with 0.05% formic acid in 1% CH<sub>3</sub>CN/water (Buffer A) and 0.05% formic acid in 99% CH<sub>3</sub>CN/water (Buffer B); gradient 5–100% Buffer B in Buffer A over 2.5 min and then 100% buffer B for 0.9 min at 2 mL/min. LCMS (B) was conducted on a Thermo LCQ Advantage equipped with a Phenomenex Gemini, C18, 5 μ, 110 Å column (30 mm × 4.6 mm) eluting with 0.1% acetic acid in water (Buffer A) and 0.1% acetic acid in CH<sub>3</sub>CN (Buffer B); gradient 5–100% Buffer B in Buffer A over 2.5 min and then 100% buffer B for 0.9 min at 2 mL/min. LCMS (C) was conducted on a Thermo LCQ Fleet with a Thermo Accela 1250 UHPLC equipped with a Phenomenex Kinetex 2.6 μm XB-C18 110 Å column (50 mm × 3.0 mm) eluting with 0.1% formic acid in water (Buffer A) and 0.1% formic acid in CH<sub>3</sub>CN (Buffer B); gradient 0–1.8 min 2–100% buffer B, 1.8–1.85 min 100–2% buffer B and then 1.85–2.00 min 2% CH<sub>3</sub>CN at 1.8 mL/min. Analytical thin-layer chromatography was performed using Merck KGaA Silica gel 60 F<sub>254</sub> glass plates with UV visualization. Preparative normal phase silica gel chromatography was carried out using a Teledyne ISCO CombiFlash Companion instrument with silica gel cartridges. Purities of the final compounds were determined by high-performance liquid chromatography (HPLC) and were greater than 95% unless otherwise noted. HPLC purity was determined on an Agilent 1100 Series HPLC equipped with a Phenomenex Kinetex C<sub>18</sub>, 2.6 μm 100 Å column (100 mm × 4.6 mm) eluting with a 2–98% gradient of 0.1% trifluoroacetic acid in water and 0.1% trifluoroacetic acid in CH<sub>3</sub>CN at a flow rate of 1.5 mL/min. Preparative HPLC was conducted on a Phenomenex Synergi 4 μm Hydro-RR 80 Å column (150 mm × 30 mm) eluting with water and CH<sub>3</sub>CN.</div><div class="NLM_p">Compounds <b>1</b>, <b>1-</b><i><b>R</b></i><b>p, 4</b>, <b>7–10</b>, <b>16a–b</b>, <b>17</b>, <b>18a–b</b>, <b>18d–g</b>, <b>18i–j</b>, and <b>19</b> have been synthesized previously.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(Acetoxymethyl)-2-(4-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-2-cyanotetrahydrofuran-3,4-diyl Diacetate (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> (36 mg, 86% yield) was prepared in a similar manner to <b>13</b> except acetic acid (29 μL, 0.50 mmol) was used instead of <i>iso</i>-butyric acid. <sup>1</sup>H NMR (300 MHz, CHCl<sub>3</sub>-<i>d</i><sub>3</sub>) δ 11.15 (bs, 1H), 8.08 (bs, 1H), 7.97 (s, 1H), 7.35 (m, 1H), 7.12 (d, <i>J</i> = 4.8 Hz, 1H), 6.06 (d, <i>J</i> = 5.7 Hz, 1H), 5.40 (t, <i>J</i> = 6.0 Hz, 1H), 4.67 (m, 1H), 4.48–4.32 (m, 2H), 2.20 (s, 3H), 2.17 (s, 3H), 2.09 (s, 3H). LCMS (B) <i>m</i>/<i>z</i> = 418.0 [M + H], 416.0 [M – H].</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-2-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-2-cyano-5-((propionyloxy)methyl)tetrahydrofuran-3,4-diyl Dipropionate (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> (44 mg, 95% yield) was prepared in a similar manner as <b>13</b> except propionic acid (37 μL, 0.50 mmol) was used instead of <i>iso</i>-butyric acid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.04 (s, 1H), 7.23 (d, <i>J</i> = 4.7 Hz, 1H), 7.03 (d, <i>J</i> = 4.7 Hz, 1H), 6.20 (d, <i>J</i> = 5.7 Hz, 1H), 5.51 (dd, <i>J</i> = 5.7, 4.6 Hz, 1H), 4.67 (td, <i>J</i> = 4.5, 3.5 Hz, 1H), 4.49 (dd, <i>J</i> = 12.3, 3.6 Hz, 1H), 4.38 (dd, <i>J</i> = 12.3, 4.6 Hz, 1H), 2.56–2.40 (m, 4H), 2.36 (qd, <i>J</i> = 7.6, 5.1 Hz, 2H), 1.30–1.06 (m, 9H). LCMS (B) <i>m</i>/<i>z</i> = 460.2 [M + H].</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-2-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-2-cyano-5-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl Bis(2-methylpropanoate) (<b>13</b>)</h3><div class="NLM_p last">Compound <b>4</b> (29 mg, 0.1 mmol) was dissolved in anhydrous DMF (1 mL). <i>Iso</i>-butyric acid (46 μL, 0.5 mmol) was added in one portion and then <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (78 μL, 0.5 mmol) was added dropwise. The reaction mixture was stirred for 15 min and then 4-(dimethylamino)pyridine (12.2 mg, 0.1 mmol) was added. The reaction mixture was stirred for 16 h, diluted with CH<sub>3</sub>CN (1 mL), and the solids were removed by filtration. The filtrate was subjected to preparative HPLC (0–95% CH<sub>3</sub>CN in water) to afford <b>13</b> (48 mg, 95% yield) as a white powder. <sup>1</sup>H NMR (300 MHz, CHCl<sub>3</sub>-<i>d</i><sub>3</sub>) δ 11.15 (bs, 1H), 8.27 (bs, 1H), 7.95 (s, 1H), 7.32 (m, 1H), 7.07 (m, 1H), 6.05 (d, <i>J</i> = 6.0 Hz, 1H), 5.44 (t, <i>J</i> = 5.1 Hz, 1H), 4.66 (t, <i>J</i> = 3.6 Hz, 1H), 4.32 (m, 2H), 2.73–2.52 (m, 3H), 1.27–1.14 (m, 18H). LCMS (B) <i>m</i>/<i>z</i> = 502.2 [M + H], 500.1 [M – H].</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> ((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl <span class="smallcaps smallerCapital">l</span>-Valinate (<b>14</b>)</h3><div class="NLM_p last">Compound <b>4</b> (50 mg, 0.17 mmol) and (<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valine (55 mg, 0.56 mmol) were dissolved in anhydrous DMF (2 mL). <i>N</i>,<i>N</i>′-Diisopropylcarbodiimide (40 μL, 0.26 mmol) was added, and the mixture was stirred for 15 min followed by the addition of (2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(4-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile (50 mg, 0.17 mmol) and Et<sub>3</sub>N (47 μL, 0.34 mmol). The resulting mixture was stirred for 16 h and additional (<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-valine (55 mg, 0.56 mmol) and <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (40 μL, 0.25 mmol) were added. The mixture was stirred for another 5 h at rt and then heated at 50 °C for 3 h and then stirred for 72 h at rt. The mixture was diluted with EtOAc and washed with saturated NaHCO<sub>3</sub> and saturated brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and subjected to silica gel chromatography eluting with EtOAc in hexanes (0–70%). The resultant product was then subjected to reverse-phase HPLC. The isolated compound was dissolved in 20% TFA in CH<sub>2</sub>Cl<sub>2</sub>, and the mixture was stirred for 30 min. The mixture was then concentrated under reduced pressure and subjected to preparative HPLC (0–95% CH<sub>3</sub>CN in water) to afford <b>14</b> (16 mg, 24%) in 91% purity. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.92 (s, 1H), 7.05 (s, 2H), 5.57 (dd, <i>J</i> = 5.8, 2.3 Hz, 1H), 5.31 (d, <i>J</i> = 5.8 Hz, 1H), 4.49 (q, <i>J</i> = 3.0 Hz, 1H), 4.18–4.04 (m, 1H), 3.93–3.77 (m, 2H), 2.53 (qd, <i>J</i> = 7.0, 4.5 Hz, 1H), 1.16 (dd, <i>J</i> = 7.0, 4.9 Hz, 6H). LCMS (B) <i>m</i>/<i>z</i> = 391.2 [M + 1].</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>S</i>,<i>S</i>′-2,2′-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[1,2-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)phosphoryl)bis(oxy)bis(ethane-2,1-diyl) Bis(2,2-dimethylpropanethioate) (<b>15</b>)</h3><div class="NLM_p last">Compound <b>4</b> (28 mg, 0.096 mmol) was dissolved in trimethylphosphate (1 mL). The reaction was stirred under N<sub>2</sub> (g) and then treated with 1<i>H</i>-tetrazole (21 mg, 0.29 mmol). The reaction mixture was cooled to 0 °C, and phosphorane<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (87 mg, 0.192 mmol) was added. The reaction was stirred for 2 h and then quenched with 30% hydrogen peroxide (0.120 mL). The mixture was stirred for 30 min at rt and then treated with saturated aqueous sodium thiosulfate (1 mL). The mixture was stirred for 10 min and then concentrated under reduced pressure. The residue was subjected to preparative HPLC (0–95% CH<sub>3</sub>CN in water) to isolate <b>15</b> (5.3 mg, 8.3%). <sup>1</sup>H NMR (300 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ 7.98 (s, 1H), 6.92 (d, 1H), 6.81 (d, 1H), 6.44 (bs, 2H), 4.82 (m, 2H), 4.47 (m, 1H), 4.24 (m, 2H), 4.00 (m, 4H), 3.80 (bs, 1H), 3.11 (m, 4H), 1.24 (s, 9H). <sup>31</sup>P NMR (121.4 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ -1.85 (s). LCMS (B) <i>m</i>/<i>z</i> 661 [M + H].</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cyclopropylmethyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>18c</b>)</h3><div class="NLM_p last">(<i>S</i>)-1-(Cyclopropylmethoxy)-1-oxopropan-2-amine hydrochloride (1.0 g, 5.57 mmol) was dried by coevaporation with CH<sub>2</sub>Cl<sub>2</sub> and then stored under reduced pressure overnight. The aminium chloride was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), cooled to −78 °C, and treated with phenyl dichlorophosphate (0.83 mL, 5.57 mmol). Et<sub>3</sub>N (1.54 mL, 11.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was added over 30 min at −78 °C. The resultant mixture was stirred for 30 min at −78 °C and then 4-nitrophenol (774 mg, 5.57 mmol) was added in one portion. Et<sub>3</sub>N (0.77 mL, 7.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added over 30 min at −78 °C. The resulting mixture was stirred for 30 min at −78 °C, washed with water, sat Na<sub>2</sub>CO<sub>3</sub> solution, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (0–20% EtOAc in hexanes) to yield cyclopropylmethyl((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate as a diastereomeric mixture (1.1 g, 47%). <sup>1</sup>H NMR (400 MHz, CHCl<sub>3</sub>-<i>d</i><sub>3</sub>) δ 8.22 (m, 2H), 7.58–7.29 (m, 4H), 7.32–7.14 (m, 3H), 4.25–4.07 (m, 1H), 4.07–3.80 (m, 3H), 1.44 (d, <i>J</i> = 2.9 Hz, 1.5H), 1.42 (d, <i>J</i> = 2.9 Hz, 1.5H), 1.26–1.01 (m, 1H), 0.66–0.49 (m, 2H), 0.42–0.15 (m, 2H). <sup>31</sup>P NMR (162 MHz, CHCl<sub>3</sub>-<i>d</i><sub>3</sub>) δ −3.07, −3.11. LCMS (C) <i>m</i>/<i>z</i> = 420.97 [M + 1]. A mixture of <b>4</b> (60 mg, 0.21 mmol), cyclopropylmethyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (120 mg, 0.29 mmol), and MgCl<sub>2</sub> (29 mg, 0.31 mmol) in DMF (4 mL) was treated dropwise with <i>N,N</i>-diisopropylethylamine (0.09 mL, 0.52 mmol) at rt. The resulting mixture was stirred at 50 °C for 1 h, concentrated under reduced pressure to ∼2 mL, and then subjected to preparative HPLC (0–70% CH<sub>3</sub>CN in water) to afford <b>18c</b> (45 mg, 38%, 1:1.9 isomeric mixture) as a white solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.85 (m, 1H), 7.28 (m, 2H), 7.24–7.10 (m, 3H), 6.99–6.80 (m, 2H), 4.79 (m, 1H), 4.50–4.23 (m, 3H), 4.25–4.13 (m, 1H), 3.97–3.74 (m, 3H), 1.26 (m, 3H), 1.08 (m, 1H), 0.50 (m, 2H), 0.24 (m, 2H). <sup>31</sup>P NMR (162 MHz, MeOH-<i>d</i><sub>4</sub>) δ 3.74 (s, 0.67P), 3.62 (s, 0.33P). LCMS (C) <i>m</i>/<i>z</i> = 573.02 [M + 1].</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cyclobutylmethyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>18h</b>)</h3><div class="NLM_p last">A solution of dichlorophosphoryloxybenzene (300 mg, 1.42 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) under an atmosphere of argon was treated with cyclobutylmethyl <span class="smallcaps smallerCapital">l</span>-alaninate hydrochloride (275 mg, 1.42 mmol) at −78 °C. <i>N</i>,<i>N</i>-Diisopropylethylamine (0.50 mL, 2.84 mmol) was added slowly over 5 min, and the reaction mixture was stirred for 15 min before warming to 0 °C. After 1 h, 2,3,4,5,6-pentafluorophenol (262 mg, 1.42 mmol) was added followed by <i>N</i>,<i>N</i>-diisopropylethylamine (0.25 mL, 1.42 mmol) and the mixture was stirred for 15 min. The reaction was stirred, allowed to warm to rt for 30 min, and then acidified with acetic acid (5 mL). The reaction mixture was washed with water (50 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (0–20% ethyl acetate in hexanes) to afford cyclobutylmethyl ((perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (616 mg, 61%) as a diastereomeric mixture. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45–7.38 (m, 2H), 7.31–7.19 (m, 3H), 6.99–6.89 (m, 1H), 4.05–3.95 (m, 3H), 2.00–1.68 (m, 7H), 1.33–1.27 (m, 3H). <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.64–0.39 (m). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −154.02 to −154.46 (m, 3F), −160.62 to −161.05 (m, 2F), −163.39 to −163.79 (m, 3F). LCMS (C) <i>m</i>/<i>z</i> = 480.8 [M + 1]. Cyclobutylmethyl ((perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (0.207 g, 0.43 mmol), <b>17</b>, and magnesium chloride (0.043 g, 0.45 mmol) were combined in acetonitrile (5 mL) and heated in a sealed vessel at 50 °C for 15 min. <i>N</i>,<i>N</i>-Diisopropylethylamine (0.20 mL, 1.13 mmol) was added, and the reaction mixture was heated for 2 h. The mixture was allowed to cool and then diluted with EtOAc (10 mL). The organic layer was washed with water, brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was dissolved in a 2:1 mixture of THF and conc. HCl (10 mL) and stirred for 4 h. The reaction mixture was neutralized with a saturated aq. solution of sodium bicarbonate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography eluting with 0–60% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford <b>18h</b> (95 mg, 42% yield). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.86–7.84 (m, 1H), 7.32–7.25 (m, 2H), 7.20–7.11 (m, 3H), 6.92–6.86 (m, 2H), 4.79 (d, <i>J</i> = 5.5 Hz, 1H), 4.45–4.34 (m, 2H), 4.33–4.26 (m, 1H), 4.22–4.16 (m, 1H), 4.08–3.93 (m, 2H), 3.91–3.79 (m, 1H), 2.63–2.53 (m, 1H), 2.08–1.68 (m, 6H), 1.32–1.22 (m, 3H). <sup>31</sup>P NMR (162 MHz, MeOH-<i>d</i><sub>4</sub>) δ 3.74–3.70 (m, 0.67P), 3.65–3.61 (m, 0.33P). LCMS (C) <i>m</i>/<i>z</i> = 587.3 [M + 1].</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cyclooctyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>18k</b>)</h3><div class="NLM_p last">A solution of cyclooctyl <span class="smallcaps smallerCapital">l</span>-alaninate hydrochloride (18.69 g, 79.28 mmol) and phenyl dichlorophosphate (11.8 mL, 79.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (300 mL) was treated with Et<sub>3</sub>N (23 mL, 166.48 mmol) at 0 °C under N<sub>2</sub> (g). After 5 min, 4-nitrophenol (10.48 g, 75.31 mmol) and Et<sub>3</sub>N (11.5 mL, 79.28 mmol) were added and the stirred mixture was allowed to warm to rt. After 1 h, the reaction mixture was diluted with Et<sub>2</sub>O and the solids were collected by filtration and washed with Et<sub>2</sub>O. The filtrate was concentrated under reduced pressure, and the crude residue was subjected to silica gel column chromatography (0–20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford cyclooctyl((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (25.8 g, 68%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ 8.26 (dd, <i>J</i> = 9.1, 1.7 Hz, 2H), 7.49–7.35 (m, 4H), 7.34–7.18 (m, 3H), 4.95–4.81 (m, 1H), 4.66 (ddd, <i>J</i> = 12.7, 10.1, 7.2 Hz, 1H), 4.10–3.96 (m, 1H), 1.79–1.43 (m, 14H), 1.31 (dd, <i>J</i> = 7.1, 4.5 Hz, 3H). <sup>31</sup>P NMR (162 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ −2.07, −2.21. LCMS (C) <i>m</i>/<i>z</i> = 476.69 [M + H]. A mixture of <b>17</b> (0.50 g, 1.51 mmol) and cyclooctyl((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (0.83 g, 1.74 mmol) in anhydrous THF (8 mL) was treated with magnesium chloride (0.58 g, 6.04 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.78 g, 6.04 mmol). The reaction mixture was stirred at 50 °C for 3 h and then concentrated under reduced pressure. The residue was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated sodium chloride solution, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was subjected to silica gel column chromatography (0–20% of (50% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) in CH<sub>2</sub>Cl<sub>2</sub>) to afford cyclooctyl ((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(4-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-6-cyano-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (0.823 g, 81%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ 7.93 (d, <i>J</i> = 1.9 Hz, 1H), 7.31 (q, <i>J</i> = 8.0 Hz, 2H), 7.21–7.00 (m, 3H), 6.90 (dd, <i>J</i> = 6.3, 4.6 Hz, 1H), 6.79 (dd, <i>J</i> = 7.5, 4.6 Hz, 1H), 6.46 (s, 2H), 5.32 (d, <i>J</i> = 6.5 Hz, 1H), 5.14 (d, <i>J</i> = 6.5 Hz, 1H), 5.00–4.77 (m, 2H), 4.60 (dd, <i>J</i> = 16.2, 4.1 Hz, 1H), 4.36–4.17 (m, 2H), 3.90–3.61 (m, 1H), 1.70 (t, <i>J</i> = 4.7 Hz, 8H), 1.58–1.42 (m, 6H), 1.39 (d, <i>J</i> = 11.1 Hz, 6H), 1.22 (ddd, <i>J</i> = 12.5, 7.1, 1.0 Hz, 3H). <sup>31</sup>P NMR (162 MHz, CH<sub>3</sub>CN-<i>d</i><sub>3</sub>) δ 2.97, 2.78. LCMS (C) <i>m</i>/<i>z</i> = 669.06 [M + H]. The mixture of cyclooctyl ((((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(4-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-6-cyano-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (0.82 g, 1.23 mmol) in CH<sub>3</sub>CN (10 mL) at 0 °C was treated with conc. HCl (0.7 mL, 19.2 mmol) and stirred at rt for 1 h. The mixture was cooled in an ice bath and then diluted with water before neutralization by the addition of 2 N NaOH. The mixture was extracted with EtOAc (2 × 20 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was subjected to preparative HPLC (15–85% CH<sub>3</sub>CN in water) to afford an ∼1:1 diastereomeric mixture of <b>18k</b> (0.59 g, 76%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 1.6 Hz, 1H), 7.31 (q, <i>J</i> = 8.0 Hz, 2H), 7.21–7.06 (m, 3H), 6.92–6.74 (m, 2H), 6.27 (dd, <i>J</i> = 11.6, 6.1 Hz, 1H), 5.94 (dt, <i>J</i> = 13.0, 9.7 Hz, 1H), 5.34 (dd, <i>J</i> = 7.9, 5.7 Hz, 1H), 4.74 (dd, <i>J</i> = 8.0, 4.2 Hz, 1H), 4.67–4.57 (m, 1H), 4.31–4.18 (m, 2H), 4.17–4.00 (m, 1H), 3.93 (dd, <i>J</i> = 10.7, 5.3 Hz, 1H), 3.78–3.59 (m, 1H), 1.77–1.28 (m, 14H), 1.14 (dd, <i>J</i> = 19.5, 7.1 Hz, 3H). <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.83 (s, 0.5P), 3.80 (s, 0.5P). LCMS (C) <i>m</i>/<i>z</i> = 628.97 [M + H].</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cell Lines for Antiviral Assays and HCV 1b Replicon Assay</h3><div class="NLM_p last">See the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> RSV A2 HEp-2 Antiviral and Cytotoxicity Assay</h3><div class="NLM_p last">Compounds were 3-fold serially diluted in source plates from which 100 nL of the diluted compound was transferred to a 384-well cell culture plate using an Echo acoustic transfer apparatus. HEp-2 cells at a density of 5 × 10<sup>4</sup> cells/mL were then infected by adding RSV A2 at a titer of 1 × 10<sup>4</sup> tissue culture infectious doses (TCID<sub>50</sub>)/mL. Immediately following virus addition, 20 μL of the virus/cell mixture was added to the 384-well cell culture plates using a μFlow liquid dispenser and cultured for 4 days at 37 °C. After incubation, the cells were allowed to equilibrate to 25 °C for 30 min. The RSV-induced cytopathic effect was determined by adding 20 μL of a CellTiter Glo viability reagent. After a 10 min incubation at 25 °C, cell viability was determined by measuring luminescence using an Envision plate reader. For the cytotoxicity assessment, HEp-2 (1.5 × 10<sup>3</sup> cells/well) were plated in 384-well plates and incubated with the appropriate medium containing a 3-fold serially diluted compound ranging from 15 to 100 000 nM. Cells were cultured for 4–5 days at 37 °C. Following the incubation, the cells were allowed to equilibrate to 25 °C, and cell viability was determined by adding a CellTiter Glo viability reagent. The mixture was incubated for 10 min, and the luminescence signal was quantified using an Envision plate reader.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> MT-4 Cytotoxicity Assay</h3><div class="NLM_p last">Test compounds were serially diluted in 1:3 increments (total 10 concentrations) in DMSO in quadruplicate and acoustically transferred into 384-well black assay plates. The top concentration is usually 10 or 20 mM in DMSO, which works out to 50 or 100 μM, respectively, in this assay format. A 10 μM puromycin-positive control was added to the last column of each assay plate as a positive control for cytotoxicity. MT-4 cells (3 × 10<sup>3</sup> cells/well) were added to each plate containing the test compound using a Viaflo 384-well pipetter. After 5 days in a humidified and temperature-controlled incubator (37 °C, 5% CO<sub>2</sub>), CellTiter Glo (Promega) was added to the assay plates with the Viaflo and mixed thoroughly, and chemiluminescent signals from each plate were read using an Envision plate reader. CC<sub>50</sub> values were defined as the compound concentration that causes a 50% decrease in luminescence signal and calculated using a sigmoidal dose–response model to generate fitted curves.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> RSV RNP Complex Assay and HCV RdRp Biochemical Assay</h3><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> for RSV RNP assay and ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> for the HCV RdRp assay methods.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> RSV NHBE Assay</h3><div class="NLM_p last">Cells (5.0 × 10<sup>3</sup>/well) were seeded in white wall/clear bottom 96-well plates (Corning) with culture medium to a final volume of 100 μL and incubated for 24 h at 37 °C with 5% CO<sub>2</sub>. On the following day, 3-fold serial dilutions (starting at 9.28 nM and ending at 2000 nM) of <b>1</b> or <b>4</b> prepared in DMSO were added to the wells using the HP D300e digital dispenser with normalization to the highest concentration of DMSO in all wells (>0.1% final volume). The cells were then infected with RSV-Fluc diluted with BEGM media at an MOI of 0.1 for a final volume of 200 μL media/well. Uninfected and untreated wells were included as controls to determine compound efficacy against RSV-Fluc. Following incubation with the compound and virus for 3 days at 37 °C with 5% CO<sub>2</sub>, 100 μL of culture supernatant was removed from each well and replaced with 100 μL of ONE-Glo luciferase reagent (Promega, Madison, WI, Cat# E6110). The plates were gently mixed by rocking for 10 min at rt, and luminescence signal was measured using an Envision plate reader (PerkinElmer). Values were normalized to the uninfected and infected DMSO controls (0 and 100% infection, respectively). Data was fit using nonlinear regression analysis using XLfit4. EC<sub>50</sub> values were then determined as the concentration reducing the firefly luciferase signal by 50%. The compiled data was generated based on the least two independent experimental replicates, each containing technical duplicates for each concentration.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> RSV HAE Assay</h3><div class="NLM_p last">Human airway epithelial (HAE) cells (donor # 33660E) were sourced from MatTek Corporation (Ashland, MA). Differentiated HAE cultures were maintained as per the manufacturer’s instruction until the day of infection and treatment. On day 0, cells were washed twice with 1× DPBS (ThermoFisher Scientific). All compounds were diluted in DMSO to a 1 μM working concentration. <b>1</b> and <b>1-Rp</b> were further diluted in the assay media (MatTek) to the final concentrations of 0.25, 0.05, and 0.01 μM, while <b>4</b> was diluted in the assay media to the final concentrations of 10, 1.25, and 0.25 μM. Two milliliters/well of the compound at the indicated concentration was added to the basolateral side of the transwell HAE culture. Cells were then infected apically with RSV A2 WT virus diluted in the assay media at an MOI of 0.1 to a final volume of 200 μL/well. Cells were incubated with the virus at 37 °C with 5% CO<sub>2</sub> for 3 h. Untreated wells were included as controls. The virus was aspirated from the wells, and cells were further incubated for 24 h at 37 °C with 5% CO<sub>2</sub>. Each subsequent day for 2 days, DPBS was added apically to the cells at a final volume of 200 μL/well. Cells were incubated for 30 min at 37 °C with 5% CO<sub>2</sub>. DPBS was aspirated from the wells, and treatment was continuously administered on days 1 and 2 by adding 2 mL/well of freshly diluted compounds (same concentration as before) to the basolateral side of the transwell HAE culture. Cells were returned to the incubator at 37 °C. On day 3, 200 μL of the DPBS was added apically to each well and the cells were incubated for 30 min at 37 °C with 5% CO<sub>2</sub>. Hundred microliters/well of the apical wash was harvested into 200 μL of lysis buffer (ThermoFisher Scientific). Xenotropic RNA (Vetmax Xeno) internal positive control (ThermoFisher Scientific) was included in the lysis buffer as a control for RNA isolation. Viral RNA was extracted from the collected samples using the MagMAx-96 Viral RNA isolation kit (ThermoFisher Scientific) and Kingfisher Flex instrument (ThermoFisher Scientific) as per the manufacturer’s instruction. Viral loads in HAE cultures were determined by RT-qPCR assay as below. Quantitative RT-PCR was performed using the TaqMan RNA-to-CT 1-Step kit (ThermoFisher Scientific). Briefly, 5 μL of the extracted viral RNA was mixed with 10 μL of the buffer from the kit, 0.5 μL of the RT enzyme, the appropriate primer/probe for either RSV N or the xenotropic RNA, and RT-PCR grade water (ThermoFisher Scientific) to a final volume of 20 μL. For the RSV-specific reactions, 0.5 μL of 40× RSV N Primer Probe (Integrated DNA Technology PrimeTime qPCR Assay XL; forward primer: 5′ GCTAGTGTGCAAGCAGAAATG 3′, reverse primer: 5′ TGGAGAAGTGAGGAAATT GAGTC 3′, and probe: 5′ FAM/ATTGGGTGG/ZEN/AGAAGCAGGGTTCTAC/3IABkFQ 3′ (Coralville, Iowa)) was added per reaction. For the 20× Vetmax Xeno Internal Positive Control-VIC Assay (ThermoFisher Scientific), 0.8 μL of the primer/probe set was added. Each reaction was performed in duplicate. PCR plates were sealed with a MicroAmp optical adhesive film (ThermoFisher Scientific) and centrifuged for 1 min at 1200 RPM. The one-step PCR reaction and subsequent amplification analysis were carried out using the QuantStudio 12K Flex Real Time PCR system using the following conditions: 48 °C for 15 min, 95 °C for 10 min, followed by 40 cycles of qPCR for 15 s at 95 °C and at 60 °C for 1 min. Reactions containing 10-fold serial dilutions of RSV A2 N gene with a pTM1 backbone solution were used to generate a standard curve against which the RSV RNA content measured from test samples was quantified. Median and interquartile ranges (IQR) of six technical replicates were determined for each treatment. The p values were determined by the Mann–Whitney Student <i>t</i> test (unpaired nonparametric).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Log <i>D</i> Measurement, Caco-2 Assay, and In Vitro 1-NTP Metabolism Methods</h3><div class="NLM_p last">See the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Methods</h3><div class="NLM_p">In vivo pharmacokinetic (PK) studies were performed at Charles River Laboratories (rat and dog; Worcester, MA), Covance (cynomolgus monkey; Madison, Wisconsin), and Lovelace Biomedical Research Institute (AGM; Albuquerque, NM) in accordance with local IACUC guidelines and the AGM RSV efficacy study at Bioqual, Inc. (Rockville, MD) under local IACUC guidelines. For nonterminal studies, compound <b>4</b> was formulated in 5% EtOH, 30% propylene glycol (PG), 45% PEG 400, and 20% water + 1 equiv of HCl at 0.50 mg/mL for IV infusion and at 2.50 mg/mL for oral dosing. Each dosing group consisted of three male Sprague–Dawley rats, or three male beagle dogs (∼11.5 kg) or three male cynomolgus monkeys (3.5–6.5 kg), or three male AGM. The animals were fasted overnight prior to dose administration and up to 4 h after dosing. For the IV infusion group, the test article was administered by intravenous infusion over 30 min. The rate of infusion was adjusted according to the body weight of each animal to deliver a dose of 1 mg/kg. For the oral dosing group, the test article was administered by oral gavage at 2 mL/kg for a dose of 5 mg/kg. For the terminal tissue collection study of <b>4</b> in three male cynomolgus monkeys, <b>4</b> was formulated in 5% ethanol, 30% propylene glycol, 45% PEG 300, and 20% water (pH 2.5) and administered by a constant rate intravenous infusion over 30 minutes at 2 mL/kg for a dose of 20 mg/kg. Compound <b>1</b> was formulated in 12% sulfobutylether-β-cyclodextrin in water (pH 3.5) and administered by a constant rate intravenous infusion over 30 minutes at 2 mL/kg for a dose of 10 mg/kg in both cynomolgus monkey and AGM. Cynomolgus monkeys were two males and one female, and AGM were three males. Serial blood samples were collected in K<sub>2</sub>EDTA tubes at each time point and kept on ice until centrifuged. Immediately after centrifugation (5000 g for 10 min at 2–4 °C), the plasma was transferred into clean collection tubes and stored at −80 °C. A liquid chromatography coupled to the triple quadrupole mass spectrometry (LCMS/MS) method was used to measure the concentration of <b>1</b> and <b>4</b> in plasma similar to methods described previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Pharmacokinetic (PK) parameters were determined following a noncompartmental analysis of the plasma concentration–time data. The following PK parameters are reported: clearance (CL; L/h/kg), volume of distribution at steady state (<i>V</i><sub>ss</sub>; L/kg), terminal half-life (<i>T</i><sub>1/2</sub>; h), maximum concentration (<i>C</i><sub>max</sub>; μM), and area under the concentration–time curve from time 0 to infinity (AUC<sub>inf</sub>; μM·h).</div><div class="NLM_p">A compound <b>13</b> mono TFA salt was formulated in 2.5% DMSO, 10% Kolliphor HS-15, 10% labrasol, 2.5% PG, and 75% water at 4 mL/kg for a targeted oral dose of 8 mg/kg <b>13</b> as its free base in rats. In cynomolgus monkey, compound <b>13</b> as its free base was formulated in 10% EtOH, 40% Kolliphor HS-15, 40% labrasol, and 10% PG at 1 mL/kg for a targeted dose of 20 mg/kg <b>13</b> in monkeys. The compound was dosed by oral gavage to three male Sprague–Dawley rats or three male cynomolgus monkeys (3.5–6.5 kg). The animals were fasted overnight prior to dose administration and up to 4 h after dosing. The in vivo dose administration and sample collection procedure remained the same as described above. An LCMS/MS method as described above was used to measure the concentration of <b>4</b> in plasma; PK parameters were derived following noncompartmental analysis of the plasma concentration–time data.</div><div class="NLM_p last">Cynomolgus monkey and AGM respiratory and other tissues were collected as a nonsurvival surgical procedure at 24 h following the initiation of IV infusion. Animals were sedated with ketamine (10 mg/kg) administered via an intramuscular injection prior to surgery. Sections of the upper trachea, lower trachea, the mainstem bronchus (right), and lower bronchus (right) were dissected and immediately placed into liquid nitrogen, all <5 min from the start of surgery, followed by the successive collection of liver and kidney sections in the same fashion. Frozen tissues were pulverized using a cell crusher and transferred into preweighed 15 mL conical tubes, all performed and maintained on dry ice. Tissue weights were obtained by subtracting the tube weight, and a 4-fold volume of dry ice-cold extraction buffer (70% methanol containing 0.1% KOH, 67 mM EDTA, and 250 nM chloro-ATP as internal standard) was added. Standard curves were generated by spiking an appropriate amount of <b>4</b>, monophosphate metabolite of <b>4</b>, diphosphate metabolite of <b>4</b>, and <b>1-NTP</b> solution, prepared in water, into blank tissues. The mixture was then promptly homogenized using an Omni Tip tissue homogenizer with a disposable hard-tissue homogenizer probe (Omni International). A 200 μL aliquot of the homogenate was filtered using a 96-well filter plate (0.2 μm polypropylene, Agilent Captiva). The filtrate was evaporated to dryness and reconstituted with 200 μL of 1 mM ammonium phosphate buffer (pH 7) for analysis by LCMS/MS. Analysis was performed using similar methods as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Undosed control tissues from the lung, liver, and kidney were used for quantification of the metabolites in the respiratory tissue, liver, and kidney, respectively.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> RSV AGM Efficacy</h3><div class="NLM_p last">Eight AGMs were included in the study (randomized 1:1), and each was challenged with 2 mL of the diluted RSV A2 WT inoculum (2 × 10<sup>5</sup> PFU total) on day 0 of the study. A viral inoculum (0.5 mL) was administered dropwise into each nostril (NP-053) and 1.0 mL was delivered intratracheally using a French rubber catheter/feeding tube, size 10, sterile (cut 4″–6″ in length). Starting 4 h prior to RSV challenge, each animal received either <b>1</b> (10 mg/kg, formulated in 12% captisol in water, pH 5) or placebo to match administered by IV (1 mL/kg) infusion over 30 min. Subsequent doses of <b>1</b> and placebo were administered at 24, 48, 72, 96, and 120 h post challenge. BAL samples were collected on study days −2, +1, +3, +5, +7, +9, +11, 13, and +15 from each monkey by instilling ∼2 mL/kg of warm sterile saline and gently suctioned back before freezing. Nasopharyngeal (NP) swabs were collected on study days −2, +1, +3, +5, +7, +9, +11, 13, and +15 from each monkey with sterile cotton swabs moistened in sterile saline. Each cotton swab was placed in a tube containing 1 mL of sterile saline and immediately frozen. Samples were collected prior to dosing of <b>1</b> or placebo. To reduce stress, an intramuscular injection of ketamine HCl (10–25 mg/kg) or other appropriate anesthetics was used prior to the procedures. Viral assessment was performed by quantitative RT-PCR as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-6"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00071" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00071?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00071</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Amino acid ester synthesis, cell line sources, HCV 1b replicon assay, tabulated RSV HAE PCR data, in vitro pharmacokinetics, in vitro <b>1-NTP</b> metabolism methods, AGM efficacy study RT-qPCR method, and appendix of final compounds NMR and HPLC spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular Formula Strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf">jm1c00071_si_001.pdf (1.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_002.csv">jm1c00071_si_002.csv (3.71 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00071" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard L. Mackman</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c092a9a3a8a1b2a4ee8da1a3abada1ae80a7a9aca5a1a4eea3afad"><span class="__cf_email__" data-cfemail="01536862696073652f4c60626a6c606f4166686d6460652f626e6c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hon C. Hui</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Perron</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="305d5a405542425f5e705f45445c5f5f5b1e535f5d1e">[email protected]</a> 1885 Justino Drive, Morgan Hill, California 95037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eisuke Murakami</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Palmiotti</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Lee</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsten Stray</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d29981a6a0b3ab929b8681fc989c98fcb1bdbffc">[email protected]</a> 611 Gateway Blvd., South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lijun Zhang</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="492520233c27332128272e09212c27263f2a2624672a262467">[email protected]</a> 9F, Building C4, 11 Kaiyuan Road, Guangzhou Science Park, Guangzhou 510535, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bindu Goyal</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwon Chun</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Byun</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin Siegel</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Simonovich</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4b383822262425243d2228230b222f2e2a322a2922246528242665">[email protected]</a> 7000 Shoreline Ct #350, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Venice Du Pont</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jared Pitts</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darius Babusis</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arya Vijjapurapu</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianghan Lu</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia Kim</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaofeng Zhao</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Chan</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Ma</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7549-2658" title="Orcid link">http://orcid.org/0000-0002-7549-2658</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane Lye</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adelle Vandersteen</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Wortman</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly T. Barrett</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Toteva</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Jordan</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="384a52574a5c59560c0d0e785f55595154165b5755">[email protected]</a> Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raju Subramanian</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Bilello</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomas Cihlar</span> - <span class="hlFld-Affiliation affiliation">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Some authors are current or former employees of Gilead Sciences and may own company stock.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4518-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to express their thanks to Alex Shornikov and David Cowfer for compound handling contributions and Dorothy Theodore and Krista McCutcheon for early assay development. The authors also thank the dedicated staff at Charles River Labs, Covance and Lovelace Biomedical Research institute for execution of the in vivo studies.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AB</td><td class="NLM_def"><p class="first last">apical to basolateral</p></td></tr><tr><td class="NLM_term">AGM</td><td class="NLM_def"><p class="first last">African Green monkey</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">basolateral to apical</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">BEGM</td><td class="NLM_def"><p class="first last">bronchial epithelial cell growth medium</p></td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration for 50% cell viability loss</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetra acetic acid</p></td></tr><tr><td class="NLM_term">HAE</td><td class="NLM_def"><p class="first last">human airway epithelial</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">International Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LOQ</td><td class="NLM_def"><p class="first last">limit of quantification</p></td></tr><tr><td class="NLM_term">MERS</td><td class="NLM_def"><p class="first last">Middle East respiratory syndrome</p></td></tr><tr><td class="NLM_term">MOI</td><td class="NLM_def"><p class="first last">multiplicity of infection</p></td></tr><tr><td class="NLM_term">NHBE</td><td class="NLM_def"><p class="first last">normal human bronchial epithelial</p></td></tr><tr><td class="NLM_term">NP</td><td class="NLM_def"><p class="first last">nasopharyngeal</p></td></tr><tr><td class="NLM_term">NTP</td><td class="NLM_def"><p class="first last">nucleotide triphosphate</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethyleneglycol)</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA-dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">RNP</td><td class="NLM_def"><p class="first last">ribonucleoprotein</p></td></tr><tr><td class="NLM_term">RSV</td><td class="NLM_def"><p class="first last">respiratory syncytial virus</p></td></tr><tr><td class="NLM_term">SARS</td><td class="NLM_def"><p class="first last">severe acute respiratory syndrome</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TCID</td><td class="NLM_def"><p class="first last">tissue culture infectious dose</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugentobler, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, A.</span></span> <span> </span><span class="NLM_article-title">Seasonality of respiratory viral infections</span>. <i>Annu. Rev. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1146/annurev-virology-012420-022445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1146%2Fannurev-virology-012420-022445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32196426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=83-101&author=M.+Moriyamaauthor=W.+J.+Hugentoblerauthor=A.+Iwasaki&title=Seasonality+of+respiratory+viral+infections&doi=10.1146%2Fannurev-virology-012420-022445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Seasonality of Respiratory Viral Infections</span></div><div class="casAuthors">Moriyama, Miyu; Hugentobler, Walter J.; Iwasaki, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-101</span>CODEN:
                <span class="NLM_cas:coden">ARVNBS</span>;
        ISSN:<span class="NLM_cas:issn">2327-0578</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The seasonal cycle of respiratory viral diseases has been widely recognized for thousands of years, as annual epidemics of the common cold and influenza disease hit the human population like clockwork in the winter season in temperate regions.  Moreover, epidemics caused by viruses such as severe acute respiratory syndrome coronavirus (SARS-CoV) and the newly emerging SARS-CoV-2 occur during the winter months.  The mechanisms underlying the seasonal nature of respiratory viral infections have been examd. and debated for many years.  The two major contributing factors are the changes in environmental parameters and human behavior.  Studies have revealed the effect of temp. and humidity on respiratory virus stability and transmission rates.  More recent research highlights the importance of the environmental factors, esp. temp. and humidity, in modulating host intrinsic, innate, and adaptive immune responses to viral infections in the respiratory tract.  Here we review evidence of how outdoor and indoor climates are linked to the seasonality of viral respiratory infections.  We further discuss determinants of host response in the seasonality of respiratory viruses by highlighting recent studies in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowTckI6kAk27Vg90H21EOLACvtfcHk0lgCc7CMQaiVhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlCqur8%253D&md5=3e4813504d05bf837b7a84c0f4baf64f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-virology-012420-022445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-virology-012420-022445%26sid%3Dliteratum%253Aachs%26aulast%3DMoriyama%26aufirst%3DM.%26aulast%3DHugentobler%26aufirst%3DW.%2BJ.%26aulast%3DIwasaki%26aufirst%3DA.%26atitle%3DSeasonality%2520of%2520respiratory%2520viral%2520infections%26jtitle%3DAnnu.%2520Rev.%2520Virol.%26date%3D2020%26volume%3D7%26spage%3D83%26epage%3D101%26doi%3D10.1146%2Fannurev-virology-012420-022445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yusuf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedimonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demmler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Caeseele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avendano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez-Bueno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murguía De Sierra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes, E. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welliver, R.,  Sr.</span></span> <span> </span><span class="NLM_article-title">The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus</span>. <i>Epidemiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1017/S095026880600776X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1017%2FS095026880600776X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=17346359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD2srmtlWltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2007&pages=1077-1090&author=S.+Yusufauthor=G.+Piedimonteauthor=A.+Auaisauthor=G.+Demmlerauthor=S.+Krishnanauthor=P.+Van+Caeseeleauthor=R.+Singletonauthor=S.+Broorauthor=S.+Parveenauthor=L.+Avendanoauthor=J.+Parraauthor=S.+Chavez-Buenoauthor=T.+Murgu%C3%ADa+De+Sierraauthor=E.+A.+F.+Simoesauthor=S.+Shahaauthor=R.+Welliver&title=The+relationship+of+meteorological+conditions+to+the+epidemic+activity+of+respiratory+syncytial+virus&doi=10.1017%2FS095026880600776X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus</span></div><div class="casAuthors">Yusuf S; Piedimonte G; Auais A; Demmler G; Krishnan S; Van Caeseele P; Singleton R; Broor S; Parveen S; Avendano L; Parra J; Chavez-Bueno S; Murguia De Sierra T; Simoes E A F; Shaha S; Welliver R</div><div class="citationInfo"><span class="NLM_cas:title">Epidemiology and infection</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-90</span>
        ISSN:<span class="NLM_cas:issn">0950-2688</span>.
    </div><div class="casAbstract">Our aim was to obtain knowledge of how meteorological conditions affect community epidemics of respiratory syncytial virus (RSV) infection.  To this end we recorded year-round RSV activity in nine cities that differ markedly in geographic location and climate.  We correlated local weather conditions with weekly or monthly RSV cases.  We reviewed similar reports from other areas varying in climate.  Weekly RSV activity was related to temperature in a bimodal fashion, with peaks of activity at temperatures above 24-30 degrees C and at 2-6 degrees C.  RSV activity was also greatest at 45-65% relative humidity.  RSV activity was inversely related to UVB radiance at three sites where this could be tested.  At sites with persistently warm temperatures and high humidity, RSV activity was continuous throughout the year, peaking in summer and early autumn.  In temperate climates, RSV activity was maximal during winter, correlating with lower temperatures.  In areas where temperatures remained colder throughout the year, RSV activity again became nearly continuous.  Community activity of RSV is substantial when both ambient temperatures and absolute humidity are very high, perhaps reflecting greater stability of RSV in aerosols.  Transmission of RSV in cooler climates is inversely related to temperature possibly as a result of increased stability of the virus in secretions in the colder environment.  UVB radiation may inactivate virus in the environment, or influence susceptibility to RSV by altering host resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1YfBAQ73zkc25P7XSLhESfW6udTcc2eb1KQ-OnSwvsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmtlWltw%253D%253D&md5=6d634f54241ea52b62dd70376580ce3f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS095026880600776X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS095026880600776X%26sid%3Dliteratum%253Aachs%26aulast%3DYusuf%26aufirst%3DS.%26aulast%3DPiedimonte%26aufirst%3DG.%26aulast%3DAuais%26aufirst%3DA.%26aulast%3DDemmler%26aufirst%3DG.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DVan%2BCaeseele%26aufirst%3DP.%26aulast%3DSingleton%26aufirst%3DR.%26aulast%3DBroor%26aufirst%3DS.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DAvendano%26aufirst%3DL.%26aulast%3DParra%26aufirst%3DJ.%26aulast%3DChavez-Bueno%26aufirst%3DS.%26aulast%3DMurgu%25C3%25ADa%2BDe%2BSierra%26aufirst%3DT.%26aulast%3DSimoes%26aufirst%3DE.%2BA.%2BF.%26aulast%3DShaha%26aufirst%3DS.%26aulast%3DWelliver%26aufirst%3DR.%26atitle%3DThe%2520relationship%2520of%2520meteorological%2520conditions%2520to%2520the%2520epidemic%2520activity%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DEpidemiol.%2520Infect.%26date%3D2007%26volume%3D135%26spage%3D1077%26epage%3D1090%26doi%3D10.1017%2FS095026880600776X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><a href="https://www.who.int/health-topics/influenza-avian-and-other-zoonotic" class="extLink">https://www.who.int/health-topics/influenza-avian-and-other-zoonotic</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.who.int%2Fhealth-topics%2Finfluenza-avian-and-other-zoonotic."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" class="extLink">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</a>. Accessed Feb 13, <span class="NLM_year">2021</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.who.int%2Femergencies%2Fdiseases%2Fnovel-coronavirus-2019.+Accessed+Feb+13%2C+2021."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><a href="http://www.veklury.com" class="extLink">www.veklury.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.veklury.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Theodore, D. A.</span></span> <span> </span><span class="NLM_article-title">Methods and Compounds for Treating Paramyxoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">US2011045102</span>, July 22, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+L.+Mackman&author=J.+P.+Parrish&author=A.+S.+Ray&author=D.+A.+Theodore&title=Methods+and+Compounds+for+Treating+Paramyxoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DMethods%2520and%2520Compounds%2520for%2520Treating%2520Paramyxoviridae%2520Virus%2520Infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shurtleff, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharaibeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomba, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trancheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1038/nature17180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1038%2Fnature17180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26934220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=381-385&author=T.+K.+Warrenauthor=R.+Jordanauthor=M.+K.+Loauthor=A.+S.+Rayauthor=R.+L.+Mackmanauthor=V.+Solovevaauthor=D.+Siegelauthor=M.+Perronauthor=R.+Bannisterauthor=H.+C.+Huiauthor=N.+Larsonauthor=R.+Strickleyauthor=J.+Wellsauthor=K.+S.+Stuthmanauthor=S.+A.+Van+Tongerenauthor=N.+L.+Garzaauthor=G.+Donnellyauthor=A.+C.+Shurtleffauthor=C.+J.+Rettererauthor=D.+Gharaibehauthor=R.+Zamaniauthor=T.+Kennyauthor=B.+P.+Eatonauthor=E.+Grimesauthor=L.+S.+Welchauthor=L.+Gombaauthor=C.+L.+Wilhelmsenauthor=D.+K.+Nicholsauthor=J.+E.+Nussauthor=E.+R.+Nagleauthor=J.+R.+Kugelmanauthor=G.+Palaciosauthor=E.+Doerfflerauthor=S.+Nevilleauthor=E.+Carraauthor=M.+O.+Clarkeauthor=L.+Zhangauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=K.+Chunauthor=L.+Wolfeauthor=D.+Babusisauthor=Y.+Parkauthor=K.+M.+Strayauthor=I.+Tranchevaauthor=J.+Y.+Fengauthor=O.+Barauskasauthor=Y.+Xuauthor=P.+Wongauthor=M.+R.+Braunauthor=M.+Flintauthor=L.+K.+McMullanauthor=S.-S.+Chenauthor=R.+Fearnsauthor=S.+Swaminathanauthor=D.+L.+Mayersauthor=C.+F.+Spiropoulouauthor=W.+A.+Leeauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+Bavari&title=Therapeutic+efficacy+of+the+small+molecule+GS-5734+against+Ebola+virus+in+rhesus+monkeys&doi=10.1038%2Fnature17180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span></div><div class="casAuthors">Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The most recent Ebola virus outbreak in West Africa, which was unprecedented in the no. of cases and fatalities, geog. distribution, and no. of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae.  No antiviral therapeutics have yet received regulatory approval or demonstrated clin. efficacy.  Here we report the discovery of a novel small mol. GS-5734, a monophosphoramidate prodrug of an adenosine analog, with antiviral activity against EBOV.  GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays.  The pharmacol. active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase.  I.v. administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain.  In a rhesus monkey model of EVD, once-daily i.v. administration of 10 mg kg-1 GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clin. disease signs and pathophysiol. markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals.  These results show the first substantive post-exposure protection by a small-mol. antiviral compd. against EBOV in nonhuman primates.  The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use.  GS-5734 is amenable to large-scale manufg., and clin. studies investigating the drug safety and pharmacokinetics are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4QsyLVjgHLVg90H21EOLACvtfcHk0lgKOWU-C57_Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D&md5=ab121d827ac0a40cc1fed3dd1df905b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature17180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17180%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DDonnelly%26aufirst%3DG.%26aulast%3DShurtleff%26aufirst%3DA.%2BC.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DGharaibeh%26aufirst%3DD.%26aulast%3DZamani%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DGrimes%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DGomba%26aufirst%3DL.%26aulast%3DWilhelmsen%26aufirst%3DC.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BK.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DNagle%26aufirst%3DE.%2BR.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DTrancheva%26aufirst%3DI.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DM.%2BR.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DChen%26aufirst%3DS.-S.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMayers%26aufirst%3DD.%2BL.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DTherapeutic%2520efficacy%2520of%2520the%2520small%2520molecule%2520GS-5734%2520against%2520Ebola%2520virus%2520in%2520rhesus%2520monkeys%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D381%26epage%3D385%26doi%3D10.1038%2Fnature17180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01594</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1648-1661&author=D.+Siegelauthor=H.+C.+Huiauthor=E.+Doerfflerauthor=M.+O.+Clarkeauthor=K.+Chunauthor=L.+Zhangauthor=S.+Nevilleauthor=E.+Carraauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=L.+Wolfeauthor=R.+Jordanauthor=V.+Solovevaauthor=J.+Knoxauthor=J.+Perryauthor=M.+Perronauthor=K.+M.+Strayauthor=O.+Barauskasauthor=J.+Y.+Fengauthor=Y.+Xuauthor=G.+Leeauthor=A.+L.+Rheingoldauthor=A.+S.+Rayauthor=B.+Bannisterauthor=R.+Strickleyauthor=S.+Swaminathanauthor=W.+A.+Leeauthor=S.+Bavariauthor=T.+Cihlarauthor=M.+K.+Loauthor=T.+K.+Warrenauthor=R.+L.+Mackman&title=Discovery+and+synthesis+of+a+phosphoramidate+prodrug+of+a+pyrrolo%5B2%2C1-f%5D%5Btriazin-4-amino%5D+adenine+C-nucleoside+%28GS-5734%29+for+the+treatment+of+Ebola+and+emerging+viruses&doi=10.1021%2Facs.jmedchem.6b01594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses</span></div><div class="casAuthors">Siegel, Dustin; Hui, Hon C.; Doerffler, Edward; Clarke, Michael O.; Chun, Kwon; Zhang, Lijun; Neville, Sean; Carra, Ernest; Lew, Willard; Ross, Bruce; Wang, Queenie; Wolfe, Lydia; Jordan, Robert; Soloveva, Veronica; Knox, John; Perry, Jason; Perron, Michel; Stray, Kirsten M.; Barauskas, Ona; Feng, Joy Y.; Xu, Yili; Lee, Gary; Rheingold, Arnold L.; Ray, Adrian S.; Bannister, Roy; Strickley, Robert; Swaminathan, Swami; Lee, William A.; Bavari, Sina; Cihlar, Tomas; Lo, Michael K.; Warren, Travis K.; Mackman, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers.  A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clin. candidate.  Structure activity relationships established that the 1'-CN group and C-linked nucleobase were crit. for optimal anti-EBOV potency and selectivity against host polymerases.  A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclin. efficacy in a non-human-primate EBOV challenge model.  Once-daily 10 mg/kg iv treatment on days 3-14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016, 531, 381-385].  A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWkPjn__gILVg90H21EOLACvtfcHk0lhe3cajHDfXTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D&md5=b2a05cfeb4fd30fbca0d1d584ddcc220</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DBannister%26aufirst%3DB.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520phosphoramidate%2520prodrug%2520of%2520a%2520pyrrolo%255B2%252C1-f%255D%255Btriazin-4-amino%255D%2520adenine%2520C-nucleoside%2520%2528GS-5734%2529%2520for%2520the%2520treatment%2520of%2520Ebola%2520and%2520emerging%2520viruses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.jmedchem.6b01594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulangu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbaya, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nzolo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oloma, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulibaly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyembe-Tamfum, J.-J.</span></span>; <span class="NLM_contrib-group">the PALM Writing Group, for the PALM Consortium Study Team</span> <span> </span><span class="NLM_article-title">A randomized, controlled trial of Ebola virus disease therapeutics</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1910993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1910993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31774950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2019&pages=2293-2303&author=S.+Mulanguauthor=L.+E.+Doddauthor=R.+T.+Daveyauthor=O.+T.+Mbayaauthor=M.+Proschanauthor=D.+Mukadiauthor=M.+L.+Manzoauthor=D.+Nzoloauthor=A.+T.+Olomaauthor=A.+Ibandaauthor=R.+Aliauthor=S.+Coulibalyauthor=A.+C.+Levineauthor=R.+Graisauthor=J.+Diazauthor=H.+C.+Laneauthor=J.-J.+Muyembe-Tamfumauthor=the+PALM+Writing+Group%2C+for+the+PALM+Consortium+Study+Team&title=A+randomized%2C+controlled+trial+of+Ebola+virus+disease+therapeutics&doi=10.1056%2FNEJMoa1910993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, controlled trial of ebola virus disease therapeutics</span></div><div class="casAuthors">Mulangu, Sabue; Dodd, Lori E.; Davey, Richard T., Jr.; Mbaya, Olivier Tshiani; Proschan, Michael; Mukadi, Daniel; Manzo, Mariano Lusakibanza; Nzolo, Didier; Oloma, Antoine Tshomba; Ibanda, Augustin; Ali, Rosine; Coulibaly, Sinare; Levine, Adam C.; Grais, Rebecca; Diaz, Janet; Lane, H. Clifford; Muyembe-Tamfum, Jean-Jacques</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2293-2303</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although several exptl. therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial. methods We conducted a trial of four investigational therapies for EVD in the Democratic Republic of Congo, where an outbreak began in August 2018.  Patients of any age who had a pos. result for Ebola virus RNA on reverse-transcriptase-polymerase-chain-reaction assay were enrolled.  All patients received std. care and were randomly assigned in a 1:1:1:1 ratio to i.v. administration of the triple monoclonal antibody ZMapp (the control group), the antiviral agent remdesivir, the single monoclonal antibody MAb114, or the triple monoclonal antibody REGN-EB3.  The REGN-EB3 group was added in a later version of the protocol, so data from these patients were compared with those of patients in the ZMapp group who were enrolled at or after the time the REGN-EB3 group was added (the ZMapp subgroup).  The primary end point was death at 28 days. results A total of 681 patients were enrolled from Nov. 20, 2018, to August 9, 2019, at which time the data and safety monitoring board recommended that patients be assigned only to the MAb114 and REGN-EB3 groups for the remainder of the trial; the recommendation was based on the results of an interim anal. that showed superiority of these groups to ZMapp and remdesivir with respect to mortality.  At 28 days, death had occurred in 61 of 174 patients (35.1%) in the MAb114 group, as compared with 84 of 169 (49.7%) in the ZMapp group (P = 0.007), and in 52 of 155 (33.5%) in the REGN-EB3 group, as compared with 79 of 154 (51.3%) in the ZMapp subgroup (P = 0.002).  A shorter duration of symptoms before admission and lower baseline values for viral load and for serum creatinine and aminotransferase levels each correlated with improved survival.  Four serious adverse events were judged to be potentially related to the trial drugs. conclusions Both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD.  Scientifically and ethically sound clin. research can be conducted during disease outbreaks and can help inform the outbreak response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF31fomvTPrVg90H21EOLACvtfcHk0lhe3cajHDfXTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP&md5=ace616255b8372f99aef8dee4864d38f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1910993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1910993%26sid%3Dliteratum%253Aachs%26aulast%3DMulangu%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DDavey%26aufirst%3DR.%2BT.%26aulast%3DMbaya%26aufirst%3DO.%2BT.%26aulast%3DProschan%26aufirst%3DM.%26aulast%3DMukadi%26aufirst%3DD.%26aulast%3DManzo%26aufirst%3DM.%2BL.%26aulast%3DNzolo%26aufirst%3DD.%26aulast%3DOloma%26aufirst%3DA.%2BT.%26aulast%3DIbanda%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DCoulibaly%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3DMuyembe-Tamfum%26aufirst%3DJ.-J.%26aulast%3D%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520Ebola%2520virus%2520disease%2520therapeutics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D381%26spage%3D2293%26epage%3D2303%26doi%3D10.1056%2FNEJMoa1910993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beigel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomashek, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zingman, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalil, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luetkemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez de Castilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paredes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Short, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touloumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lye, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Palacios, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fätkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortepeter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiker, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neaton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnett, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinusi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group">for the ACTT-1 Study Group Members</span> <span> </span><span class="NLM_article-title">Remdesivir for the treatment of Covid-19–Final report</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1826</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2007764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa2007764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32445440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1yltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2020&pages=1813-1826&author=J.+H.+Beigelauthor=K.+M.+Tomashekauthor=L.+E.+Doddauthor=A.+K.+Mehtaauthor=B.+S.+Zingmanauthor=A.+C.+Kalilauthor=E.+Hohmannauthor=H.+Y.+Chuauthor=A.+Luetkemeyerauthor=S.+Klineauthor=D.+Lopez+de+Castillaauthor=R.+W.+Finbergauthor=K.+Dierbergauthor=V.+Tapsonauthor=L.+Hsiehauthor=T.+F.+Pattersonauthor=R.+Paredesauthor=D.+A.+Sweeneyauthor=W.+R.+Shortauthor=G.+Touloumiauthor=D.+C.+Lyeauthor=N.+Ohmagariauthor=M.+Ohauthor=G.+M.+Ruiz-Palaciosauthor=T.+Benfieldauthor=G.+F%C3%A4tkenheuerauthor=M.+G.+Kortepeterauthor=R.+L.+Atmarauthor=C.+B.+Creechauthor=J.+Lundgrenauthor=A.+G.+Babikerauthor=S.+Pettauthor=J.+D.+Neatonauthor=T.+H.+Burgessauthor=T.+Bonnettauthor=M.+Greenauthor=M.+Makowskiauthor=A.+Osinusiauthor=S.+Nayakauthor=H.+C.+Laneauthor=for+the+ACTT-1+Study+Group+Members&title=Remdesivir+for+the+treatment+of+Covid-19%E2%80%93Final+report&doi=10.1056%2FNEJMoa2007764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir for the treatment of Covid-19 - Final Report</span></div><div class="casAuthors">Beigel, J. H.; Tomashek, K. M.; Dodd, L. E.; Mehta, A. K.; Zingman, B. S.; Kalil, A. C.; Hohmann, E.; Chu, H. Y.; Luetkemeyer, A.; Kline, S.; de Castilla, D. Lopez; Finberg, R. W.; Dierberg, K.; Tapson, V.; Hsieh, L.; Patterson, T. F.; Paredes, R.; Sweeney, D. A.; Short, W. R.; Touloumi, G.; Lye, D. C.; Ohmagari, N.; Oh, M.; Ruiz-Palacios, G. M.; Benfield, T.; Fatkenheuer, G.; Kortepeter, M. G.; Atmar, R. L.; Creech, C. B.; Lundgren, J.; Babiker, A. G.; Pett, S.; Neaton, J. D.; Burgess, T. H.; Bonnett, T.; Green, M.; Makowski, M.; Osinusi, A.; Nayak, S.; Lane, H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1813-1826</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. methods the authors conducted a double-blind, randomized, placebo-controlled trial of i.v. remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.  Patients were randomly assigned to receive either remdesivir (200 mg loading dose on day 1, followed by 100 mg daily for up to 9 addnl. days) or placebo for up to 10 days.  The primary outcome was the time to recovery, defined by either discharge from the hospital or hospitalization for infection-control purposes only. results A total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo).  Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).  In an anal. that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clin. improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity).  The Kaplan-Meier ests. of mortality were 6.7% with remdesivir and 11.9% with placebo by day 15 and 11.4% with remdesivir and 15.2% with placebo by day 29 (hazard ratio, 0.73; 95% CI, 0.52 to 1.03).  Serious adverse events were reported in 131 of the 532 patients who received remdesivir (24.6%) and in 163 of the 516 patients who received placebo (31.6%). conclusions the authors' data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotyQ9MMc8Xo7Vg90H21EOLACvtfcHk0liwZlj-XCPUvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1yltL7O&md5=6824e8433486a105b147b1cf1bf222c9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2007764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2007764%26sid%3Dliteratum%253Aachs%26aulast%3DBeigel%26aufirst%3DJ.%2BH.%26aulast%3DTomashek%26aufirst%3DK.%2BM.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DMehta%26aufirst%3DA.%2BK.%26aulast%3DZingman%26aufirst%3DB.%2BS.%26aulast%3DKalil%26aufirst%3DA.%2BC.%26aulast%3DHohmann%26aufirst%3DE.%26aulast%3DChu%26aufirst%3DH.%2BY.%26aulast%3DLuetkemeyer%26aufirst%3DA.%26aulast%3DKline%26aufirst%3DS.%26aulast%3DLopez%2Bde%2BCastilla%26aufirst%3DD.%26aulast%3DFinberg%26aufirst%3DR.%2BW.%26aulast%3DDierberg%26aufirst%3DK.%26aulast%3DTapson%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DSweeney%26aufirst%3DD.%2BA.%26aulast%3DShort%26aufirst%3DW.%2BR.%26aulast%3DTouloumi%26aufirst%3DG.%26aulast%3DLye%26aufirst%3DD.%2BC.%26aulast%3DOhmagari%26aufirst%3DN.%26aulast%3DOh%26aufirst%3DM.%26aulast%3DRuiz-Palacios%26aufirst%3DG.%2BM.%26aulast%3DBenfield%26aufirst%3DT.%26aulast%3DF%25C3%25A4tkenheuer%26aufirst%3DG.%26aulast%3DKortepeter%26aufirst%3DM.%2BG.%26aulast%3DAtmar%26aufirst%3DR.%2BL.%26aulast%3DCreech%26aufirst%3DC.%2BB.%26aulast%3DLundgren%26aufirst%3DJ.%26aulast%3DBabiker%26aufirst%3DA.%2BG.%26aulast%3DPett%26aufirst%3DS.%26aulast%3DNeaton%26aufirst%3DJ.%2BD.%26aulast%3DBurgess%26aufirst%3DT.%2BH.%26aulast%3DBonnett%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DMakowski%26aufirst%3DM.%26aulast%3DOsinusi%26aufirst%3DA.%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3D%26atitle%3DRemdesivir%2520for%2520the%2520treatment%2520of%2520Covid-19%25E2%2580%2593Final%2520report%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D383%26spage%3D1813%26epage%3D1826%26doi%3D10.1056%2FNEJMoa2007764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes, E. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polack, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsells, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acacio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alassani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awori, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azziz-Baumgartner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggett, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmaseda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barahona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassat, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basualdo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigogo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breiman, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carosone-Link, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipeta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Cuellar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash-yandag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deloria-Knoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dherani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebruke, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echavarria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Lázaro Emediato, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feikin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halasa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirve, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homaira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howie, S. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jara, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jroundi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kartasasmita, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khuri-Bulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotloff, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucion, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupisan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcone, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munywoki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutyara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nokes, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nymadawa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa Oliveira, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paranhos-Baccalà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picot, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakoto-Andrianarivelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russomando, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salimi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawatwong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltema, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutanto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thamthitiwat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waicharoen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watthanaworawit, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, H.</span></span>; <span class="NLM_contrib-group">for RSV Global Epidemiology Network.</span> <span> </span><span class="NLM_article-title">Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)30938-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2FS0140-6736%2817%2930938-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=28689664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BC1cjlslKluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=946-958&author=T.+Shiauthor=D.+A.+McAllisterauthor=K.+L.+O%E2%80%99Brienauthor=E.+A.+F.+Simoesauthor=S.+A.+Madhiauthor=B.+D.+Gessnerauthor=F.+P.+Polackauthor=E.+Balsellsauthor=S.+Acacioauthor=C.+Aguayoauthor=I.+Alassaniauthor=A.+Aliauthor=M.+Antonioauthor=S.+Awasthiauthor=J.+O.+Aworiauthor=E.+Azziz-Baumgartnerauthor=H.+C.+Baggettauthor=V.+L.+Baillieauthor=A.+Balmasedaauthor=A.+Barahonaauthor=S.+Basnetauthor=Q.+Bassatauthor=W.+Basualdoauthor=G.+Bigogoauthor=L.+Bontauthor=R.+F.+Breimanauthor=W.+A.+Brooksauthor=S.+Broorauthor=N.+Bruceauthor=D.+Brudenauthor=P.+Buchyauthor=S.+Campbellauthor=P.+Carosone-Linkauthor=M.+Chadhaauthor=J.+Chipetaauthor=M.+Chouauthor=W.+Claraauthor=C.+Cohenauthor=E.+de+Cuellarauthor=D.-A.+Dangauthor=B.+Dash-yandagauthor=M.+Deloria-Knollauthor=M.+Dheraniauthor=T.+Eapauthor=B.+E.+Ebrukeauthor=M.+Echavarriaauthor=C.+C.+de+Freitas+L%C3%A1zaro+Emediatoauthor=R.+A.+Fasceauthor=D.+R.+Feikinauthor=L.+Fengauthor=A.+Gentileauthor=A.+Gordonauthor=D.+Goswamiauthor=S.+Goyetauthor=M.+Groomeauthor=N.+Halasaauthor=S.+Hirveauthor=N.+Homairaauthor=S.+R.+C.+Howieauthor=J.+Jaraauthor=I.+Jroundiauthor=C.+B.+Kartasasmitaauthor=N.+Khuri-Bulosauthor=K.+L.+Kotloffauthor=A.+Krishnanauthor=R.+Libsterauthor=O.+Lopezauthor=M.+G.+Luceroauthor=F.+Lucionauthor=S.+P.+Lupisanauthor=D.+N.+Marconeauthor=J.+P.+McCrackenauthor=M.+Mejiaauthor=J.+C.+Moisiauthor=J.+M.+Montgomeryauthor=D.+P.+Mooreauthor=C.+Moraledaauthor=J.+Moyesauthor=P.+Munywokiauthor=K.+Mutyaraauthor=M.+P.+Nicolauthor=D.+J.+Nokesauthor=P.+Nymadawaauthor=M.+T.+da+Costa+Oliveiraauthor=H.+Oshitaniauthor=N.+Pandeyauthor=G.+Paranhos-Baccal%C3%A0author=L.+N.+Phillipsauthor=V.+S.+Picotauthor=M.+Rahmanauthor=M.+Rakoto-Andrianariveloauthor=Z.+A.+Rasmussenauthor=B.+A.+Rathauthor=A.+Robinsonauthor=C.+Romeroauthor=G.+Russomandoauthor=V.+Salimiauthor=P.+Sawatwongauthor=N.+Scheltemaauthor=B.+Schweigerauthor=J.+A.+G.+Scottauthor=P.+Seidenbergauthor=K.+Shenauthor=R.+Singletonauthor=V.+Sotomayorauthor=T.+A.+Strandauthor=A.+Sutantoauthor=M.+Syllaauthor=M.+D.+Tapiaauthor=S.+Thamthitiwatauthor=E.+D.+Thomasauthor=R.+Tokarzauthor=C.+Turnerauthor=M.+Venterauthor=S.+Waicharoenauthor=J.+Wangauthor=W.+Watthanaworawitauthor=L.-M.+Yoshidaauthor=H.+Yuauthor=H.+J.+Zarauthor=H.+Campbellauthor=H.+Nairauthor=for+RSV+Global+Epidemiology+Network.&title=Global%2C+regional%2C+and+national+disease+burden+estimates+of+acute+lower+respiratory+infections+due+to+respiratory+syncytial+virus+in+young+children+in+2015%3A+A+systematic+review+and+modelling+study&doi=10.1016%2FS0140-6736%2817%2930938-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study</span></div><div class="casAuthors">Shi Ting; Balsells Evelyn; Campbell Stuart; Campbell Harry; McAllister David A; O'Brien Katherine L; Deloria-Knoll Maria; Simoes Eric A F; Madhi Shabir A; Groome Michelle; Moore David P; Gessner Bradford D; Moisi Jennifer C; Polack Fernando P; Acacio Sozinho; Aguayo Claudia; Sotomayor Viviana; Alassani Issifou; Ali Asad; Antonio Martin; Ebruke Bernard E; Awasthi Shally; Pandey Nitin; Awori Juliet O; Azziz-Baumgartner Eduardo; Baggett Henry C; Baillie Vicky L; Balmaseda Angel; Barahona Alfredo; Basnet Sudha; Bassat Quique; Basualdo Wilma; Bigogo Godfrey; Bont Louis; Scheltema Nienke; Breiman Robert F; Brooks W Abdullah; Goswami Doli; Broor Shobha; Krishnan Anand; Bruce Nigel; Dherani Mukesh; Bruden Dana; Buchy Philippe; Carosone-Link Phyllis; Chadha Mandeep; Chipeta James; Chou Monidarin; Clara Wilfrido; Cohen Cheryl; Moyes Jocelyn; de Cuellar Elizabeth; Dang Duc-Anh; Dash-Yandag Budragchaagiin; Eap Tekchheng; Echavarria Marcela; Marcone Debora N; de Freitas Lazaro Emediato Carla Cecilia; da Costa Oliveira Maria Tereza; Fasce Rodrigo A; Feikin Daniel R; Feng Luzhao; Yu Hongjie; Gentile Angela; Lucion Florencia; Gordon Aubree; Goyet Sophie; Halasa Natasha; Hirve Siddhivinayak; Homaira Nusrat; Howie Stephen R C; Jara Jorge; McCracken John P; Jroundi Imane; Kartasasmita Cissy B; Mutyara Kuswandewi; Khuri-Bulos Najwa; Kotloff Karen L; Tapia Milagritos D; Libster Romina; Lopez Olga; Lucero Marilla G; Lupisan Socorro P; Mejia Mario; Montgomery Joel M; Moraleda Cinta; Munywoki Patrick; Nicol Mark P; Nokes D James; Nymadawa Pagbajabyn; Oshitani Histoshi; Paranhos-Baccala Glaucia; Picot Valentina Sanchez; Phillips Lia N; Rahman Mustafizur; Rakoto-Andrianarivelo Mala; Rasmussen Zeba A; Thomas Elizabeth D; Rath Barbara A; Robinson Annick; Romero Candice; Russomando Graciela; Salimi Vahid; Sawatwong Pongpun; Thamthitiwat Somsak; Schweiger Brunhilde; Scott J Anthony G; Seidenberg Phil; Shen Kunling; Singleton Rosalyn; Strand Tor A; Sutanto Agustinus; Sylla Mariam; Tokarz Rafal; Turner Claudia; Watthanaworawit Wanitda; Venter Marietjie; Waicharoen Sunthareeya; Wang Jianwei; Yoshida Lay-Myint; Zar Heather J; Nair Harish</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10098</span>),
    <span class="NLM_cas:pages">946-958</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005.  In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries.  With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015.  METHODS:  We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies.  We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates.  We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies.  We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity.  FINDINGS:  We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years.  In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI.  We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400).  Incidence and mortality varied substantially from year to year in any given population.  INTERPRETATION:  Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services.  About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months.  An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group.  FUNDING:  The Bill & Melinda Gates Foundation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1wEfflojsmwxyojvcjibhfW6udTcc2ebInbBb9iMdgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjlslKluw%253D%253D&md5=e31889022b79f89577df68e5c4fa2788</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2930938-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252930938-8%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DT.%26aulast%3DMcAllister%26aufirst%3DD.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DK.%2BL.%26aulast%3DSimoes%26aufirst%3DE.%2BA.%2BF.%26aulast%3DMadhi%26aufirst%3DS.%2BA.%26aulast%3DGessner%26aufirst%3DB.%2BD.%26aulast%3DPolack%26aufirst%3DF.%2BP.%26aulast%3DBalsells%26aufirst%3DE.%26aulast%3DAcacio%26aufirst%3DS.%26aulast%3DAguayo%26aufirst%3DC.%26aulast%3DAlassani%26aufirst%3DI.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DAntonio%26aufirst%3DM.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DAwori%26aufirst%3DJ.%2BO.%26aulast%3DAzziz-Baumgartner%26aufirst%3DE.%26aulast%3DBaggett%26aufirst%3DH.%2BC.%26aulast%3DBaillie%26aufirst%3DV.%2BL.%26aulast%3DBalmaseda%26aufirst%3DA.%26aulast%3DBarahona%26aufirst%3DA.%26aulast%3DBasnet%26aufirst%3DS.%26aulast%3DBassat%26aufirst%3DQ.%26aulast%3DBasualdo%26aufirst%3DW.%26aulast%3DBigogo%26aufirst%3DG.%26aulast%3DBont%26aufirst%3DL.%26aulast%3DBreiman%26aufirst%3DR.%2BF.%26aulast%3DBrooks%26aufirst%3DW.%2BA.%26aulast%3DBroor%26aufirst%3DS.%26aulast%3DBruce%26aufirst%3DN.%26aulast%3DBruden%26aufirst%3DD.%26aulast%3DBuchy%26aufirst%3DP.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DCarosone-Link%26aufirst%3DP.%26aulast%3DChadha%26aufirst%3DM.%26aulast%3DChipeta%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DM.%26aulast%3DClara%26aufirst%3DW.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3Dde%2BCuellar%26aufirst%3DE.%26aulast%3DDang%26aufirst%3DD.-A.%26aulast%3DDash-yandag%26aufirst%3DB.%26aulast%3DDeloria-Knoll%26aufirst%3DM.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DEap%26aufirst%3DT.%26aulast%3DEbruke%26aufirst%3DB.%2BE.%26aulast%3DEchavarria%26aufirst%3DM.%26aulast%3Dde%2BFreitas%2BL%25C3%25A1zaro%2BEmediato%26aufirst%3DC.%2BC.%26aulast%3DFasce%26aufirst%3DR.%2BA.%26aulast%3DFeikin%26aufirst%3DD.%2BR.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DGentile%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DGoswami%26aufirst%3DD.%26aulast%3DGoyet%26aufirst%3DS.%26aulast%3DGroome%26aufirst%3DM.%26aulast%3DHalasa%26aufirst%3DN.%26aulast%3DHirve%26aufirst%3DS.%26aulast%3DHomaira%26aufirst%3DN.%26aulast%3DHowie%26aufirst%3DS.%2BR.%2BC.%26aulast%3DJara%26aufirst%3DJ.%26aulast%3DJroundi%26aufirst%3DI.%26aulast%3DKartasasmita%26aufirst%3DC.%2BB.%26aulast%3DKhuri-Bulos%26aufirst%3DN.%26aulast%3DKotloff%26aufirst%3DK.%2BL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DLibster%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DO.%26aulast%3DLucero%26aufirst%3DM.%2BG.%26aulast%3DLucion%26aufirst%3DF.%26aulast%3DLupisan%26aufirst%3DS.%2BP.%26aulast%3DMarcone%26aufirst%3DD.%2BN.%26aulast%3DMcCracken%26aufirst%3DJ.%2BP.%26aulast%3DMejia%26aufirst%3DM.%26aulast%3DMoisi%26aufirst%3DJ.%2BC.%26aulast%3DMontgomery%26aufirst%3DJ.%2BM.%26aulast%3DMoore%26aufirst%3DD.%2BP.%26aulast%3DMoraleda%26aufirst%3DC.%26aulast%3DMoyes%26aufirst%3DJ.%26aulast%3DMunywoki%26aufirst%3DP.%26aulast%3DMutyara%26aufirst%3DK.%26aulast%3DNicol%26aufirst%3DM.%2BP.%26aulast%3DNokes%26aufirst%3DD.%2BJ.%26aulast%3DNymadawa%26aufirst%3DP.%26aulast%3Dda%2BCosta%2BOliveira%26aufirst%3DM.%2BT.%26aulast%3DOshitani%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DN.%26aulast%3DParanhos-Baccal%25C3%25A0%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DL.%2BN.%26aulast%3DPicot%26aufirst%3DV.%2BS.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DRakoto-Andrianarivelo%26aufirst%3DM.%26aulast%3DRasmussen%26aufirst%3DZ.%2BA.%26aulast%3DRath%26aufirst%3DB.%2BA.%26aulast%3DRobinson%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DC.%26aulast%3DRussomando%26aufirst%3DG.%26aulast%3DSalimi%26aufirst%3DV.%26aulast%3DSawatwong%26aufirst%3DP.%26aulast%3DScheltema%26aufirst%3DN.%26aulast%3DSchweiger%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DSeidenberg%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DK.%26aulast%3DSingleton%26aufirst%3DR.%26aulast%3DSotomayor%26aufirst%3DV.%26aulast%3DStrand%26aufirst%3DT.%2BA.%26aulast%3DSutanto%26aufirst%3DA.%26aulast%3DSylla%26aufirst%3DM.%26aulast%3DTapia%26aufirst%3DM.%2BD.%26aulast%3DThamthitiwat%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DE.%2BD.%26aulast%3DTokarz%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DM.%26aulast%3DWaicharoen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWatthanaworawit%26aufirst%3DW.%26aulast%3DYoshida%26aufirst%3DL.-M.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZar%26aufirst%3DH.%2BJ.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DNair%26aufirst%3DH.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520disease%2520burden%2520estimates%2520of%2520acute%2520lower%2520respiratory%2520infections%2520due%2520to%2520respiratory%2520syncytial%2520virus%2520in%2520young%2520children%2520in%25202015%253A%2520A%2520systematic%2520review%2520and%2520modelling%2520study%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D946%26epage%3D958%26doi%3D10.1016%2FS0140-6736%2817%2930938-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brammer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, K.</span></span> <span> </span><span class="NLM_article-title">Mortality associated with influenza and respiratory syncytial virus in the United States</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1001/jama.289.2.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1001%2Fjama.289.2.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=12517228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=179-186&author=W.+W.+Thompsonauthor=D.+K.+Shayauthor=E.+Weintraubauthor=L.+Brammerauthor=N.+Coxauthor=L.+J.+Andersonauthor=K.+Fukuda&title=Mortality+associated+with+influenza+and+respiratory+syncytial+virus+in+the+United+States&doi=10.1001%2Fjama.289.2.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality associated with influenza and respiratory syncytial virus in the United States</span></div><div class="casAuthors">Thompson William W; Shay David K; Weintraub Eric; Brammer Lynnette; Cox Nancy; Anderson Larry J; Fukuda Keiji</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality.  Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation.  OBJECTIVE:  To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype.  DESIGN, SETTING, AND POPULATION:  Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths.  Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons.  MAIN OUTCOME MEASURES:  Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes.  RESULTS:  Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category).  For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1).  Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36 155 (11 055) and 11 321 (668) underlying respiratory and circulatory deaths, and 51 203 (15 081) and 17 358 (1086) all-cause deaths.  For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older.  Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year.  On average, influenza was associated with 3 times as many deaths as RSV.  CONCLUSIONS:  Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons.  Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QBM7LTwlvHqj_yg7twvpfW6udTcc2eZDmJJhYavWgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D&md5=76dba2ff0597ae7dafd32c90820fa1f7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Fjama.289.2.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.289.2.179%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BW.%26aulast%3DShay%26aufirst%3DD.%2BK.%26aulast%3DWeintraub%26aufirst%3DE.%26aulast%3DBrammer%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DFukuda%26aufirst%3DK.%26atitle%3DMortality%2520associated%2520with%2520influenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D179%26epage%3D186%26doi%3D10.1001%2Fjama.289.2.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartert, T. V.</span></span> <span> </span><span class="NLM_article-title">Evidence for a causal relationship between respiratory syncytial virus infection and asthma</span>. <i>Expert Rev. Anti-infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1586/eri.11.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1586%2Feri.11.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=21905783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfislemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=731-745&author=P.+Wuauthor=T.+V.+Hartert&title=Evidence+for+a+causal+relationship+between+respiratory+syncytial+virus+infection+and+asthma&doi=10.1586%2Feri.11.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a causal relationship between respiratory syncytial virus infection and asthma</span></div><div class="casAuthors">Wu Pingsheng; Hartert Tina V</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of anti-infective therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">731-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) infects all children early in life, is the most common cause of infant lower respiratory tract infections, and causes disease exacerbations in children with asthma.  Episodes of lower respiratory tract infection in early life are associated with asthma development.  Whether RSV infection early in life directly causes asthma or simply identifies infants who are genetically predisposed to develop subsequent wheezing is debatable.  Recent studies suggest that these two explanations are not mutually exclusive, and are likely both important in asthma development.  An open-label study of RSV immunoprophylaxis administered to preterm infants reduced recurrent wheezing by 50%.  Clinical trials of infant RSV prevention, delay or severity reduction on the outcome of childhood asthma would confirm the causal relationship between RSV infection and asthma, and offer a primary prevention strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7ykLg-qbEDXtlzo9xastyfW6udTcc2eZDmJJhYavWgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfislemug%253D%253D&md5=441cea807a4e7c0e8cc585463b3c8c6e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1586%2Feri.11.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.11.92%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHartert%26aufirst%3DT.%2BV.%26atitle%3DEvidence%2520for%2520a%2520causal%2520relationship%2520between%2520respiratory%2520syncytial%2520virus%2520infection%2520and%2520asthma%26jtitle%3DExpert%2520Rev.%2520Anti-infect.%2520Ther.%26date%3D2011%26volume%3D9%26spage%3D731%26epage%3D745%26doi%3D10.1586%2Feri.11.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tin
Tin Htar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerramalla, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moïsi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, D. L.</span></span> <span> </span><span class="NLM_article-title">The burden of respiratory syncytial virus in adults: A systematic review and meta-analysis</span>. <i>Epidemiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>148</i></span>, <span class="NLM_elocation-id">e48</span> <span class="refDoi"> DOI: 10.1017/S0950268820000400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1017%2FS0950268820000400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32052719" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2020&author=M.+Tin%0ATin+Htarauthor=M.+S.+Yerramallaauthor=J.+C.+Mo%C3%AFsiauthor=D.+L.+Swerdlow&title=The+burden+of+respiratory+syncytial+virus+in+adults%3A+A+systematic+review+and+meta-analysis&doi=10.1017%2FS0950268820000400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1017%2FS0950268820000400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0950268820000400%26sid%3Dliteratum%253Aachs%26aulast%3DTin%2BTin%2BHtar%26aufirst%3DM.%26aulast%3DYerramalla%26aufirst%3DM.%2BS.%26aulast%3DMo%25C3%25AFsi%26aufirst%3DJ.%2BC.%26aulast%3DSwerdlow%26aufirst%3DD.%2BL.%26atitle%3DThe%2520burden%2520of%2520respiratory%2520syncytial%2520virus%2520in%2520adults%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DEpidemiol.%2520Infect.%26date%3D2020%26volume%3D148%26doi%3D10.1017%2FS0950268820000400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. K.</span></span> <span> </span><span class="NLM_article-title">High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections</span>. <i>Clin Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1077</span>, <span class="refDoi"> DOI: 10.1093/cid/cit471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Fcid%2Fcit471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=23876395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFygu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1069-1077&author=N.+Leeauthor=G.+C.+Luiauthor=K.+T.+Wongauthor=T.+C.+Liauthor=E.+C.+Tseauthor=J.+Y.+Chanauthor=J.+Yuauthor=S.+S.+Wongauthor=K.+W.+Choiauthor=R.+Y.+Wongauthor=K.+L.+Ngaiauthor=D.+S.+Huiauthor=P.+K.+Chan&title=High+morbidity+and+mortality+in+adults+hospitalized+for+respiratory+syncytial+virus+infections&doi=10.1093%2Fcid%2Fcit471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections</span></div><div class="casAuthors">Lee, N.; Lui, G. C. Y.; Wong, K. T.; Li, T. C. M.; Tse, E. C. M.; Chan, J. Y. C.; Yu, J.; Wong, S. S. M.; Choi, K. W.; Wong, R. Y. K.; Ngai, K. L. K.; Hui, D. S. C.; Chan, P. K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1069-1077</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In a large hospital cohort, older adults with respiratory syncytial virus infections were shown to have high rates of lower respiratory tract complications (72%) and respiratory failure requiring assisted ventilation (>10%), prolonged hospitalization, and high mortality (>10%).  Background. Better understanding of complications and outcomes of adults hospitalized with respiratory syncytial virus (RSV) infection is necessary.  Methods. A retrospective cohort study was conducted on all adults (≥18 years) admitted to 3 acute care general hospitals in Hong Kong with virol. confirmed RSV infection during 2009-2011 (N = 607).  Adults hospitalized for seasonal influenza during the period were used for comparison (n = 547).  Both infections were prospectively diagnosed following a std. protocol.  Independent reviews of chest radiographs were performed by radiologists.  Main outcome measures were all-cause death, respiratory failure requiring ventilatory support, and hospitalization duration.  Cox proportional hazards models were used for analyses.  Results. The mean age of RSV patients was 75 (SD, 16) years; 87% had underlying conditions.  Lower respiratory and cardiovascular complications were diagnosed in 71.9% (pneumonia, 42.3%; acute bronchitis, 21.9%; chronic obstructive pulmonary disease/asthma exacerbation, 27.3%) and 14.3% of patients, resp.; 12.5% had bacterial superinfections.  Supplemental oxygen and ventilatory support were required in 67.9% and 11.1%, resp.  Crude all-cause mortality was 9.1% and 11.9% within 30 days and 60 days, resp.; mean length of stay of survivors was 12 (SD, 13) days.  Advanced age, radiog. pneumonia, requirement for ventilation, bacterial superinfection, and elevated urea level and white blood cell count were independently assocd. with poorer survival.  Systemic corticosteroid use was assocd. with longer hospitalization and secondary infections.  The overall outcomes of survival and length of stay were not significantly different from those in influenza.  Conclusions. RSV can cause severe lower respiratory complications in older adults, resulting in respiratory failure, prolonged hospitalization, and high mortality similar to seasonal influenza.  Corticosteroids did not seem to improve outcomes.  The unmet need for antiviral therapy and vaccination against RSV in adults should be promptly addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Tm2SRrtGyrVg90H21EOLACvtfcHk0liKO3Co5PCUJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFygu7jK&md5=6876b479c6d8fbf2e1d1a73f12ae8e29</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit471%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.%26aulast%3DLui%26aufirst%3DG.%2BC.%26aulast%3DWong%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DT.%2BC.%26aulast%3DTse%26aufirst%3DE.%2BC.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DChoi%26aufirst%3DK.%2BW.%26aulast%3DWong%26aufirst%3DR.%2BY.%26aulast%3DNgai%26aufirst%3DK.%2BL.%26aulast%3DHui%26aufirst%3DD.%2BS.%26aulast%3DChan%26aufirst%3DP.%2BK.%26atitle%3DHigh%2520morbidity%2520and%2520mortality%2520in%2520adults%2520hospitalized%2520for%2520respiratory%2520syncytial%2520virus%2520infections%26jtitle%3DClin%2520Infect.%2520Dis.%26date%3D2013%26volume%3D57%26spage%3D1069%26epage%3D1077%26doi%3D10.1093%2Fcid%2Fcit471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falsey, A. R.</span></span> <span> </span><span class="NLM_article-title">Risk factors for severe respiratory syncytial virus infection in elderly persons</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1086/380907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1086%2F380907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=14722887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FitlCgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2004&pages=233-238&author=E.+E.+Walshauthor=D.+R.+Petersonauthor=A.+R.+Falsey&title=Risk+factors+for+severe+respiratory+syncytial+virus+infection+in+elderly+persons&doi=10.1086%2F380907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Risk factors for severe respiratory syncytial virus infection in elderly persons</span></div><div class="casAuthors">Walsh Edward E; Peterson Derick R; Falsey Ann R</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-8</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">Risk factors for severe respiratory syncytial virus (RSV) infection were determined in 3 cohorts of adults during 2 consecutive winters (1999-2000 and 2000-2001) in Rochester, New York.  Community-dwelling healthy persons > or =65 years old and persons >21 years old who had underlying symptomatic cardiopulmonary conditions were prospectively evaluated for RSV infection.  Evidence of infection was also sought in persons who were > or =65 years old or had underlying cardiopulmonary disease and who were hospitalized with acute respiratory symptoms.  Sixty-nine RSV infections were identified by culture, reverse-transcription polymerase chain reaction, or serologic testing in the prospective groups, and 61 were identified in the hospitalized group.  The presence of underlying chronic pulmonary disease (odds ratio [OR], 3.97), functional disability (OR, 1.67/integer increase in Instruments of Activities of Daily Living score), and low serum neutralizing antibody titer (OR, 5.89) were each independently associated with increased risk of severe disease, defined as "hospitalization with RSV infection." These data suggest that the induction of neutralizing serum antibody with an RSV vaccine may potentially reduce disease severity in adult populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1oqRk11s5o7P3FVUi_gf8fW6udTcc2ebyRfLwEfug8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FitlCgsA%253D%253D&md5=e71db55d15f961f245b7f149cf7d9a3a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F380907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F380907%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DFalsey%26aufirst%3DA.%2BR.%26atitle%3DRisk%2520factors%2520for%2520severe%2520respiratory%2520syncytial%2520virus%2520infection%2520in%2520elderly%2520persons%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D189%26spage%3D233%26epage%3D238%26doi%3D10.1086%2F380907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falsey, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessey, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formica, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus infection in elderly and high-risk adults</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa043951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa043951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=15858184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1749-1759&author=A.+R.+Falseyauthor=P.+A.+Hennesseyauthor=M.+A.+Formicaauthor=C.+Coxauthor=E.+E.+Walsh&title=Respiratory+syncytial+virus+infection+in+elderly+and+high-risk+adults&doi=10.1056%2FNEJMoa043951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection in elderly and high-risk adults</span></div><div class="casAuthors">Falsey, Ann R.; Hennessey, Patricia A.; Formica, Maria A.; Cox, Christopher; Walsh, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1749-1759</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults.  Data on the epidemiol. and clin. effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development.  METHODS During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (≥65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions.  RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serol. studies.  RESULTS A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled.  A total of 2514 illnesses were evaluated.  RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients.  RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults.  Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups.  In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, resp.), and mortality (8 percent and 7 percent, resp.).  On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clin. Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma.  CONCLUSIONS RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high.  An effective RSV vaccine may offer benefits for these adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4DLnaPCjP7Vg90H21EOLACvtfcHk0liKO3Co5PCUJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsr8%253D&md5=84051565564c0794974fde0b28a0e887</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa043951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa043951%26sid%3Dliteratum%253Aachs%26aulast%3DFalsey%26aufirst%3DA.%2BR.%26aulast%3DHennessey%26aufirst%3DP.%2BA.%26aulast%3DFormica%26aufirst%3DM.%2BA.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%2520in%2520elderly%2520and%2520high-risk%2520adults%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1749%26epage%3D1759%26doi%3D10.1056%2FNEJMoa043951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boeckh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuypers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, R.</span></span> <span> </span><span class="NLM_article-title">Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1086/509930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1086%2F509930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=17173225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2007&pages=245-249&author=M.+Boeckhauthor=J.+Englundauthor=Y.+Liauthor=C.+Millerauthor=A.+Crossauthor=H.+Fernandezauthor=J.+Kuypersauthor=H.+Kimauthor=J.+Gnannauthor=R.+Whitley&title=Randomized+controlled+multicenter+trial+of+aerosolized+ribavirin+for+respiratory+syncytial+virus+upper+respiratory+tract+infection+in+hematopoietic+cell+transplant+recipients&doi=10.1086%2F509930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients</span></div><div class="casAuthors">Boeckh, Michael; Englund, Janet; Li, Yufeng; Miller, Carole; Cross, Alan; Fernandez, Humberto; Kuypers, Jane; Kim, Hyung; Gnann, John; Whitley, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus infection of the upper airways may progress to fatal pneumonia in hematopoietic cell transplant recipients.  The safety and efficacy of aerosolized ribavirin in preventing disease progression is unknown.  Methods: In a multicenter prospective trial, hematopoietic cell transplant recipients with respiratory syncytial virus infection of the upper airways were randomized to receive ribavirin (2g 3 times daily) or supportive care for 10 days.  The primary end point was progression to radiog. proven pneumonia.  Secondary end points included virol. proven respiratory syncytial virus pneumonia, viral load changes, and safety.  Results: Fourteen patients were randomized to 1 of 2 treatment arms.  The trial was discontinued after 5 years because of slow accrual.  Pneumonia at 1 mo after randomization occurred in 1 of 9 patients who received ribavirin and in 2 of 5 patients who received supportive care (P = .51); virol. proven respiratory syncytial virus pneumonia occurred in 0 of 9 and 2 of 5 patients, resp. (P = .11). At 10 days after randomization, the av. viral load decreased by 0.75 log10 copies/mL in ribavirin recipients, compared with a viral load increase of 1.26 log10 copies/mL in untreated patients (P = .07).  No discontinuations of ribavirin therapy because of adverse effects occurred during 84 drug administrations.  Rates of adverse events were similar in both groups.  Conclusions: Preemptive aerosolized ribavirin treatment appeared to be safe, and trends of decreasing viral load over time were obsd.  However, proof of efficacy remains elusive in hematopoietic cell transplant recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeJWblyEW72rVg90H21EOLACvtfcHk0lgHlckTYLY6fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKkt7s%253D&md5=98e0890e9a040091ec33dbe070559193</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1086%2F509930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F509930%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckh%26aufirst%3DM.%26aulast%3DEnglund%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%26aulast%3DKuypers%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DGnann%26aufirst%3DJ.%26aulast%3DWhitley%26aufirst%3DR.%26atitle%3DRandomized%2520controlled%2520multicenter%2520trial%2520of%2520aerosolized%2520ribavirin%2520for%2520respiratory%2520syncytial%2520virus%2520upper%2520respiratory%2520tract%2520infection%2520in%2520hematopoietic%2520cell%2520transplant%2520recipients%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2007%26volume%3D44%26spage%3D245%26epage%3D249%26doi%3D10.1086%2F509930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. R.</span></span> <span> </span><span class="NLM_article-title">Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: Results from four years of palivizumab usage</span>. <i>Pediatr. Infect. Dis. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">S46</span>– <span class="NLM_lpage">S54</span>, <span class="refDoi"> DOI: 10.1097/01.inf.0000053885.34703.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1097%2F01.inf.0000053885.34703.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=12671452" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=S46-S54&author=J.+R.+Romero&title=Palivizumab+prophylaxis+of+respiratory+syncytial+virus+disease+from+1998+to+2002%3A+Results+from+four+years+of+palivizumab+usage&doi=10.1097%2F01.inf.0000053885.34703.84"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2F01.inf.0000053885.34703.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.inf.0000053885.34703.84%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DJ.%2BR.%26atitle%3DPalivizumab%2520prophylaxis%2520of%2520respiratory%2520syncytial%2520virus%2520disease%2520from%25201998%2520to%25202002%253A%2520Results%2520from%2520four%2520years%2520of%2520palivizumab%2520usage%26jtitle%3DPediatr.%2520Infect.%2520Dis.%2520J.%26date%3D2003%26volume%3D22%26spage%3DS46%26epage%3DS54%26doi%3D10.1097%2F01.inf.0000053885.34703.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gala, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildreth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Eyck, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. J.</span></span> <span> </span><span class="NLM_article-title">Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1056/NEJM198306163082403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJM198306163082403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=6343860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADyaL3s3hvFSrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1983&pages=1443-1447&author=C.+B.+Hallauthor=J.+T.+McBrideauthor=E.+E.+Walshauthor=D.+M.+Bellauthor=C.+L.+Galaauthor=S.+Hildrethauthor=L.+G.+Ten+Eyckauthor=W.+J.+Hall&title=Aerosolized+ribavirin+treatment+of+infants+with+respiratory+syncytial+viral+infection.+A+randomized+double-blind+study&doi=10.1056%2FNEJM198306163082403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study</span></div><div class="casAuthors">Hall C B; McBride J T; Walsh E E; Bell D M; Gala C L; Hildreth S; Ten Eyck L G; Hall W J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1443-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus.  Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days.  Seventeen infants were treated with placebo, and 16 with ribavirin.  By the end of treatment, infants receiving ribavirin had significantly greater improvement in their overall score for severity of illness, in lower-respiratory-tract signs, and in arterial oxygen saturation.  Viral shedding was also diminished in the treated groups as compared with the placebo group.  No side effects or toxicity were associated with the aerosol therapy.  Isolates of respiratory syncytial virus obtained from the infants over the course of therapy showed no change in sensitivity to ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ9XKtcKu4OC-bLEOO4dYpfW6udTcc2eYBRCIcQ6PVPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s3hvFSrsA%253D%253D&md5=b1ed2d8c6c38451ac61b41369de5f8ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2FNEJM198306163082403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198306163082403%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DC.%2BB.%26aulast%3DMcBride%26aufirst%3DJ.%2BT.%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26aulast%3DBell%26aufirst%3DD.%2BM.%26aulast%3DGala%26aufirst%3DC.%2BL.%26aulast%3DHildreth%26aufirst%3DS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BG.%26aulast%3DHall%26aufirst%3DW.%2BJ.%26atitle%3DAerosolized%2520ribavirin%2520treatment%2520of%2520infants%2520with%2520respiratory%2520syncytial%2520viral%2520infection.%2520A%2520randomized%2520double-blind%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1983%26volume%3D308%26spage%3D1443%26epage%3D1447%26doi%3D10.1056%2FNEJM198306163082403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taber, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaudt, W. R.</span></span> <span> </span><span class="NLM_article-title">Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=6356005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADyaL2c%252FktFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1983&pages=613-618&author=L.+H.+Taberauthor=V.+Knightauthor=B.+E.+Gilbertauthor=H.+W.+McClungauthor=S.+Z.+Wilsonauthor=H.+J.+Nortonauthor=J.+M.+Thursonauthor=W.+H.+Gordonauthor=R.+L.+Atmarauthor=W.+R.+Schlaudt&title=Ribavirin+aerosol+treatment+of+bronchiolitis+associated+with+respiratory+syncytial+virus+infection+in+infants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants</span></div><div class="casAuthors">Taber L H; Knight V; Gilbert B E; McClung H W; Wilson S Z; Norton H J; Thurson J M; Gordon W H; Atmar R L; Schlaudt W R</div><div class="citationInfo"><span class="NLM_cas:title">Pediatrics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-8</span>
        ISSN:<span class="NLM_cas:issn">0031-4005</span>.
    </div><div class="casAbstract">In a double-blind study, bronchiolitis associated with respiratory syncytial virus infection in 12 randomly selected patients treated with ribavirin aerosol improved more rapidly than in 14 control patients given saline aerosol (P = .044, Wilcoxon rank sum test, two-tailed).  An estimated 10 mg of ribavirin per kilogram of body weight was administered in daily 12-hour treatments over a five-day period.  Respiratory syncytial virus disappeared from secretions at about the same rate in treated and control patients.  There was no local or systemic intolerance, and there was no evidence of hematologic or other organ toxicity in the ribavirin-treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBC8mxSsJG78zK395ZObgVfW6udTcc2eYBRCIcQ6PVPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FktFamsg%253D%253D&md5=4f1345f8b9df6ef9281bcdd422979d58</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaber%26aufirst%3DL.%2BH.%26aulast%3DKnight%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DB.%2BE.%26aulast%3DMcClung%26aufirst%3DH.%2BW.%26aulast%3DWilson%26aufirst%3DS.%2BZ.%26aulast%3DNorton%26aufirst%3DH.%2BJ.%26aulast%3DThurson%26aufirst%3DJ.%2BM.%26aulast%3DGordon%26aufirst%3DW.%2BH.%26aulast%3DAtmar%26aufirst%3DR.%2BL.%26aulast%3DSchlaudt%26aufirst%3DW.%2BR.%26atitle%3DRibavirin%2520aerosol%2520treatment%2520of%2520bronchiolitis%2520associated%2520with%2520respiratory%2520syncytial%2520virus%2520infection%2520in%2520infants%26jtitle%3DPediatrics%26date%3D1983%26volume%3D72%26spage%3D613%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P. L.</span>; <span class="NLM_string-name">Fearns, R.</span>; <span class="NLM_string-name">Graham, B. S.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus: Virology, reverse genetics, and pathogenesis of disease</span>.  <i>Challenges and Opportunities for Respiratory Syncytial Virus Vaccines</i>; <span class="NLM_series">Current Topics in Microbiology and Immunology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">372</span>, pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">38</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1007%2F978-3-642-38919-1_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=3-38&author=P.+L.+Collins&author=R.+Fearns&author=B.+S.+Graham&title=Challenges+and+Opportunities+for+Respiratory+Syncytial+Virus+Vaccines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-38919-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-38919-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BL.%26atitle%3DRespiratory%2520syncytial%2520virus%253A%2520Virology%252C%2520reverse%2520genetics%252C%2520and%2520pathogenesis%2520of%2520disease%26btitle%3DChallenges%2520and%2520Opportunities%2520for%2520Respiratory%2520Syncytial%2520Virus%2520Vaccines%26pub%3DSpringer%26date%3D2013%26volume%3D372%26spage%3D3%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglioni-Weinlich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambkin-Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Riordan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toback, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, J. W.</span></span> <span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1401184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.-L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1401184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0lh6gFZ4ep0ovA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.-L.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722%26doi%3D10.1056%2FNEJMoa1401184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meals, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fok-Seang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntjens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lounis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariën, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmerie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roymans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verloes, R.</span></span> <span> </span><span class="NLM_article-title">Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: A placebo-controlled study</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiy227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Finfdis%2Fjiy227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=29684148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCnt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2018&pages=748-756&author=M.+Stevensauthor=S.+Ruschauthor=J.+DeVincenzoauthor=Y.-I.+Kimauthor=L.+Harrisonauthor=E.+A.+Mealsauthor=A.+Boyersauthor=J.+Fok-Seangauthor=D.+Huntjensauthor=N.+Lounisauthor=K.+Mari%C3%ABnauthor=B.+Remmerieauthor=D.+Roymansauthor=A.+Koulauthor=R.+Verloes&title=Antiviral+activity+of+oral+JNJ-53718678+in+healthy+adult+volunteers+challenged+with+respiratory+syncytial+virus%3A+A+placebo-controlled+study&doi=10.1093%2Finfdis%2Fjiy227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: a placebo-controlled study</span></div><div class="casAuthors">Stevens, Marita; Rusch, Sarah; DeVincenzo, John; Kim, Young-In; Harrison, Lisa; Meals, Elizabeth A.; Boyers, Alison; Fok-Seang, Juin; Huntjens, Dymphy; Lounis, Nacer; Marien, Kris; Remmerie, Bart; Roymans, Dirk; Koul, Anil; Verloes, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">748-756</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Respiratory syncytial virus (RSV) disease has no effective treatment.  JNJ-53718678 is a fusion inhibitor with selective activity against RSV.  After confirmation of RSV infection or 5 days after inoculation with RSV, participants (n = 69) were randomized to JNJ-53718678 75 mg (n = 15), 200 mg (n = 17), 500 mg (n = 18), or placebo (n = 17) orally once daily for 7 days.  Antiviral effects were evaluated by assessing RSV RNA viral load (VL) area under the curve (AUC) from baseline (before the first dose) until discharge, time-to-peak VL, duration of viral shedding, clin. symptoms, and quantity of nasal secretions.  Mean VL AUC was lower for individuals treated with different doses of JNJ-53718678 vs. placebo (203.8-253.8 vs 432.8 log10 PFUe.hour/mL).  Also, mean peak VL, time to peak VL, duration of viral shedding, mean overall symptom score, and nasal secretion wt. were lower in each JNJ-53718678-treated group vs. placebo.  No clear exposure-response relationship was obsd.  Three participants discontinued due to treatment-emergent adverse events of grade 2 and 1 ECG change (JNJ-53718678 75 mg and 200 mg, resp.) and grade 2 urticaria (placebo).  Conclusions.  JNJ-53718678 at all 3 doses substantially reduced VL and clin. disease severity, thus establishing clin. proof of concept and the compd.'s potential as a novel RSV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9lct-FnOIM7Vg90H21EOLACvtfcHk0lh6gFZ4ep0ovA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCnt77J&md5=a7da58b73e29e9c06537292a14dc3408</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiy227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiy227%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DM.%26aulast%3DRusch%26aufirst%3DS.%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-I.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DMeals%26aufirst%3DE.%2BA.%26aulast%3DBoyers%26aufirst%3DA.%26aulast%3DFok-Seang%26aufirst%3DJ.%26aulast%3DHuntjens%26aufirst%3DD.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DMari%25C3%25ABn%26aufirst%3DK.%26aulast%3DRemmerie%26aufirst%3DB.%26aulast%3DRoymans%26aufirst%3DD.%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DVerloes%26aufirst%3DR.%26atitle%3DAntiviral%2520activity%2520of%2520oral%2520JNJ-53718678%2520in%2520healthy%2520adult%2520volunteers%2520challenged%2520with%2520respiratory%2520syncytial%2520virus%253A%2520A%2520placebo-controlled%2520study%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2018%26volume%3D218%26spage%3D748%26epage%3D756%26doi%3D10.1093%2Finfdis%2Fjiy227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efthimiou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littler, E.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">e01884</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1128/AAC.01884-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1128%2FAAC.01884-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31712214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2020&pages=e01884-19&author=J.+DeVincenzoauthor=D.+Taitauthor=J.+Efthimiouauthor=J.+Moriauthor=Y.-I.+Kimauthor=E.+Thomasauthor=L.+Wilsonauthor=R.+Harlandauthor=N.+Mathewsauthor=S.+Cockerillauthor=K.+Powellauthor=E.+Littler&title=A+randomized%2C+placebo-controlled%2C+respiratory+syncytial+virus+human+challenge+study+of+the+antiviral+efficacy%2C+safety%2C+and+pharmacokinetics+of+RV521%2C+an+inhibitor+of+the+RSV-F+protein&doi=10.1128%2FAAC.01884-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein</span></div><div class="casAuthors">DeVincenzo, John; Tait, Dereck; Efthimiou, John; Mori, Julie; Kim, Young-In; Thomas, Elaine; Wilson, Lynn; Harland, Rachel; Mathews, Neil; Cockerill, Stuart; Powell, Kenneth; Littler, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e01884</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Effective treatments for respiratory syncytial virus (RSV) infection are lacking.  Here, we report a human proof-of-concept study for RV521, a small-mol. antiviral inhibitor of the RSV-F protein.  In this randomized, double-blind, placebo-controlled trial, healthy adults were challenged with RSV-A Memphis-37b.  After infection was confirmed (or 5 days after challenge virus inoculation), subjects received RV521 (350 mg or 200 mg) or placebo orally every 12 h for 5 days.  The primary endpoint was area under the curve (AUC) for viral load, as assessed by reverse transcriptase quant. PCR (RT-qPCR) of nasal wash samples.  The primary efficacy anal. set included subjects successfully infected with RSV who received ≥1 dose of study drug.  A total of 66 subjects were enrolled (n = 22 per group); 53 were included in the primary anal. set (RV521 350 mg: n = 16; 200 mg: n = 18; placebo: n = 19).  The mean AUC of RT-qPCR-assessed RSV viral load (log10 PFU equiv. [PFUe]/mL.h) was significantly lower with RV521 350 mg (185.26; std. error [SE], 31.17; P = 0.002) and 200 mg (224.35; SE, 37.60; P = 0.007) vs. placebo (501.39; SE, 86.57).  Disease severity improved with RV521 350 mg and 200 mg vs. placebo (P = 0.002 and P = 0.009, resp., for AUC total symptom score [score × hours]).  Daily nasal mucus wt. was significantly reduced (P = 0.010 and P = 0.038 for RV521 350 mg and 200 mg, resp., vs. placebo).  All treatment-emergent adverse events were grade 1 or 2.  No subjects discontinued due to adverse events.  There was no evidence of clin. significant viral resistance, and only three variants were detected.  RV521 effectively reduced RSV viral load and disease severity in humans and was well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVsGp1QWwVrVg90H21EOLACvtfcHk0lj46Ir5r7b4Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFygs7g%253D&md5=9e3b634f6cca773406727b57776eea0d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01884-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01884-19%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DTait%26aufirst%3DD.%26aulast%3DEfthimiou%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-I.%26aulast%3DThomas%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DHarland%26aufirst%3DR.%26aulast%3DMathews%26aufirst%3DN.%26aulast%3DCockerill%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DK.%26aulast%3DLittler%26aufirst%3DE.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%252C%2520respiratory%2520syncytial%2520virus%2520human%2520challenge%2520study%2520of%2520the%2520antiviral%2520efficacy%252C%2520safety%252C%2520and%2520pharmacokinetics%2520of%2520RV521%252C%2520an%2520inhibitor%2520of%2520the%2520RSV-F%2520protein%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2020%26volume%3D64%26spage%3De01884%26epage%3D19%26doi%3D10.1128%2FAAC.01884-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coakley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenhoor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noulin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvathova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adda, N.</span></span> <span> </span><span class="NLM_article-title">LB6. EDP-938, a novel RSV N-inhibitor, administered once or twice daily was safe and demonstrated robust antiviral and clinical efficacy in a healthy volunteer challenge study</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S995</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofz415.2489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Fofid%2Fofz415.2489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=S995&author=E.+Coakleyauthor=A.+Ahmadauthor=K.+Larsonauthor=T.+McClureauthor=K.+Linauthor=K.+Linauthor=K.+Tenhoorauthor=K.+Ezeauthor=N.+Noulinauthor=V.+Horvathovaauthor=B.+Murrayauthor=M.+Bailletauthor=J.+Moriauthor=N.+Adda&title=LB6.+EDP-938%2C+a+novel+RSV+N-inhibitor%2C+administered+once+or+twice+daily+was+safe+and+demonstrated+robust+antiviral+and+clinical+efficacy+in+a+healthy+volunteer+challenge+study&doi=10.1093%2Fofid%2Fofz415.2489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofz415.2489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofz415.2489%26sid%3Dliteratum%253Aachs%26aulast%3DCoakley%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DLarson%26aufirst%3DK.%26aulast%3DMcClure%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DTenhoor%26aufirst%3DK.%26aulast%3DEze%26aufirst%3DK.%26aulast%3DNoulin%26aufirst%3DN.%26aulast%3DHorvathova%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DBaillet%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DAdda%26aufirst%3DN.%26atitle%3DLB6.%2520EDP-938%252C%2520a%2520novel%2520RSV%2520N-inhibitor%252C%2520administered%2520once%2520or%2520twice%2520daily%2520was%2520safe%2520and%2520demonstrated%2520robust%2520antiviral%2520and%2520clinical%2520efficacy%2520in%2520a%2520healthy%2520volunteer%2520challenge%2520study%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2019%26volume%3D6%26spage%3DS995%26doi%3D10.1093%2Fofid%2Fofz415.2489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambkin-Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, J.</span></span> <span> </span><span class="NLM_article-title">Activity of oral ALS-008176 in a respiratory syncytial virus challenge study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2058</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1413275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1413275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26580997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2048-2058&author=J.+P.+DeVincenzoauthor=M.+W.+McClureauthor=J.+A.+Symonsauthor=H.+Fathiauthor=C.+Westlandauthor=S.+Chandaauthor=R.+Lambkin-Williamsauthor=P.+Smithauthor=Q.+Zhangauthor=L.+Beigelmanauthor=L.+M.+Blattauthor=J.+Fry&title=Activity+of+oral+ALS-008176+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1413275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of oral ALS-008176 in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; McClure, Matthew W.; Symons, Julian A.; Fathi, Hosnieh; Westland, Christopher; Chanda, Sushmita; Lambkin-Williams, Rob; Smith, Patrick; Zhang, Qingling; Beigelman, Leo; Blatt, Lawrence M.; Fry, John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2048-2058</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality.  There is no known effective therapy.  We conducted a randomized, double-blind, clin. trial in healthy adults inoculated with RSV.  Participants received the oral nucleoside analog ALS-008176 or placebo 12 h after confirmation of RSV infection or 6 days after inoculation.  Treatment was administered every 12 h for 5 days.  Viral load, disease severity, resistance, and safety were measured throughout the 28-day study period, with measurement beginning before inoculation.  The primary end point was the area under the curve (AUC) for viral load, which was assessed immediately before administration of the first dose through the 12th day after inoculation in participants infected with RSV.  A total of 62 participants received placebo or one of three ALS-008176 dosing regimens: 1 loading dose of 750 mg followed by 9 maintenance doses of 500 mg (group 1), 1 loading dose of 750 mg followed by 9 maintenance doses of 150 mg (group 2), or 10 doses of 375 mg (group 3).  In the 35 infected participants (23 of whom were treated with ALS-008176), the AUCs for viral load for groups 1, 2, and 3 and the placebo group were 59.9, 73.7, 133.4, and 500.9 log10 plaque-forming-unit equiv. × hours per mL, resp. (P≤0.001).  The time to nondetectability on polymerase-chain-reaction assay (P<0.001), the peak viral load (P≤0.001), the AUC for symptom score (P<0.05), and the AUC for mucus wt. were lower in all groups receiving ALS-008176 than in the placebo group.  Antiviral activity was greatest in the two groups that received a loading dose - viral clearance was accelerated (P≤0.05), and the AUC for viral load decreased by 85 to 88% as compared with the placebo group.  Within this small trial, no viral rebound or resistance was identified.  There were no serious adverse events, and there was no need for premature discontinuation of the study drug.  In this RSV challenge study, more rapid RSV clearance and a greater redn. of viral load, with accompanying improvements in the severity of clin. disease, were obsd. in the groups treated with ALS-008176 than in the placebo group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVhsAaDKW-4bVg90H21EOLACvtfcHk0lj46Ir5r7b4Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVSrsro%253D&md5=e1cac2ef1b91f47abf768403cb072ec0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1413275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1413275%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DMcClure%26aufirst%3DM.%2BW.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DFathi%26aufirst%3DH.%26aulast%3DWestland%26aufirst%3DC.%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DFry%26aufirst%3DJ.%26atitle%3DActivity%2520of%2520oral%2520ALS-008176%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2048%26epage%3D2058%26doi%3D10.1056%2FNEJMoa1413275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span> <span> </span><span class="NLM_article-title">Nucleosides for the treatment of respiratory RNA virus infections</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">2040206618764483</span> <span class="refDoi"> DOI: 10.1177/2040206618764483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1177%2F2040206618764483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&author=P.+C.+Jordanauthor=S.+K.+Stevensauthor=J.+Deval&title=Nucleosides+for+the+treatment+of+respiratory+RNA+virus+infections&doi=10.1177%2F2040206618764483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F2040206618764483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040206618764483%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DP.%2BC.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DNucleosides%2520for%2520the%2520treatment%2520of%2520respiratory%2520RNA%2520virus%2520infections%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2018%26volume%3D26%26doi%3D10.1177%2F2040206618764483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boojamra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedra, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinkade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theodore, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1021/jm5017768</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1yltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1630-1643&author=R.+L.+Mackmanauthor=M.+Sangiauthor=D.+Sperandioauthor=J.+P.+Parrishauthor=E.+Eisenbergauthor=M.+Perronauthor=H.+Huiauthor=L.+Zhangauthor=D.+Siegelauthor=H.+Yangauthor=O.+Saundersauthor=C.+Boojamraauthor=G.+Leeauthor=D.+Samuelauthor=K.+Babaogluauthor=A.+Careyauthor=B.+E.+Gilbertauthor=P.+A.+Piedraauthor=R.+Strickleyauthor=Q.+Iwataauthor=J.+Hayesauthor=K.+Strayauthor=A.+Kinkadeauthor=D.+Theodoreauthor=R.+Jordanauthor=M.+Desaiauthor=T.+Cihlar&title=Discovery+of+an+oral+respiratory+syncytial+virus+%28RSV%29+fusion+inhibitor+%28GS-5806%29+and+clinical+proof+of+concept+in+a+human+RSV+challenge+study&doi=10.1021%2Fjm5017768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study</span></div><div class="casAuthors">Mackman, Richard L.; Sangi, Michael; Sperandio, David; Parrish, Jay P.; Eisenberg, Eugene; Perron, Michel; Hui, Hon; Zhang, Lijun; Siegel, Dustin; Yang, Hai; Saunders, Oliver; Boojamra, Constantine; Lee, Gary; Samuel, Dharmaraj; Babaoglu, Kerim; Carey, Anne; Gilbert, Brian E.; Piedra, Pedro A.; Strickley, Robert; Iwata, Quynh; Hayes, Jaclyn; Stray, Kirsten; Kinkade, April; Theodore, Dorothy; Jordan, Robert; Desai, Manoj; Cihlar, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1630-1643</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GS-5806 I is a novel, orally bioavailable RSV fusion inhibitor discovered following a lead optimization campaign on a screening hit.  The oral absorption properties were optimized by converting to the pyrazolo[1,5-a]-pyrimidine heterocycle, while potency, metabolic, and physicochem. properties were optimized by introducing the para-chloro and aminopyrrolidine groups.  A mean EC50 = 0.43 nM was found toward a panel of 75 RSV A and B clin. isolates and dose-dependent antiviral efficacy in the cotton rat model of RSV infection.  Oral bioavailability in preclin. species ranged from 46 to 100%, with evidence of efficient penetration into lung tissue.  In healthy human volunteers exptl. infected with RSV, a potent antiviral effect was obsd. with a mean 4.2 log10 redn. in peak viral load and a significant redn. in disease severity compared to placebo.  In conclusion, a potent, once daily, oral RSV fusion inhibitor with the potential to treat RSV infection in infants and adults is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL4lY74Xv7GbVg90H21EOLACvtfcHk0ljYCJz0Sz919g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1yltw%253D%253D&md5=5a723ce1defe717da8cb7985ee297811</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm5017768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017768%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSangi%26aufirst%3DM.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DParrish%26aufirst%3DJ.%2BP.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSaunders%26aufirst%3DO.%26aulast%3DBoojamra%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DCarey%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DB.%2BE.%26aulast%3DPiedra%26aufirst%3DP.%2BA.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DQ.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DStray%26aufirst%3DK.%26aulast%3DKinkade%26aufirst%3DA.%26aulast%3DTheodore%26aufirst%3DD.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DCihlar%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520oral%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520fusion%2520inhibitor%2520%2528GS-5806%2529%2520and%2520clinical%2520proof%2520of%2520concept%2520in%2520a%2520human%2520RSV%2520challenge%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1630%26epage%3D1643%26doi%3D10.1021%2Fjm5017768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Kim, C.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">1′-Substituted Carba-Nucleoside Analogs for Antiviral Treatment</span>. <span class="NLM_patent">WO2009/132135</span>, Gilead Sciences, April 22, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Butler&author=A.+Cho&author=C.+Kim&author=O.+L.+Saunders&author=L.+Zhang&title=1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs+for+Antiviral+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3D1%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%2520for%2520Antiviral%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suanders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.bmcl.2012.02.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=22446091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2705-2707&author=A.+Choauthor=O.+L.+Suandersauthor=T.+Butlerauthor=L.+Zhangauthor=J.+Xuauthor=J.+E.+Velaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+and+antiviral+activity+of+a+series+of+1%E2%80%B2-substituted+4-aza-7%2C9-dideazaadenosine+C-nucleosides&doi=10.1016%2Fj.bmcl.2012.02.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span></div><div class="casAuthors">Cho, Aesop; Saunders, Oliver L.; Butler, Thomas; Zhang, Lijun; Xu, Jie; Vela, Jennifer E.; Feng, Joy Y.; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2705-2707</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1'-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside, e.g. I, were prepd. and evaluated for the potential as antiviral agents.  These compds. showed a broad range of inhibitory activity against various RNA viruses.  In particular, the whole cell potency against HCV when R = CN was attributed to inhibition of HCV NS5B polymerase and intracellular concn. of the corresponding nucleoside triphosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAj_ComFGJ9LVg90H21EOLACvtfcHk0ljYCJz0Sz919g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D&md5=b7576da7b34ae7b3862d80b52645465a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.105%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DSuanders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520a%2520series%2520of%25201%25E2%2580%25B2-substituted%25204-aza-7%252C9-dideazaadenosine%2520C-nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2705%26epage%3D2707%26doi%3D10.1016%2Fj.bmcl.2012.02.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHutchison, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1021/jm400201a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400201a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1812-1825&author=A.+Choauthor=L.+Zhangauthor=J.+Xuauthor=R.+Leeauthor=T.+Butlerauthor=S.+Metoboauthor=V.+Aktoudianakisauthor=W.+Lewauthor=H.+Yeauthor=M.+Clarkeauthor=E.+Doerfflerauthor=D.+Byunauthor=T.+Wangauthor=D.+Babusisauthor=A.+C.+Careyauthor=P.+Bermanauthor=D.+Sauerauthor=W.+Zhongauthor=S.+Rossiauthor=M.+Fenauxauthor=J.+G.+McHutchisonauthor=J.+Perryauthor=J.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Discovery+of+the+first+C-nucleoside+HCV+polymerase+inhibitor+%28GS-6620%29+with+demonstrated+antiviral+response+in+HCV+infected+patients&doi=10.1021%2Fjm400201a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span></div><div class="casAuthors">Cho, Aesop; Zhang, Lijun; Xu, Jie; Lee, Rick; Butler, Thomas; Metobo, Sammy; Aktoudianakis, Vangelis; Lew, Willard; Ye, Hong; Clarke, Michael; Doerffler, Edward; Byun, Daniel; Wang, Ting; Babusis, Darius; Carey, Anne C.; German, Polina; Sauer, Dorothea; Zhong, Weidong; Rossi, Stephen; Fenaux, Martijn; McHutchison, John G.; Perry, Jason; Feng, Joy; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1812-1825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection presents an unmet medical need requiring more effective treatment options.  Nucleoside inhibitors (NI) of HCV polymerase (NS5B) have demonstrated pan-genotypic activity and durable antiviral response in the clinic, and they are likely to become a key component of future treatment regimens.  NI candidates that have entered clin. development thus far have all been N-nucleoside derivs.  Herein, we report the discovery of a C-nucleoside class of NS5B inhibitors.  Exploration of adenosine analogs in this class identified 1'-cyano-2'-C-Me 4-aza-7,9-dideaza adenosine as a potent and selective inhibitor of NS5B.  A monophosphate prodrug approach afforded a series of compds. showing submicromolar activity in HCV replicon assays.  Further pharmacokinetic optimization for sufficient oral absorption and liver triphosphate loading led to identification of a clin. development candidate GS-6620 (I).  In a phase I clin. study, the potential for potent activity was demonstrated but with high intra- and interpatient pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0DWejYRAB7Vg90H21EOLACvtfcHk0litwhdElkkG1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D&md5=60cb14dcd3d500933bcf4e55e9257fc6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400201a%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DV.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DA.%2BC.%26aulast%3DBerman%26aufirst%3DP.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DRossi%26aufirst%3DS.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520the%2520first%2520C-nucleoside%2520HCV%2520polymerase%2520inhibitor%2520%2528GS-6620%2529%2520with%2520demonstrated%2520antiviral%2520response%2520in%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1812%26epage%3D1825%26doi%3D10.1021%2Fjm400201a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyatkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4′-chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1878</span>, <span class="refDoi"> DOI: 10.1021/jm5017279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1862-1878&author=G.+Wangauthor=J.+Devalauthor=J.+Hongauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=J.+Taylorauthor=A.+Fungauthor=Z.+Jinauthor=S.+K.+Stevensauthor=V.+Serebryanyauthor=J.+Liuauthor=Q.+Zhangauthor=Y.+Tamauthor=S.+M.+Chandaauthor=D.+B.+Smithauthor=J.+A.+Symonsauthor=L.+M.+Blattauthor=L.+Beigelman&title=Discovery+of+4%E2%80%B2-chloromethyl-2%E2%80%B2-deoxy-3%E2%80%B2%2C5%E2%80%B2-di-O-isobutyryl-2%E2%80%B2-fluorocytidine+%28ALS-8176%29%2C+a+first-in-class+RSV+polymerase+inhibitor+for+treatment+of+human+respiratory+syncytial+virus+infection&doi=10.1021%2Fjm5017279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4'-Chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection</span></div><div class="casAuthors">Wang, Guangyi; Deval, Jerome; Hong, Jin; Dyatkina, Natalia; Prhavc, Marija; Taylor, Joshua; Fung, Amy; Jin, Zhinan; Stevens, Sarah K.; Serebryany, Vladimir; Liu, Jyanwei; Zhang, Qingling; Tam, Yuen; Chanda, Sushmita M.; Smith, David B.; Symons, Julian A.; Blatt, Lawrence M.; Beigelman, Leo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1862-1878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is assocd. with significant morbidity and mortality.  To date, ribavirin is the only approved small mol. drug, which has limited use.  The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis.  Clearly, there is an urgent need for small mol. RSV drugs.  This article reports the design, synthesis, anti-RSV activity, metab., and pharmacokinetics of a series of 4'-substituted cytidine nucleosides.  Among tested compds. 4'-chloromethyl-2'-deoxy-2'-fluorocytidine I exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM.  The 5'-triphosphate of I (I-TP)inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM.  ALS-8176 II, the 3',5'-di-O-isobutyryl prodrug of I, demonstrated good oral bioavailability and a high level of I-TP in vivo.  Compd. II is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clin. RSV challenge study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaKHh4AhV9drVg90H21EOLACvtfcHk0litwhdElkkG1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D&md5=da9e883eb67f20ca259dec06a6a05367</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm5017279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017279%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-O-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2520%2528ALS-8176%2529%252C%2520a%2520first-in-class%2520RSV%2520polymerase%2520inhibitor%2520for%2520treatment%2520of%2520human%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1862%26epage%3D1878%26doi%3D10.1021%2Fjm5017279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalayanov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sund, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winqvist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltseva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leveque, V. J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajyaguru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkestock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span> <span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: The discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′,2′-difluorocytidine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2971</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm801595c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=C.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+4%E2%80%B2-azidocytidine+against+hepatitis+C+virus+replication%3A+The+discovery+of+4%E2%80%B2-azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine&doi=10.1021%2Fjm801595c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4'-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4'-Azido-2'-deoxy-2'-fluorocytidine and 4'-Azido-2'-dideoxy-2',2'-difluorocytidine</span></div><div class="casAuthors">Smith, David B.; Kalayanov, Genadiy; Sund, Christian; Winqvist, Anna; Maltseva, Tatiana; Leveque, Vincent J.-P.; Rajyaguru, Sonal; Le Pogam, Sophie; Najera, Isabel; Benkestock, Kurt; Zhou, Xiao-Xiong; Kaiser, Ann C.; Maag, Hans; Cammack, Nick; Martin, Joseph A.; Swallow, Steven; Johansson, Nils Gunnar; Klumpp, Klaus; Smith, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2971-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 4'-azidocytidine (R1479) (J. Biol. Chem.2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 μM), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the synthesis and biol. evaluation of several monofluoro and difluoro derivs. of 4'-azidocytidine.  The most potent compds. in this series were 4'-azido-2'-deoxy-2',2'-difluorocytidine I (R = F) and 4'-azido-2'-deoxy-2'-fluoroarabinocytidine I (R = H) with antiviral EC50 of 66 nM and 24 nM in the HCV replicon system, resp.  The structure-activity relationships within this series were discussed, which led to the discovery of these novel nucleoside analogs with the most potent compd., showing more than a 50-fold increase in antiviral potency as compared to 4'-azidocytidine (R1479).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWf69k-wQED7Vg90H21EOLACvtfcHk0li1r3gRURNztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKrtbc%253D&md5=c9d96b25d6d3247580087a5d657a9c1f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%25204%25E2%2580%25B2-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520The%2520discovery%2520of%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978%26doi%3D10.1021%2Fjm801595c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7202</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.1021/jm100863x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Micolochick+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus&doi=10.1021%2Fjm100863x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0li1r3gRURNztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218%26doi%3D10.1021%2Fjm100863x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span> <span> </span><span class="NLM_article-title">Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1006889</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1006889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1371%2Fjournal.ppat.1006889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=29425244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsleltrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=P.+C.+Jordanauthor=C.+Liuauthor=P.+Raynaudauthor=M.+K.+Loauthor=C.+F.+Spiropoulouauthor=J.+A.+Symonsauthor=L.+Beigelmanauthor=J.+Deval&title=Initiation%2C+extension%2C+and+termination+of+RNA+synthesis+by+a+paramyxovirus+polymerase&doi=10.1371%2Fjournal.ppat.1006889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase</span></div><div class="casAuthors">Jordan, Paul C.; Liu, Cheng; Raynaud, Pauline; Lo, Michael K.; Spiropoulou, Christina F.; Symons, Julian A.; Beigelman, Leo; Deval, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006889/1-e1006889/23</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Paramyxoviruses represent a family of RNA viruses causing significant human diseases.  These include measles virus, the most infectious virus ever reported, in addn. to parainfluenza virus, and other emerging viruses.  Paramyxoviruses likely share common replication machinery but their mechanisms of RNA biosynthesis activities and details of their complex polymerase structures are unknown.  Mechanistic and functional details of a paramyxovirus polymerase would have sweeping implications for understanding RNA virus replication and for the development of new antiviral medicines.  To study paramyxovirus polymerase structure and function, we expressed an active recombinant Nipah virus (NiV) polymerase complex assembled from the multifunctional NiV L protein bound to its phosphoprotein cofactor.  NiV is an emerging highly pathogenic virus that causes severe encephalitis and has been declared a global public health concern due to its high mortality rate.  Using neg.-stain electron microscopy, we demonstrated NiV polymerase forms ring-like particles resembling related RNA polymerases.  We identified conserved sequence elements driving recognition of the 3'- terminal genomic promoter by NiV polymerase, and leading to initiation of RNA synthesis, primer extension, and transition to elongation mode.  Polyadenylation resulting from NiV polymerase stuttering provides a mechanistic basis for transcription termination.  It also suggests a divergent adaptation in promoter recognition between pneumo- and paramyxoviruses.  The lack of available antiviral therapy for NiV prompted us to identify the triphosphate forms of R1479 and GS-5734, two clin. relevant nucleotide analogs, as substrates and inhibitors of NiV polymerase activity by delayed chain termination.  Overall, these findings provide low-resoln. structural details and the mechanism of an RNA polymerase from a previously uncharacterized virus family.  This work illustrates important functional differences yet remarkable similarities between the polymerases of nonsegmented neg.-strand RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SobNcmdy9rVg90H21EOLACvtfcHk0li1r3gRURNztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsleltrvM&md5=c4e11dad7faf0fb43d2dfff9f3dc202a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006889%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DP.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DP.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DInitiation%252C%2520extension%252C%2520and%2520termination%2520of%2520RNA%2520synthesis%2520by%2520a%2520paramyxovirus%2520polymerase%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1006889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyatkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoycheva, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span> <span> </span><span class="NLM_article-title">Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2′-fluoro-4′-chloromethyl-cytidine triphosphate</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004995</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1371%2Fjournal.ppat.1004995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26098424" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=J.+Devalauthor=J.+Hongauthor=G.+Wangauthor=J.+Taylorauthor=L.+K.+Smithauthor=A.+Fungauthor=S.+K.+Stevensauthor=H.+Liuauthor=Z.+Jinauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=A.+D.+Stoychevaauthor=V.+Serebryanyauthor=J.+Liuauthor=D.+B.+Smithauthor=Y.+Tamauthor=Q.+Zhangauthor=M.+L.+Mooreauthor=R.+Fearnsauthor=S.+M.+Chandaauthor=L.+M.+Blattauthor=J.+A.+Symonsauthor=L.+Beigelman&title=Molecular+basis+for+the+selective+inhibition+of+respiratory+syncytial+virus+RNA+polymerase+by+2%E2%80%B2-fluoro-4%E2%80%B2-chloromethyl-cytidine+triphosphate&doi=10.1371%2Fjournal.ppat.1004995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004995%26sid%3Dliteratum%253Aachs%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DL.%2BK.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DStoycheva%26aufirst%3DA.%2BD.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520selective%2520inhibition%2520of%2520respiratory%2520syncytial%2520virus%2520RNA%2520polymerase%2520by%25202%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-chloromethyl-cytidine%2520triphosphate%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.ppat.1004995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchesnokov, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span> <span> </span><span class="NLM_article-title">Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">6785</span>– <span class="NLM_lpage">6797</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA120.013679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1074%2Fjbc.RA120.013679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32284326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Wqt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=6785-6797&author=C.+J.+Gordonauthor=E.+P.+Tchesnokovauthor=E.+Woolnerauthor=J.+K.+Perryauthor=J.+Y.+Fengauthor=D.+P.+Porterauthor=M.+G%C3%B6tte&title=Remdesivir+is+a+direct-acting+antiviral+that+inhibits+RNA-dependent+RNA+polymerase+from+severe+acute+respiratory+syndrome+coronavirus+2+with+high+potency&doi=10.1074%2Fjbc.RA120.013679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency</span></div><div class="casAuthors">Gordon, Calvin J.; Tchesnokov, Egor P.; Woolner, Emma; Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6785-6797</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to control this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Replication of SARS-CoV-2 depends on the viral RNA-dependent RNA polymerase (RdRp), which is the likely target of the investigational nucleotide analog remdesivir (RDV).  RDV shows broad-spectrum antiviral activity against RNA viruses, and previous studies with RdRps from Ebola virus and Middle East respiratory syndrome coronavirus (MERS-CoV) have revealed that delayed chain termination is RDV's plausible mechanism of action.  Here, we expressed and purified active SARS-CoV-2 RdRp composed of the nonstructural proteins nsp8 and nsp12.  Enzyme kinetics indicated that this RdRp efficiently incorporates the active triphosphate form of RDV (RDV-TP) into RNA.  Incorporation of RDV-TP at position i caused termination of RNA synthesis at position i + 3.  We obtained almost identical results with SARS-CoV, MERS-CoV, and SARS-CoV-2 RdRps.  A unique property of RDV-TP is its high selectivity over incorporation of its natural nucleotide counterpart ATP.  In this regard, the triphosphate forms of 2'-C-methylated compds., including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits.  Furthermore, we provide evidence for the target specificity of RDV, as RDV-TP was less efficiently incorporated by the distantly related Lassa virus RdRp, and termination of RNA synthesis was not obsd.  These results collectively provide a unifying, refined mechanism of RDV-mediated RNA synthesis inhibition in coronaviruses and define this nucleotide analog as a direct-acting antiviral.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHbFv_ESm2rVg90H21EOLACvtfcHk0lh53kx3_w4Y8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Wqt7bN&md5=10cbcacce46953727591712e0edebed8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013679%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BJ.%26aulast%3DTchesnokov%26aufirst%3DE.%2BP.%26aulast%3DWoolner%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26atitle%3DRemdesivir%2520is%2520a%2520direct-acting%2520antiviral%2520that%2520inhibits%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%25202%2520with%2520high%2520potency%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D6785%26epage%3D6797%26doi%3D10.1074%2Fjbc.RA120.013679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick
Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">34337</span>– <span class="NLM_lpage">34347</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1074%2Fjbc.M110.161802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=20801890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34337-34347&author=E.+Murakamiauthor=T.+Tolstykhauthor=H.+Baoauthor=C.+Niuauthor=H.+M.+Micolochick%0ASteuerauthor=D.+Baoauthor=W.+Changauthor=C.+Espirituauthor=S.+Bansalauthor=A.+M.+Lamauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furman&title=Mechanism+of+activation+of+PSI-7851+and+its+diastereoisomer+PSI-7977&doi=10.1074%2Fjbc.M110.161802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977</span></div><div class="casAuthors">Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34337-34347</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A phosphoramidate prodrug of 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo.  PSI-7851 is a mixt. of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay.  To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form.  The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction.  Western blot anal. showed that CatA and CES1 are both expressed in primary human hepatocytes.  However, expression of CES1 is undetectable in clone A replicon cells.  Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis.  Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the prodn. of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers.  The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411.  SiRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411.  PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SPaB9Whp17Vg90H21EOLACvtfcHk0lh53kx3_w4Y8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O&md5=28287a5f7547ab85158f594cd5fb1cd0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161802%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520activation%2520of%2520PSI-7851%2520and%2520its%2520diastereoisomer%2520PSI-7977%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34337%26epage%3D34347%26doi%3D10.1074%2Fjbc.M110.161802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klena, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span> <span> </span><span class="NLM_article-title">Remdesivir (GS-5734) protects African Green monkeys from Nipah virus challenge</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">eaau9242</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aau9242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1126%2Fscitranslmed.aau9242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31142680" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&author=M.+K.+Loauthor=F.+Feldmannauthor=J.+M.+Garyauthor=R.+Jordanauthor=R.+Bannisterauthor=J.+Croninauthor=N.+R.+Patelauthor=J.+D.+Klenaauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+R.+Zakiauthor=H.+Feldmannauthor=C.+F.+Spiropoulouauthor=E.+de+Wit&title=Remdesivir+%28GS-5734%29+protects+African+Green+monkeys+from+Nipah+virus+challenge&doi=10.1126%2Fscitranslmed.aau9242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aau9242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aau9242%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DGary%26aufirst%3DJ.%2BM.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DCronin%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKlena%26aufirst%3DJ.%2BD.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DZaki%26aufirst%3DS.%2BR.%26aulast%3DFeldmann%26aufirst%3DH.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3Dde%2BWit%26aufirst%3DE.%26atitle%3DRemdesivir%2520%2528GS-5734%2529%2520protects%2520African%2520Green%2520monkeys%2520from%2520Nipah%2520virus%2520challenge%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2019%26volume%3D11%26doi%3D10.1126%2Fscitranslmed.aau9242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span> <span> </span><span class="NLM_article-title">Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6771</span>– <span class="NLM_lpage">6776</span>, <span class="refDoi"> DOI: 10.1073/pnas.1922083117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1073%2Fpnas.1922083117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32054787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsl2jtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=6771-6776&author=E.+de%0AWitauthor=F.+Feldmannauthor=J.+Croninauthor=R.+Jordanauthor=A.+Okumuraauthor=T.+Thomasauthor=D.+Scottauthor=T.+Cihlarauthor=H.+Feldmann&title=Prophylactic+and+therapeutic+remdesivir+%28GS-5734%29+treatment+in+the+rhesus+macaque+model+of+MERS-CoV+infection&doi=10.1073%2Fpnas.1922083117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection</span></div><div class="casAuthors">de Wit, Emmie; Feldmann, Friederike; Cronin, Jacqueline; Jordan, Robert; Okumura, Atsushi; Thomas, Tina; Scott, Dana; Cihlar, Tomas; Feldmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6771-6776</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of effective antiviral treatments.  Remdesivir (GS-5734) effectively inhibited MERS coronavirus (MERS-CoV) replication in vitro, and showed efficacy against Severe Acute Respiratory Syndrome (SARS)-CoV in a mouse model.  Here, we tested the efficacy of prophylactic and therapeutic remdesivir treatment in a nonhuman primate model of MERS-CoV infection, the rhesus macaque.  Prophylactic remdesivir treatment initiated 24 h prior to inoculation completely prevented MERS-CoV-induced clin. disease, strongly inhibited MERS-CoV replication in respiratory tissues, and prevented the formation of lung lesions.  Therapeutic remdesivir treatment initiated 12 h postinoculation also provided a clear clin. benefit, with a redn. in clin. signs, reduced virus replication in the lungs, and decreased presence and severity of lung lesions.  The data presented here support testing of the efficacy of remdesivir treatment in the context of a MERS clin. trial.  It may also be considered for a wider range of coronaviruses, including the currently emerging novel coronavirus 2019-nCoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCmXVnq9TNnLVg90H21EOLACvtfcHk0limBt3FNSQ0Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsl2jtLw%253D&md5=42bcd1ccac323048b1d67893af237a99</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1922083117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1922083117%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DCronin%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DFeldmann%26aufirst%3DH.%26atitle%3DProphylactic%2520and%2520therapeutic%2520remdesivir%2520%2528GS-5734%2529%2520treatment%2520in%2520the%2520rhesus%2520macaque%2520model%2520of%2520MERS-CoV%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2020%26volume%3D117%26spage%3D6771%26epage%3D6776%26doi%3D10.1073%2Fpnas.1922083117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrc, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trantcheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaal3653</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aal3653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1126%2Fscitranslmed.aal3653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=28659436" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=T.+P.+Sheahanauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=V.+D.+Menacheryauthor=L.+E.+Gralinskiauthor=J.+B.+Caseauthor=S.+R.+Leistauthor=K.+Pyrcauthor=J.+Y.+Fengauthor=I.+Trantchevaauthor=R.+Bannisterauthor=Y.+Parkauthor=D.+Babusisauthor=M.+O.+Clarkeauthor=R.+L.+Mackmanauthor=J.+E.+Spahnauthor=C.+A.+Palmiottiauthor=D.+Siegelauthor=A.+S.+Rayauthor=T.+C.+Cihlarauthor=R.+Jordanauthor=M.+R.+Denisonauthor=R.+S.+Baric&title=Broad-spectrum+antiviral+GS-5734+inhibits+both+epidemic+and+zoonotic+coronaviruses&doi=10.1126%2Fscitranslmed.aal3653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal3653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal3653%26sid%3Dliteratum%253Aachs%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26aulast%3DGralinski%26aufirst%3DL.%2BE.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DPyrc%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DTrantcheva%26aufirst%3DI.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSpahn%26aufirst%3DJ.%2BE.%26aulast%3DPalmiotti%26aufirst%3DC.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%2BC.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26atitle%3DBroad-spectrum%2520antiviral%2520GS-5734%2520inhibits%2520both%2520epidemic%2520and%2520zoonotic%2520coronaviruses%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aal3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade-White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doremalen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yinda, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovaglio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturday, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span> <span> </span><span class="NLM_article-title">Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2423-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1038%2Fs41586-020-2423-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32516797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslelu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2020&pages=273-276&author=B.+N.+Williamsonauthor=F.+Feldmannauthor=B.+Schwarzauthor=K.+Meade-Whiteauthor=D.+P.+Porterauthor=J.+Schulzauthor=N.+van+Doremalenauthor=I.+Leightonauthor=C.+K.+Yindaauthor=L.+P%C3%A9rez-P%C3%A9rezauthor=A.+Okumuraauthor=J.+Lovaglioauthor=P.+W.+Hanleyauthor=G.+Saturdayauthor=C.+M.+Bosioauthor=S.+Anzickauthor=K.+Barbianauthor=T.+Cihlarauthor=C.+Martensauthor=D.+P.+Scottauthor=V.+J.+Munsterauthor=E.+de+Wit&title=Clinical+benefit+of+remdesivir+in+rhesus+macaques+infected+with+SARS-CoV-2&doi=10.1038%2Fs41586-020-2423-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2</span></div><div class="casAuthors">Williamson, Brandi N.; Feldmann, Friederike; Schwarz, Benjamin; Meade-White, Kimberly; Porter, Danielle P.; Schulz, Jonathan; van Doremalen, Neeltje; Leighton, Ian; Yinda, Claude Kwe; Perez-Perez, Lizzette; Okumura, Atsushi; Lovaglio, Jamie; Hanley, Patrick W.; Saturday, Greg; Bosio, Catharine M.; Anzick, Sarah; Barbian, Kent; Cihlar, Tomas; Martens, Craig; Scott, Dana P.; Munster, Vincent J.; de Wit, Emmie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">7824</span>),
    <span class="NLM_cas:pages">273-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed.  While many investigational, approved, and repurposed drugs have been suggested as potential treatments, preclin. data from animal models can guide the search for effective treatments by ruling out those that lack efficacy in vivo.  Remdesivir (GS-5734) is a nucleotide analog prodrug with broad antiviral activity1,2 that is currently being investigated in COVID-19 clin. trials and recently received Emergency Use Authorization from the US Food and Drug Administration3,4.  In animal models, remdesivir was effective against infection with Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)2,5,6.  In vitro, remdesivir inhibited replication of SARS-CoV-27,8.  Here we investigate the efficacy of remdesivir in a rhesus macaque model of SARS-CoV-2 infection9.  Unlike vehicle-treated animals, macaques treated with remdesivir did not show signs of respiratory disease; they also showed reduced pulmonary infiltrates on radiographs and reduced virus titers in bronchoalveolar lavages twelve hours after the first dose.  Virus shedding from the upper respiratory tract was not reduced by remdesivir treatment.  At necropsy, remdesivir-treated animals had lower lung viral loads and reduced lung damage.  Thus, treatment with remdesivir initiated early during infection had a clin. benefit in rhesus macaques infected with SARS-CoV-2.  Although the rhesus macaque model does not represent the severe disease obsd. in some patients with COVID-19, our data support the early initiation of remdesivir treatment in patients with COVID-19 to prevent progression to pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fZodXTdabLVg90H21EOLACvtfcHk0li0MgLKcjsIqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslelu7rJ&md5=68d6cbbababc8d7b3d005285528b896e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2423-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2423-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DB.%2BN.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DSchwarz%26aufirst%3DB.%26aulast%3DMeade-White%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DSchulz%26aufirst%3DJ.%26aulast%3Dvan%2BDoremalen%26aufirst%3DN.%26aulast%3DLeighton%26aufirst%3DI.%26aulast%3DYinda%26aufirst%3DC.%2BK.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DL.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DLovaglio%26aufirst%3DJ.%26aulast%3DHanley%26aufirst%3DP.%2BW.%26aulast%3DSaturday%26aufirst%3DG.%26aulast%3DBosio%26aufirst%3DC.%2BM.%26aulast%3DAnzick%26aufirst%3DS.%26aulast%3DBarbian%26aufirst%3DK.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DMartens%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BP.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3Dde%2BWit%26aufirst%3DE.%26atitle%3DClinical%2520benefit%2520of%2520remdesivir%2520in%2520rhesus%2520macaques%2520infected%2520with%2520SARS-CoV-2%26jtitle%3DNature%26date%3D2020%26volume%3D585%26spage%3D273%26epage%3D276%26doi%3D10.1038%2Fs41586-020-2423-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pruijssers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinksi, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinnon, K. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gully, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Pont, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilello, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span> <span> </span><span class="NLM_article-title">Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span>, <span class="NLM_elocation-id">107940</span> <span class="refDoi"> DOI: 10.1016/j.celrep.2020.107940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.celrep.2020.107940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32668216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2isrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&author=A.+J.+Pruijssersauthor=A.+S.+Georgeauthor=A.+Sch%C3%A4ferauthor=S.+R.+Leistauthor=L.+E.+Gralinksiauthor=K.+H.+Dinnonauthor=B.+L.+Yountauthor=M.+L.+Agostiniauthor=L.+J.+Stevensauthor=J.+D.+Chappellauthor=X.+Luauthor=T.+M.+Hughesauthor=K.+Gullyauthor=D.+R.+Martinezauthor=A.+J.+Brownauthor=R.+L.+Grahamauthor=J.+K.+Perryauthor=V.+Du+Pontauthor=J.+Pittsauthor=B.+Maauthor=D.+Babusisauthor=E.+Murakamiauthor=J.+Y.+Fengauthor=J.+P.+Bilelloauthor=D.+P.+Porterauthor=T.+Tomas+Cihlarauthor=R.+S.+Baricauthor=M.+R.+Denisonauthor=T.+P.+Sheahan&title=Remdesivir+inhibits+SARS-CoV-2+in+human+lung+cells+and+chimeric+SARS-CoV+expressing+the+SARS-CoV-2+RNA+polymerase+in+mice&doi=10.1016%2Fj.celrep.2020.107940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice</span></div><div class="casAuthors">Pruijssers, Andrea J.; George, Amelia S.; Schafer, Alexandra; Leist, Sarah R.; Gralinksi, Lisa E.; Dinnon, Kenneth H.; Yount, Boyd L.; Agostini, Maria L.; Stevens, Laura J.; Chappell, James D.; Lu, Xiaotao; Hughes, Tia M.; Gully, Kendra; Martinez, David R.; Brown, Ariane J.; Graham, Rachel L.; Perry, Jason K.; Du Pont, Venice; Pitts, Jared; Ma, Bin; Babusis, Darius; Murakami, Eisuke; Feng, Joy Y.; Bilello, John P.; Porter, Danielle P.; Cihlar, Tomas; Baric, Ralph S.; Denison, Mark R.; Sheahan, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107940</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the novel viral disease COVID-19.  With no approved therapies, this pandemic illustrates the urgent need for broad-spectrum antiviral countermeasures against SARS-CoV-2 and future emerging CoVs.  We report that remdesivir (RDV) potently inhibits SARS-CoV-2 replication in human lung cells and primary human airway epithelial cultures (EC50 = 0.01μM).  Weaker activity is obsd. in Vero E6 cells (EC50 = 1.65μM) because of their low capacity to metabolize RDV.  To rapidly evaluate in vivo efficacy, we engineered a chimeric SARS-CoV encoding the viral target of RDV, the RNA-dependent RNA polymerase of SARS-CoV-2.  In mice infected with the chimeric virus, therapeutic RDV administration diminishes lung viral load and improves pulmonary function compared with vehicle-treated animals.  These data demonstrate that RDV is potently active against SARS-CoV-2 in vitro and in vivo, supporting its further clin. testing for treatment of COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUzmxM5ARME7Vg90H21EOLACvtfcHk0li0MgLKcjsIqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2isrzL&md5=d869e7d9f406848283f0a92d14e8f9ed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107940%26sid%3Dliteratum%253Aachs%26aulast%3DPruijssers%26aufirst%3DA.%2BJ.%26aulast%3DGeorge%26aufirst%3DA.%2BS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DA.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DGralinksi%26aufirst%3DL.%2BE.%26aulast%3DDinnon%26aufirst%3DK.%2BH.%26aulast%3DYount%26aufirst%3DB.%2BL.%26aulast%3DAgostini%26aufirst%3DM.%2BL.%26aulast%3DStevens%26aufirst%3DL.%2BJ.%26aulast%3DChappell%26aufirst%3DJ.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHughes%26aufirst%3DT.%2BM.%26aulast%3DGully%26aufirst%3DK.%26aulast%3DMartinez%26aufirst%3DD.%2BR.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DDu%2BPont%26aufirst%3DV.%26aulast%3DPitts%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBilello%26aufirst%3DJ.%2BP.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DTomas%2BCihlar%26aufirst%3DT.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26atitle%3DRemdesivir%2520inhibits%2520SARS-CoV-2%2520in%2520human%2520lung%2520cells%2520and%2520chimeric%2520SARS-CoV%2520expressing%2520the%2520SARS-CoV-2%2520RNA%2520polymerase%2520in%2520mice%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D32%26doi%3D10.1016%2Fj.celrep.2020.107940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosserman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getty, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/jm030424e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030424e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVygtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2283-2295&author=A.+B.+Eldrupauthor=C.+R.+Allersonauthor=C.+F.+Bennettauthor=S.+Beraauthor=B.+Bhatauthor=N.+Bhatauthor=M.+R.+Bossermanauthor=J.+Brooksauthor=C.+Burleinauthor=S.+S.+Carrollauthor=P.+D.+Cookauthor=K.+L.+Gettyauthor=M.+MacCossauthor=D.+R.+McMastersauthor=D.+B.+Olsenauthor=T.+P.+Prakashauthor=M.+Prhavcauthor=Q.+Songauthor=J.+E.+Tomassiniauthor=J.+Xia&title=Structure-activity+relationship+of+purine+ribonucleosides+for+inhibition+of+hepatitis+C+virus+RNA-dependent+RNA+polymerase&doi=10.1021%2Fjm030424e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase</span></div><div class="casAuthors">Eldrup, Anne B.; Allerson, Charles R.; Bennett, C. Frank; Bera, Sanjib; Bhat, Balkrishen; Bhat, Neelima; Bosserman, Michele R.; Brooks, Jennifer; Burlein, Christine; Carroll, Steven S.; Cook, P. Dan; Getty, Krista L.; MacCoss, Malcolm; McMasters, Daniel R.; Olsen, David B.; Prakash, Thazha P.; Prhavc, Marija; Song, Quanlai; Tomassini, Joanne E.; Xia, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2283-2295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of a continued effort to identify inhibitors of hepatitis C viral (HCV) replication, we report here the synthesis and evaluation of a series of nucleoside analogs and their corresponding triphosphates.  Nucleosides were evaluated for their ability to inhibit HCV RNA replication in a cell-based, subgenomic replicon system, while nucleoside triphosphates were evaluated for their ability to inhibit in vitro RNA synthesis mediated by the HCV RNA-dependent RNA polymerase, NS5B.  2'-C-Methyladenosine and 2'-C-methylguanosine were identified as potent inhibitors of HCV RNA replication, and the corresponding triphosphates were found to be potent inhibitors of HCV NS5B-mediated RNA synthesis.  The data generated in the cell-based assay demonstrated a fairly stringent structure-activity relationship around the active nucleosides.  Increase in steric bulk beyond Me on C2, change in the stereo- or regiochem. of the Me substituent, or change of identity of the heterobase beyond that of the endogenous adenine or guanine was found to lead to loss of inhibitory activity.  The results highlight the importance of the ribo configuration 2'- and 3'-hydroxy pharmacophores for inhibition of HCV RNA replication in the cell-based assay and demonstrate that inclusion of the 2'-C-methylribonucleoside pharmacophore leads to increased resistance to adenosine deaminase and purine nucleoside phosphorylase mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN5TEtkVswmbVg90H21EOLACvtfcHk0li0MgLKcjsIqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVygtrg%253D&md5=a932a7398e472269f75c7ab029e8630f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm030424e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030424e%26sid%3Dliteratum%253Aachs%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DAllerson%26aufirst%3DC.%2BR.%26aulast%3DBennett%26aufirst%3DC.%2BF.%26aulast%3DBera%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBhat%26aufirst%3DN.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DCook%26aufirst%3DP.%2BD.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DPrakash%26aufirst%3DT.%2BP.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DXia%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520purine%2520ribonucleosides%2520for%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2283%26epage%3D2295%26doi%3D10.1021%2Fjm030424e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of β-D-2′-deoxy-2′-α-fluoro-4′-α-cyano-5-aza-7,9-dideazaadenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.bmcl.2015.04.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=25978965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2484-2487&author=M.+O.+Clarkeauthor=R.+Mackmanauthor=D.+Byunauthor=H.+Huiauthor=O.+Barauskasauthor=G.+Birkusauthor=B.-K.+Chunauthor=E.+Doerfflerauthor=J.+Fengauthor=K.+Karkiauthor=G.+Leeauthor=M.+Perronauthor=D.+Siegelauthor=S.+Swaminathanauthor=W.+Lee&title=Discovery+of+%CE%B2-D-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-4%E2%80%B2-%CE%B1-cyano-5-aza-7%2C9-dideazaadenosine+as+a+potent+nucleoside+inhibitor+of+respiratory+syncytial+virus+with+excellent+selectivity+over+mitochondrial+RNA+and+DNA+polymerases&doi=10.1016%2Fj.bmcl.2015.04.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-D-2'-deoxy-2'-α-fluoro-4'-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span></div><div class="casAuthors">Clarke, Michael O.; Mackman, Richard; Byun, Daniel; Hui, Hon; Barauskas, Ona; Birkus, Gabriel; Chun, Byoung-Kwon; Doerffler, Edward; Feng, Joy; Karki, Kapil; Lee, Gary; Perron, Michel; Siegel, Dustin; Swaminathan, Swami; Lee, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2484-2487</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 4'-substituted β-D-2'-deoxy-2'-α-fluoro (2'd2'F) nucleoside inhibitors of respiratory syncytial virus (RSV) are reported.  The introduction of 4'-substitution onto 2'd2'F nucleoside analogs resulted in compds. demonstrating potent cell based RSV inhibition, improved inhibition of the RSV polymerase by the nucleoside triphosphate metabolites, and enhanced selectivity over incorporation by mitochondrial RNA and DNA polymerases.  Selectivity over the mitochondrial polymerases was found to be extremely sensitive to the specific 4'-substitution and not readily predictable.  Combining the most potent and selective 4'-groups from N-nucleoside analogs onto a 2'd2'F C-nucleoside analog resulted in the identification of I as a promising nucleoside lead for RSV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr67PvLBml7Vg90H21EOLACvtfcHk0lijXQpw9ATFQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D&md5=744a3a2680ef899fcd84258c386471d2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.073%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-4%25E2%2580%25B2-%25CE%25B1-cyano-5-aza-7%252C9-dideazaadenosine%2520as%2520a%2520potent%2520nucleoside%2520inhibitor%2520of%2520respiratory%2520syncytial%2520virus%2520with%2520excellent%2520selectivity%2520over%2520mitochondrial%2520RNA%2520and%2520DNA%2520polymerases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2484%26epage%3D2487%26doi%3D10.1016%2Fj.bmcl.2015.04.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warhurst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gifford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastmond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and <span class="smallcaps smallerCapital">d</span>-peptides</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1021/js970120d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1021%2Fjs970120d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=9572915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADyaK1cXivVeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1998&pages=626-633&author=Y.-L.+Heauthor=S.+Murbyauthor=G.+Warhurstauthor=L.+Giffordauthor=D.+Walkerauthor=J.+Ayrtonauthor=R.+Eastmondauthor=M.+Rowland&title=Species+differences+in+size+discrimination+in+the+paracellular+pathway+reflected+by+oral+bioavailability+of+poly%28ethylene+glycol%29+and+d-peptides&doi=10.1021%2Fjs970120d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of polyethylene glycol and D-peptides</span></div><div class="casAuthors">He, Yan-Ling; Murby, Susan; Warhurst, Geoffrey; Gifford, Larry; Walker, David; Ayrton, John; Eastmond, Richard; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">626-633</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Animal models are frequently used to aid prediction of intestinal absorption in humans.  However, there is little comparative quant. information on species differences in paracellular permeation, which is an important route for oral absorption of small to medium-sized hydrophilic drug mols.  This study addresses this issue by comparing the mol. mass (MM) dependency in oral bioavailability between rat and dog of PEG, a polydispersed model mixt. commonly used to characterize paracellular absorption, and of a series of 8 D-peptides (based on D-phenylalanine).  Fasted rats and dogs received PEG (400/900) and the D-peptides (MM 236-406 Da), orally and i.v., with total 24-48 h urine collection to est. oral bioavailability.  After HPLC sepn., the individual PEG oligomers and D-peptides were detd. by using radiometric detection, for radiolabeled material, and LC-MS, for unlabeled (PEG) material.  All compds. were predominantly excreted unchanged following i.v. administration.  After oral administration, the predominant peak in the radio chromatogram was unchanged material, indicating stability of the compds. in the gastrointestinal tract.  A clear mol. mass dependency in oral bioavailability was seen with both series, but with absorption much greater in dog than rat.  Thus, for PEG in rat, bioavailability decreased sharply from 79 to around 2% with increasing MM between 282 and 591 Da, and then tapered to around 1.5% up to 1295 Da. .  Whereas in dog, bioavailability remained around 100% for oligomers up to 600 Da and then decreased quite sharply with increasing MM, tending to plateau around 13% beyond 900 Da.  Likewise, for the D-peptides in rat, bioavailability decreased from 30 to 1% with increasing MM between 236 and 406 Da, whereas in dog it was 100%, declining to 16% over the same mol. range.  This species difference appears to be due to a larger pore size and greater frequency of pores in the paracellular pathway of dog compared to rat.  Furthermore, on the basis of comparison with literature data for PEG and selected drugs, rat would appear to be a better predictor than dog of absorption of hydrophilic compds. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeYs7HYKui57Vg90H21EOLACvtfcHk0lijXQpw9ATFQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVeltLs%253D&md5=76f94525ac770ea72fa1584477e29dd1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjs970120d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs970120d%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.-L.%26aulast%3DMurby%26aufirst%3DS.%26aulast%3DWarhurst%26aufirst%3DG.%26aulast%3DGifford%26aufirst%3DL.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DAyrton%26aufirst%3DJ.%26aulast%3DEastmond%26aufirst%3DR.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DSpecies%2520differences%2520in%2520size%2520discrimination%2520in%2520the%2520paracellular%2520pathway%2520reflected%2520by%2520oral%2520bioavailability%2520of%2520poly%2528ethylene%2520glycol%2529%2520and%2520d-peptides%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1998%26volume%3D87%26spage%3D626%26epage%3D633%26doi%3D10.1021%2Fjs970120d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, M. E.</span></span> <span> </span><span class="NLM_article-title">Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10824137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1artbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2000&pages=781-789&author=M.+Sugawaraauthor=W.+Huangauthor=Y.-J.+Feiauthor=F.+H.+Leibachauthor=V.+Ganapathyauthor=M.+E.+Ganapathy&title=Transport+of+valganciclovir%2C+a+ganciclovir+prodrug%2C+via+peptide+transporters+PEPT1+and+PEPT2&doi=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2</span></div><div class="casAuthors">Sugawara, Mitsuru; Huang, Wei; Fei, You-Jun; Leibach, Frederick H.; Ganapathy, Vadivel; Ganapathy, Malliga E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In clin. trials, valganciclovir, the valyl ester of ganciclovir, has been shown to enhance the bioavailability of ganciclovir when taken orally by patients with cytomegalovirus infection.  We investigated the role of the intestinal peptide transporter PEPT1 in this process by comparing the interaction of ganciclovir and valganciclovir with the transporter in different exptl. systems.  We also studied the interaction of these two compds. with the renal peptide transporter PEPT2.  In cell culture model systems using Caco-2 cells for PEPT1 and SKPT cells for PEPT2, valganciclovir inhibited glycylsarcosine transport mediated by PEPT1 and PEPT2 with Ki values (inhibition const.) of 1.68 ± 0.30 and 0.043 ± 0.005 mM, resp.  The inhibition by valganciclovir was competitive in both cases.  Ganciclovir did not interact with either transporter.  Similar studies done with cloned PEPT1 and PEPT2 in heterologous expression systems yielded comparable results.  The transport of valganciclovir via PEPT1 was investigated directly in PEPT1-expressing Xenopus laevis oocytes with an electrophysiol. approach.  Valganciclovir, but not ganciclovir, induced inward currents in PEPT1-expressing oocytes.  These results demonstrate that the increased bioavailability of valganciclovir is related to its recognition as a substrate by the intestinal peptide transporter PEPT1.  This prodrug is also recognized by the renal peptide transporter PEPT2 with high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBcbDYOSpJvrVg90H21EOLACvtfcHk0ljIjB1k1B4SeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1artbY%253D&md5=bff73ba55562df124b08ecdaebcaa8b6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-6017%2528200006%252989%253A6%253C781%253A%253AAID-JPS10%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSugawara%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DFei%26aufirst%3DY.-J.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DGanapathy%26aufirst%3DM.%2BE.%26atitle%3DTransport%2520of%2520valganciclovir%252C%2520a%2520ganciclovir%2520prodrug%252C%2520via%2520peptide%2520transporters%2520PEPT1%2520and%2520PEPT2%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D89%26spage%3D781%26epage%3D789%26doi%3D10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisa, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for repurpose and design of nucleoside drugs for treating COVID-19</span>. <i>bioRxiv</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">11.01.363812</span> <span class="refDoi"> DOI: 10.1101/2020.11.01.363812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1101%2F2020.11.01.363812" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=W.+Yinauthor=X.+Luanauthor=Z.+Liauthor=Y.+Xieauthor=Z.+Zhouauthor=J.+Liuauthor=M.+Gaoauthor=X.+Wangauthor=F.+Zhouauthor=Q.+Wangauthor=Q.+Wangauthor=D.+Shenauthor=Y.+Zhangauthor=G.+Tianauthor=H.+A.+Aisaauthor=T.+Huauthor=D.+Weiauthor=Y.+Jiangauthor=G.+Xiaoauthor=H.+Jiangauthor=L.+Zhangauthor=X.+Yuauthor=J.+Shenauthor=S.+Zhangauthor=H.+E.+Xu&title=Structural+basis+for+repurpose+and+design+of+nucleoside+drugs+for+treating+COVID-19&doi=10.1101%2F2020.11.01.363812"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1101%2F2020.11.01.363812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.11.01.363812%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DAisa%26aufirst%3DH.%2BA.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520repurpose%2520and%2520design%2520of%2520nucleoside%2520drugs%2520for%2520treating%2520COVID-19%26jtitle%3DbioRxiv%26date%3D2020%26doi%3D10.1101%2F2020.11.01.363812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Périgaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubertin, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbach, J.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, decomposition pathways and “In Vitro” evaluation of bioreversible phosphotriesters of Azt</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1080/15257779508012467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1080%2F15257779508012467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=763-766&author=I.+Lefebvreauthor=A.+Pomponauthor=C.+P%C3%A9rigaudauthor=J.-L.+Girardetauthor=G.+Gosselinauthor=A.-M.+Aubertinauthor=A.+Kirnauthor=J.-L.+Imbach&title=Synthesis%2C+decomposition+pathways+and+%E2%80%9CIn+Vitro%E2%80%9D+evaluation+of+bioreversible+phosphotriesters+of+Azt&doi=10.1080%2F15257779508012467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1080%2F15257779508012467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257779508012467%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DI.%26aulast%3DPompon%26aufirst%3DA.%26aulast%3DP%25C3%25A9rigaud%26aufirst%3DC.%26aulast%3DGirardet%26aufirst%3DJ.-L.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DAubertin%26aufirst%3DA.-M.%26aulast%3DKirn%26aufirst%3DA.%26aulast%3DImbach%26aufirst%3DJ.-L.%26atitle%3DSynthesis%252C%2520decomposition%2520pathways%2520and%2520%25E2%2580%259CIn%2520Vitro%25E2%2580%259D%2520evaluation%2520of%2520bioreversible%2520phosphotriesters%2520of%2520Azt%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1995%26volume%3D14%26spage%3D763%26epage%3D766%26doi%3D10.1080%2F15257779508012467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Axt, S. D.</span>; <span class="NLM_string-name">Badalov, P. R.</span>; <span class="NLM_string-name">Brak, K.</span>; <span class="NLM_string-name">Campagna, S.</span>; <span class="NLM_string-name">Chtchemelinine, A.</span>; <span class="NLM_string-name">Doerffler, E.</span>; <span class="NLM_string-name">Frick, M. M.</span>; <span class="NLM_string-name">Gao, D.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Hoang, B.</span>; <span class="NLM_string-name">Lew, W.</span>; <span class="NLM_string-name">Milburn, R. R.</span>; <span class="NLM_string-name">Neville, S. T.</span>; <span class="NLM_string-name">Ross, B.</span>; <span class="NLM_string-name">Rueden, E.</span>; <span class="NLM_string-name">Scott, R. W.</span>; <span class="NLM_string-name">Siegel, D.</span>; <span class="NLM_string-name">Stevens, A. C.</span>; <span class="NLM_string-name">Tadeus, C.</span>; <span class="NLM_string-name">Vieira, T.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Whitcomb, M. C.</span>; <span class="NLM_string-name">Wolfe, L.</span>; <span class="NLM_string-name">Yu, C.-Y.</span></span> <span> </span><span class="NLM_article-title">Methods for the Preparation of Ribosides</span>. <span class="NLM_patent">WO2016069825A1</span>, Gilead Sciences, May 6, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+D.+Axt&author=P.+R.+Badalov&author=K.+Brak&author=S.+Campagna&author=A.+Chtchemelinine&author=E.+Doerffler&author=M.+M.+Frick&author=D.+Gao&author=L.+V.+Heumann&author=B.+Hoang&author=W.+Lew&author=R.+R.+Milburn&author=S.+T.+Neville&author=B.+Ross&author=E.+Rueden&author=R.+W.+Scott&author=D.+Siegel&author=A.+C.+Stevens&author=C.+Tadeus&author=T.+Vieira&author=A.+W.+Waltman&author=X.+Wang&author=M.+C.+Whitcomb&author=L.+Wolfe&author=C.-Y.+Yu&title=Methods+for+the+Preparation+of+Ribosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAxt%26aufirst%3DS.%2BD.%26atitle%3DMethods%2520for%2520the%2520Preparation%2520of%2520Ribosides%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, A. J.</span>; <span class="NLM_string-name">Wiemer, D. F.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of phosphonates and phosphates: Crossing the membrane barrier</span>.  <i>Phosphorus Chemistry I. Topics in Current Chemistry</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">360</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=115-160&author=A.+J.+Wiemer&author=D.+F.+Wiemer&title=Phosphorus+Chemistry+I.+Topics+in+Current+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26atitle%3DProdrugs%2520of%2520phosphonates%2520and%2520phosphates%253A%2520Crossing%2520the%2520membrane%2520barrier%26btitle%3DPhosphorus%2520Chemistry%2520I.%2520Topics%2520in%2520Current%2520Chemistry%26pub%3DSpringer%26date%3D2015%26volume%3D360%26spage%3D115%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serpi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertusati, F.</span></span> <span> </span><span class="NLM_article-title">Phosphoramidates and phosphonamidates (ProTides) with antiviral activity</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">2040206618775243</span> <span class="refDoi"> DOI: 10.1177/2040206618775243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1177%2F2040206618775243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&author=M.+Slusarczykauthor=M.+Serpiauthor=F.+Pertusati&title=Phosphoramidates+and+phosphonamidates+%28ProTides%29+with+antiviral+activity&doi=10.1177%2F2040206618775243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1177%2F2040206618775243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040206618775243%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarczyk%26aufirst%3DM.%26aulast%3DSerpi%26aufirst%3DM.%26aulast%3DPertusati%26aufirst%3DF.%26atitle%3DPhosphoramidates%2520and%2520phosphonamidates%2520%2528ProTides%2529%2520with%2520antiviral%2520activity%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2018%26volume%3D26%26doi%3D10.1177%2F2040206618775243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisbe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohloff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparacino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terhorst, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1081/NCN-100002338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1081%2FNCN-100002338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=11563079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=621-628&author=H.+Chapmanauthor=M.+Kernanauthor=E.+Prisbeauthor=J.+Rohloffauthor=M.+Sparacinoauthor=T.+Terhorstauthor=R.+Yu&title=Practical+synthesis%2C+separation%2C+and+stereochemical+assignment+of+the+PMPA+pro-drug+GS-7340&doi=10.1081%2FNCN-100002338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340</span></div><div class="casAuthors">Chapman, H.; Kernan, M.; Prisbe, E.; Rohloff, J.; Sparacino, M.; Terhorst, T.; Yu, R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4-7</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The practical synthesis of a mixed phenoxy-amidate deriv. of PMPA with high oral bioavailability and favorable pharmacokinetics is described.  The non-stereoselective synthetic route produces a 1:1 mixt. of two diastereomers at phosphorous.  Simulated moving bed chromatog. using Chiral pak AS enabled kilo-scale isolation of the more potent diastereomer I (GS-7340).  The GS-7340 phosphorous chiral center was found to be (S) by X-ray crystallog.  I was tested in vitro as antiviral agent (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrje-dv-gsW4rVg90H21EOLACvtfcHk0liI38UfYJc8hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslCqtr4%253D&md5=cd6f353bdf365a1f3dd2fdb2288bff21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1081%2FNCN-100002338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-100002338%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DH.%26aulast%3DKernan%26aufirst%3DM.%26aulast%3DPrisbe%26aufirst%3DE.%26aulast%3DRohloff%26aufirst%3DJ.%26aulast%3DSparacino%26aufirst%3DM.%26aulast%3DTerhorst%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DPractical%2520synthesis%252C%2520separation%252C%2520and%2520stereochemical%2520assignment%2520of%2520the%2520PMPA%2520pro-drug%2520GS-7340%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2001%26volume%3D20%26spage%3D621%26epage%3D628%26doi%3D10.1081%2FNCN-100002338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeples, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickles, R. J.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">5654</span>– <span class="NLM_lpage">5666</span>, <span class="refDoi"> DOI: 10.1128/JVI.76.11.5654-5666.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1128%2FJVI.76.11.5654-5666.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=11991994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD38XjslGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=5654-5666&author=L.+Zhangauthor=M.+E.+Peeplesauthor=R.+C.+Boucherauthor=P.+L.+Collinsauthor=R.+J.+Pickles&title=Respiratory+syncytial+virus+infection+of+human+airway+epithelial+cells+is+polarized%2C+specific+to+ciliated+cells%2C+and+without+obvious+cytopathology&doi=10.1128%2FJVI.76.11.5654-5666.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology</span></div><div class="casAuthors">Zhang, Liqun; Peeples, Mark E.; Boucher, Richard C.; Collins, Peter L.; Pickles, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5654-5666</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gene therapy for cystic fibrosis (CF) lung disease requires efficient gene transfer to airway epithelial cells after intralumenal delivery.  Most gene transfer vectors so far tested have not provided the efficiency required.  Although human respiratory syncytial virus (RSV), a common respiratory virus, is known to infect the respiratory epithelium, the mechanism of infection and the epithelial cell type targeted by RSV have not been detd.  We have utilized human primary airway epithelial cell cultures that generate a well-differentiated pseudostratified mucociliary epithelium to investigate whether RSV infects airway epithelium via the lumenal (apical) surface.  A recombinant RSV expressing green fluorescent protein (rgRSV) infected epithelial cell cultures with high gene transfer efficiency when applied to the apical surface but not after basolateral inoculation.  Analyses of the cell types infected by RSV revealed that lumenal columnar cells, specifically ciliated epithelial cells, were targeted by RSV and that cultures became susceptible to infection as they differentiated into a ciliated phenotype.  In addn. to infection of ciliated cells via the apical membrane, RSV was shed exclusively from the apical surface and spread to neighboring ciliated cells by the motion of the cilial beat.  Gross histol. examn. of cultures infected with RSV revealed no evidence of obvious cytopathol., suggesting that RSV infection in the absence of an immune response can be tolerated for >3 mo.  Therefore, rgRSV efficiently transduced the airway epithelium via the lumenal surface and specifically targeted ciliated airway epithelial cells.  Since rgRSV appears to breach the lumenal barriers encountered by other gene transfer vectors in the airway, this virus may be a good candidate for the development of a gene transfer vector for CF lung disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdM4PYqfjIs7Vg90H21EOLACvtfcHk0liI38UfYJc8hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjslGnurg%253D&md5=b2438d0048b474f84513b89547c28f91</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FJVI.76.11.5654-5666.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.76.11.5654-5666.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DPickles%26aufirst%3DR.%2BJ.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%2520of%2520human%2520airway%2520epithelial%2520cells%2520is%2520polarized%252C%2520specific%2520to%2520ciliated%2520cells%252C%2520and%2520without%2520obvious%2520cytopathology%26jtitle%3DJ.%2520Virol.%26date%3D2002%26volume%3D76%26spage%3D5654%26epage%3D5666%26doi%3D10.1128%2FJVI.76.11.5654-5666.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humeniuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinusi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1111/cts.12840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1111%2Fcts.12840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32589775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVant7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=896-906&author=R.+Humeniukauthor=A.+Mathiasauthor=H.+Caoauthor=A.+Osinusiauthor=G.+Shenauthor=E.+Chngauthor=J.+Lingauthor=A.+Vuauthor=P.+German&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+remdesivir%2C+an+antiviral+for+treatment+of+COVID-19%2C+in+healthy+subjects&doi=10.1111%2Fcts.12840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects</span></div><div class="casAuthors">Humeniuk, Rita; Mathias, Anita; Cao, Huyen; Osinusi, Anu; Shen, Gong; Chng, Estelle; Ling, John; Vu, Amanda; German, Polina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">896-906</span>CODEN:
                <span class="NLM_cas:coden">CTSLCA</span>;
        ISSN:<span class="NLM_cas:issn">1752-8062</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Remdesivir (RDV), a single diastereomeric monophosphoramidate prodrug that inhibits viral RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).  RDV received the US Food and Drug Administration (FDA)'s emergency use authorization in the United States and approval in Japan for treatment of patients with severe coronavirus disease 2019 (COVID-19).  This report describes two phase I studies that evaluated the safety and pharmacokinetics (PKs) of single escalating and multiple i.v. doses of RDV (soln. or lyophilized formulation) in healthy subjects.  Lyophilized formulation was evaluated for potential future use in clin. trials due to its storage stability in resource-limited settings.  All adverse events were grade 1 or 2 in severity.  Overall, RDV exhibited a linear profile following single-dose i.v. administration over 2 h of RDV soln. formulation across the dose range of 3-225 mg.  Both lyophilized and soln. formulations provided comparable PK parameters.  High intracellular concns. of the active triphosphate (∼ 220-fold to 370-fold higher than the in vitro half-maximal effective concn. against SARS-CoV-2 clin. isolate) were achieved following infusion of 75 mg or 150 mg lyophilized formulation over 30 min or 2 h.  Following multiple-doses of RDV 150 mg once daily for 7 or 14 days, RDV exhibited a PK profile similar to single-dose administration.  Metabolite GS-441524 accumulated ∼ 1.9-fold after daily dosing.  Overall, RDV exhibited favorable safety and PK profiles that supported once-daily dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-fP8Z8aWbbVg90H21EOLACvtfcHk0liI38UfYJc8hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVant7nF&md5=55f4dd660988005ffaf9b9c921c71bec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fcts.12840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12840%26sid%3Dliteratum%253Aachs%26aulast%3DHumeniuk%26aufirst%3DR.%26aulast%3DMathias%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DOsinusi%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DChng%26aufirst%3DE.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DA.%26aulast%3DGerman%26aufirst%3DP.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520remdesivir%252C%2520an%2520antiviral%2520for%2520treatment%2520of%2520COVID-19%252C%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D13%26spage%3D896%26epage%3D906%26doi%3D10.1111%2Fcts.12840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of RSV and HCV RdRp nucleoside inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Ester Prodrugs on <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC), 4-dimethylaminopyridine (DMAP), <i>N</i>,<i>N</i>-dimethylformamide (DMF), acetic acid (86%), propionic acid (95%), <i>iso</i>-butyric acid (95%); (ii), DIC, Et<sub>3</sub>N, BOC-valine; and (iii) 20% TFA in CH<sub>2</sub>Cl<sub>2</sub>, 24% over two steps.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Phosphate Prodrugs on <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) PO(OMe)<sub>3</sub>, 1<i>H-</i>tetrazole, (<i>i</i>-Pr)<sub>2</sub>NP(OCH<sub>2</sub>CH<sub>2</sub>SC(═O)C(CH<sub>3</sub>)<sub>3</sub>) (ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>); (ii) MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, DMF, cyclopropylmethyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, 50 °C, <b>18c</b> (38%); (iii) MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, tetrahydrofuran (THF), cyclooctyl((4-nitrophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, 50 °C 81%; and (iv) HCl, 0 °C, over two steps <b>18h</b> (42%), <b>18k</b> (62%).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed intracellular metabolism pathway of <b>1</b>. The prodrug is broken down via carboxyl ester hydrolysis, phenol ejection, and Hint1-mediated phosphorus–nitrogen bond cleavage to release the monophosphate metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. RSV viral loads in HAE cultures following a 3 day basolateral compartment treatment with <b>4</b>, <b>1</b>, <b>1-</b><i><b>R</b></i><b>p</b>, or the dimethyl sulfoxide (DMSO) control. A representative of two experiments is displayed. Presented are box and whisker plots of the median and interquartile ranges of six technical replicates for each treatment. <i>p</i> values were determined by the Mann–Whitney Student <i>t</i> test (unpaired nonparametric). LOQ is the limit of quantitation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Intracellular metabolism of <b>4</b> (red), <b>1</b> (black), and diastereomeric mixture <b>18j</b> (blue) to the active metabolite <b>1-NTP</b>. (A) HEp-2 cells with continuous incubation at 1 and 10 μM. (B) NHBE cells with continuous incubation and a 2 h pulse incubation at 1 μM. (C) HAE culture, two donors with continuous incubation at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo plasma and lung pharmacokinetics of <b>1</b> and <b>4</b> following a 30 min IV infusion administration at 10 and 20 mg/kg, respectively. (A) African Green monkey and Cynomolgus monkey plasma pharmacokinetics. (B) Respiratory tissue <b>1</b>-<b>NTP</b> concentrations at 24 h post initiation of IV infusion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/medium/jm1c00071_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy in RSV A2-infected African Green monkeys following 30 min IV infusion of <b>1</b> (green crosses) compared to vehicle (black circles) beginning at −4 h relative to RSV challenge, followed by daily dosing initiated at 24 h post inoculation for five doses. (A) Study outline. (B) Viral load assessed by the real-time quantitative polymerase chain reaction (RT-qPCR) RT-qPCR in bronchoalveolar (BAL) fluid samples. (C) Viral load assessed by RT-qPCR in nasopharyngeal (NP) swabs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.1c00071/20210415/images/large/jm1c00071_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hugentobler, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, A.</span></span> <span> </span><span class="NLM_article-title">Seasonality of respiratory viral infections</span>. <i>Annu. Rev. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1146/annurev-virology-012420-022445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1146%2Fannurev-virology-012420-022445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32196426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=83-101&author=M.+Moriyamaauthor=W.+J.+Hugentoblerauthor=A.+Iwasaki&title=Seasonality+of+respiratory+viral+infections&doi=10.1146%2Fannurev-virology-012420-022445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Seasonality of Respiratory Viral Infections</span></div><div class="casAuthors">Moriyama, Miyu; Hugentobler, Walter J.; Iwasaki, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-101</span>CODEN:
                <span class="NLM_cas:coden">ARVNBS</span>;
        ISSN:<span class="NLM_cas:issn">2327-0578</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The seasonal cycle of respiratory viral diseases has been widely recognized for thousands of years, as annual epidemics of the common cold and influenza disease hit the human population like clockwork in the winter season in temperate regions.  Moreover, epidemics caused by viruses such as severe acute respiratory syndrome coronavirus (SARS-CoV) and the newly emerging SARS-CoV-2 occur during the winter months.  The mechanisms underlying the seasonal nature of respiratory viral infections have been examd. and debated for many years.  The two major contributing factors are the changes in environmental parameters and human behavior.  Studies have revealed the effect of temp. and humidity on respiratory virus stability and transmission rates.  More recent research highlights the importance of the environmental factors, esp. temp. and humidity, in modulating host intrinsic, innate, and adaptive immune responses to viral infections in the respiratory tract.  Here we review evidence of how outdoor and indoor climates are linked to the seasonality of viral respiratory infections.  We further discuss determinants of host response in the seasonality of respiratory viruses by highlighting recent studies in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowTckI6kAk27Vg90H21EOLACvtfcHk0lg_BM618STcGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlCqur8%253D&md5=3e4813504d05bf837b7a84c0f4baf64f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-virology-012420-022445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-virology-012420-022445%26sid%3Dliteratum%253Aachs%26aulast%3DMoriyama%26aufirst%3DM.%26aulast%3DHugentobler%26aufirst%3DW.%2BJ.%26aulast%3DIwasaki%26aufirst%3DA.%26atitle%3DSeasonality%2520of%2520respiratory%2520viral%2520infections%26jtitle%3DAnnu.%2520Rev.%2520Virol.%26date%3D2020%26volume%3D7%26spage%3D83%26epage%3D101%26doi%3D10.1146%2Fannurev-virology-012420-022445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yusuf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedimonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demmler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Caeseele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avendano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez-Bueno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murguía De Sierra, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes, E. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welliver, R.,  Sr.</span></span> <span> </span><span class="NLM_article-title">The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus</span>. <i>Epidemiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1017/S095026880600776X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1017%2FS095026880600776X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=17346359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD2srmtlWltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2007&pages=1077-1090&author=S.+Yusufauthor=G.+Piedimonteauthor=A.+Auaisauthor=G.+Demmlerauthor=S.+Krishnanauthor=P.+Van+Caeseeleauthor=R.+Singletonauthor=S.+Broorauthor=S.+Parveenauthor=L.+Avendanoauthor=J.+Parraauthor=S.+Chavez-Buenoauthor=T.+Murgu%C3%ADa+De+Sierraauthor=E.+A.+F.+Simoesauthor=S.+Shahaauthor=R.+Welliver&title=The+relationship+of+meteorological+conditions+to+the+epidemic+activity+of+respiratory+syncytial+virus&doi=10.1017%2FS095026880600776X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus</span></div><div class="casAuthors">Yusuf S; Piedimonte G; Auais A; Demmler G; Krishnan S; Van Caeseele P; Singleton R; Broor S; Parveen S; Avendano L; Parra J; Chavez-Bueno S; Murguia De Sierra T; Simoes E A F; Shaha S; Welliver R</div><div class="citationInfo"><span class="NLM_cas:title">Epidemiology and infection</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-90</span>
        ISSN:<span class="NLM_cas:issn">0950-2688</span>.
    </div><div class="casAbstract">Our aim was to obtain knowledge of how meteorological conditions affect community epidemics of respiratory syncytial virus (RSV) infection.  To this end we recorded year-round RSV activity in nine cities that differ markedly in geographic location and climate.  We correlated local weather conditions with weekly or monthly RSV cases.  We reviewed similar reports from other areas varying in climate.  Weekly RSV activity was related to temperature in a bimodal fashion, with peaks of activity at temperatures above 24-30 degrees C and at 2-6 degrees C.  RSV activity was also greatest at 45-65% relative humidity.  RSV activity was inversely related to UVB radiance at three sites where this could be tested.  At sites with persistently warm temperatures and high humidity, RSV activity was continuous throughout the year, peaking in summer and early autumn.  In temperate climates, RSV activity was maximal during winter, correlating with lower temperatures.  In areas where temperatures remained colder throughout the year, RSV activity again became nearly continuous.  Community activity of RSV is substantial when both ambient temperatures and absolute humidity are very high, perhaps reflecting greater stability of RSV in aerosols.  Transmission of RSV in cooler climates is inversely related to temperature possibly as a result of increased stability of the virus in secretions in the colder environment.  UVB radiation may inactivate virus in the environment, or influence susceptibility to RSV by altering host resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1YfBAQ73zkc25P7XSLhESfW6udTcc2eYwDoRWsS-wUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmtlWltw%253D%253D&md5=6d634f54241ea52b62dd70376580ce3f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS095026880600776X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS095026880600776X%26sid%3Dliteratum%253Aachs%26aulast%3DYusuf%26aufirst%3DS.%26aulast%3DPiedimonte%26aufirst%3DG.%26aulast%3DAuais%26aufirst%3DA.%26aulast%3DDemmler%26aufirst%3DG.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DVan%2BCaeseele%26aufirst%3DP.%26aulast%3DSingleton%26aufirst%3DR.%26aulast%3DBroor%26aufirst%3DS.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DAvendano%26aufirst%3DL.%26aulast%3DParra%26aufirst%3DJ.%26aulast%3DChavez-Bueno%26aufirst%3DS.%26aulast%3DMurgu%25C3%25ADa%2BDe%2BSierra%26aufirst%3DT.%26aulast%3DSimoes%26aufirst%3DE.%2BA.%2BF.%26aulast%3DShaha%26aufirst%3DS.%26aulast%3DWelliver%26aufirst%3DR.%26atitle%3DThe%2520relationship%2520of%2520meteorological%2520conditions%2520to%2520the%2520epidemic%2520activity%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DEpidemiol.%2520Infect.%26date%3D2007%26volume%3D135%26spage%3D1077%26epage%3D1090%26doi%3D10.1017%2FS095026880600776X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><a href="https://www.who.int/health-topics/influenza-avian-and-other-zoonotic" class="extLink">https://www.who.int/health-topics/influenza-avian-and-other-zoonotic</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.who.int%2Fhealth-topics%2Finfluenza-avian-and-other-zoonotic."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" class="extLink">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</a>. Accessed Feb 13, <span class="NLM_year">2021</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.who.int%2Femergencies%2Fdiseases%2Fnovel-coronavirus-2019.+Accessed+Feb+13%2C+2021."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><a href="http://www.veklury.com" class="extLink">www.veklury.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.veklury.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Theodore, D. A.</span></span> <span> </span><span class="NLM_article-title">Methods and Compounds for Treating Paramyxoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">US2011045102</span>, July 22, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+L.+Mackman&author=J.+P.+Parrish&author=A.+S.+Ray&author=D.+A.+Theodore&title=Methods+and+Compounds+for+Treating+Paramyxoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DMethods%2520and%2520Compounds%2520for%2520Treating%2520Paramyxoviridae%2520Virus%2520Infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shurtleff, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharaibeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomba, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trancheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1038/nature17180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1038%2Fnature17180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26934220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=381-385&author=T.+K.+Warrenauthor=R.+Jordanauthor=M.+K.+Loauthor=A.+S.+Rayauthor=R.+L.+Mackmanauthor=V.+Solovevaauthor=D.+Siegelauthor=M.+Perronauthor=R.+Bannisterauthor=H.+C.+Huiauthor=N.+Larsonauthor=R.+Strickleyauthor=J.+Wellsauthor=K.+S.+Stuthmanauthor=S.+A.+Van+Tongerenauthor=N.+L.+Garzaauthor=G.+Donnellyauthor=A.+C.+Shurtleffauthor=C.+J.+Rettererauthor=D.+Gharaibehauthor=R.+Zamaniauthor=T.+Kennyauthor=B.+P.+Eatonauthor=E.+Grimesauthor=L.+S.+Welchauthor=L.+Gombaauthor=C.+L.+Wilhelmsenauthor=D.+K.+Nicholsauthor=J.+E.+Nussauthor=E.+R.+Nagleauthor=J.+R.+Kugelmanauthor=G.+Palaciosauthor=E.+Doerfflerauthor=S.+Nevilleauthor=E.+Carraauthor=M.+O.+Clarkeauthor=L.+Zhangauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=K.+Chunauthor=L.+Wolfeauthor=D.+Babusisauthor=Y.+Parkauthor=K.+M.+Strayauthor=I.+Tranchevaauthor=J.+Y.+Fengauthor=O.+Barauskasauthor=Y.+Xuauthor=P.+Wongauthor=M.+R.+Braunauthor=M.+Flintauthor=L.+K.+McMullanauthor=S.-S.+Chenauthor=R.+Fearnsauthor=S.+Swaminathanauthor=D.+L.+Mayersauthor=C.+F.+Spiropoulouauthor=W.+A.+Leeauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+Bavari&title=Therapeutic+efficacy+of+the+small+molecule+GS-5734+against+Ebola+virus+in+rhesus+monkeys&doi=10.1038%2Fnature17180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span></div><div class="casAuthors">Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The most recent Ebola virus outbreak in West Africa, which was unprecedented in the no. of cases and fatalities, geog. distribution, and no. of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae.  No antiviral therapeutics have yet received regulatory approval or demonstrated clin. efficacy.  Here we report the discovery of a novel small mol. GS-5734, a monophosphoramidate prodrug of an adenosine analog, with antiviral activity against EBOV.  GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays.  The pharmacol. active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase.  I.v. administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain.  In a rhesus monkey model of EVD, once-daily i.v. administration of 10 mg kg-1 GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clin. disease signs and pathophysiol. markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals.  These results show the first substantive post-exposure protection by a small-mol. antiviral compd. against EBOV in nonhuman primates.  The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use.  GS-5734 is amenable to large-scale manufg., and clin. studies investigating the drug safety and pharmacokinetics are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4QsyLVjgHLVg90H21EOLACvtfcHk0ljBP-qjemEggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D&md5=ab121d827ac0a40cc1fed3dd1df905b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature17180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17180%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DDonnelly%26aufirst%3DG.%26aulast%3DShurtleff%26aufirst%3DA.%2BC.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DGharaibeh%26aufirst%3DD.%26aulast%3DZamani%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DGrimes%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DGomba%26aufirst%3DL.%26aulast%3DWilhelmsen%26aufirst%3DC.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BK.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DNagle%26aufirst%3DE.%2BR.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DTrancheva%26aufirst%3DI.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DM.%2BR.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DChen%26aufirst%3DS.-S.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMayers%26aufirst%3DD.%2BL.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DTherapeutic%2520efficacy%2520of%2520the%2520small%2520molecule%2520GS-5734%2520against%2520Ebola%2520virus%2520in%2520rhesus%2520monkeys%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D381%26epage%3D385%26doi%3D10.1038%2Fnature17180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01594</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1648-1661&author=D.+Siegelauthor=H.+C.+Huiauthor=E.+Doerfflerauthor=M.+O.+Clarkeauthor=K.+Chunauthor=L.+Zhangauthor=S.+Nevilleauthor=E.+Carraauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=L.+Wolfeauthor=R.+Jordanauthor=V.+Solovevaauthor=J.+Knoxauthor=J.+Perryauthor=M.+Perronauthor=K.+M.+Strayauthor=O.+Barauskasauthor=J.+Y.+Fengauthor=Y.+Xuauthor=G.+Leeauthor=A.+L.+Rheingoldauthor=A.+S.+Rayauthor=B.+Bannisterauthor=R.+Strickleyauthor=S.+Swaminathanauthor=W.+A.+Leeauthor=S.+Bavariauthor=T.+Cihlarauthor=M.+K.+Loauthor=T.+K.+Warrenauthor=R.+L.+Mackman&title=Discovery+and+synthesis+of+a+phosphoramidate+prodrug+of+a+pyrrolo%5B2%2C1-f%5D%5Btriazin-4-amino%5D+adenine+C-nucleoside+%28GS-5734%29+for+the+treatment+of+Ebola+and+emerging+viruses&doi=10.1021%2Facs.jmedchem.6b01594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses</span></div><div class="casAuthors">Siegel, Dustin; Hui, Hon C.; Doerffler, Edward; Clarke, Michael O.; Chun, Kwon; Zhang, Lijun; Neville, Sean; Carra, Ernest; Lew, Willard; Ross, Bruce; Wang, Queenie; Wolfe, Lydia; Jordan, Robert; Soloveva, Veronica; Knox, John; Perry, Jason; Perron, Michel; Stray, Kirsten M.; Barauskas, Ona; Feng, Joy Y.; Xu, Yili; Lee, Gary; Rheingold, Arnold L.; Ray, Adrian S.; Bannister, Roy; Strickley, Robert; Swaminathan, Swami; Lee, William A.; Bavari, Sina; Cihlar, Tomas; Lo, Michael K.; Warren, Travis K.; Mackman, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers.  A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clin. candidate.  Structure activity relationships established that the 1'-CN group and C-linked nucleobase were crit. for optimal anti-EBOV potency and selectivity against host polymerases.  A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclin. efficacy in a non-human-primate EBOV challenge model.  Once-daily 10 mg/kg iv treatment on days 3-14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016, 531, 381-385].  A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWkPjn__gILVg90H21EOLACvtfcHk0lhZ0RsSqwOIMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D&md5=b2a05cfeb4fd30fbca0d1d584ddcc220</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DBannister%26aufirst%3DB.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520phosphoramidate%2520prodrug%2520of%2520a%2520pyrrolo%255B2%252C1-f%255D%255Btriazin-4-amino%255D%2520adenine%2520C-nucleoside%2520%2528GS-5734%2529%2520for%2520the%2520treatment%2520of%2520Ebola%2520and%2520emerging%2520viruses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.jmedchem.6b01594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulangu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbaya, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nzolo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oloma, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulibaly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyembe-Tamfum, J.-J.</span></span>; <span class="NLM_contrib-group">the PALM Writing Group, for the PALM Consortium Study Team</span> <span> </span><span class="NLM_article-title">A randomized, controlled trial of Ebola virus disease therapeutics</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1910993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1910993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31774950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2019&pages=2293-2303&author=S.+Mulanguauthor=L.+E.+Doddauthor=R.+T.+Daveyauthor=O.+T.+Mbayaauthor=M.+Proschanauthor=D.+Mukadiauthor=M.+L.+Manzoauthor=D.+Nzoloauthor=A.+T.+Olomaauthor=A.+Ibandaauthor=R.+Aliauthor=S.+Coulibalyauthor=A.+C.+Levineauthor=R.+Graisauthor=J.+Diazauthor=H.+C.+Laneauthor=J.-J.+Muyembe-Tamfumauthor=the+PALM+Writing+Group%2C+for+the+PALM+Consortium+Study+Team&title=A+randomized%2C+controlled+trial+of+Ebola+virus+disease+therapeutics&doi=10.1056%2FNEJMoa1910993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, controlled trial of ebola virus disease therapeutics</span></div><div class="casAuthors">Mulangu, Sabue; Dodd, Lori E.; Davey, Richard T., Jr.; Mbaya, Olivier Tshiani; Proschan, Michael; Mukadi, Daniel; Manzo, Mariano Lusakibanza; Nzolo, Didier; Oloma, Antoine Tshomba; Ibanda, Augustin; Ali, Rosine; Coulibaly, Sinare; Levine, Adam C.; Grais, Rebecca; Diaz, Janet; Lane, H. Clifford; Muyembe-Tamfum, Jean-Jacques</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2293-2303</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although several exptl. therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial. methods We conducted a trial of four investigational therapies for EVD in the Democratic Republic of Congo, where an outbreak began in August 2018.  Patients of any age who had a pos. result for Ebola virus RNA on reverse-transcriptase-polymerase-chain-reaction assay were enrolled.  All patients received std. care and were randomly assigned in a 1:1:1:1 ratio to i.v. administration of the triple monoclonal antibody ZMapp (the control group), the antiviral agent remdesivir, the single monoclonal antibody MAb114, or the triple monoclonal antibody REGN-EB3.  The REGN-EB3 group was added in a later version of the protocol, so data from these patients were compared with those of patients in the ZMapp group who were enrolled at or after the time the REGN-EB3 group was added (the ZMapp subgroup).  The primary end point was death at 28 days. results A total of 681 patients were enrolled from Nov. 20, 2018, to August 9, 2019, at which time the data and safety monitoring board recommended that patients be assigned only to the MAb114 and REGN-EB3 groups for the remainder of the trial; the recommendation was based on the results of an interim anal. that showed superiority of these groups to ZMapp and remdesivir with respect to mortality.  At 28 days, death had occurred in 61 of 174 patients (35.1%) in the MAb114 group, as compared with 84 of 169 (49.7%) in the ZMapp group (P = 0.007), and in 52 of 155 (33.5%) in the REGN-EB3 group, as compared with 79 of 154 (51.3%) in the ZMapp subgroup (P = 0.002).  A shorter duration of symptoms before admission and lower baseline values for viral load and for serum creatinine and aminotransferase levels each correlated with improved survival.  Four serious adverse events were judged to be potentially related to the trial drugs. conclusions Both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD.  Scientifically and ethically sound clin. research can be conducted during disease outbreaks and can help inform the outbreak response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF31fomvTPrVg90H21EOLACvtfcHk0lhZ0RsSqwOIMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP&md5=ace616255b8372f99aef8dee4864d38f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1910993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1910993%26sid%3Dliteratum%253Aachs%26aulast%3DMulangu%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DDavey%26aufirst%3DR.%2BT.%26aulast%3DMbaya%26aufirst%3DO.%2BT.%26aulast%3DProschan%26aufirst%3DM.%26aulast%3DMukadi%26aufirst%3DD.%26aulast%3DManzo%26aufirst%3DM.%2BL.%26aulast%3DNzolo%26aufirst%3DD.%26aulast%3DOloma%26aufirst%3DA.%2BT.%26aulast%3DIbanda%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DCoulibaly%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3DMuyembe-Tamfum%26aufirst%3DJ.-J.%26aulast%3D%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520Ebola%2520virus%2520disease%2520therapeutics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D381%26spage%3D2293%26epage%3D2303%26doi%3D10.1056%2FNEJMoa1910993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beigel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomashek, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zingman, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalil, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luetkemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez de Castilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paredes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Short, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touloumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lye, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Palacios, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fätkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortepeter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiker, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neaton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnett, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinusi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group">for the ACTT-1 Study Group Members</span> <span> </span><span class="NLM_article-title">Remdesivir for the treatment of Covid-19–Final report</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1826</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2007764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa2007764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32445440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1yltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2020&pages=1813-1826&author=J.+H.+Beigelauthor=K.+M.+Tomashekauthor=L.+E.+Doddauthor=A.+K.+Mehtaauthor=B.+S.+Zingmanauthor=A.+C.+Kalilauthor=E.+Hohmannauthor=H.+Y.+Chuauthor=A.+Luetkemeyerauthor=S.+Klineauthor=D.+Lopez+de+Castillaauthor=R.+W.+Finbergauthor=K.+Dierbergauthor=V.+Tapsonauthor=L.+Hsiehauthor=T.+F.+Pattersonauthor=R.+Paredesauthor=D.+A.+Sweeneyauthor=W.+R.+Shortauthor=G.+Touloumiauthor=D.+C.+Lyeauthor=N.+Ohmagariauthor=M.+Ohauthor=G.+M.+Ruiz-Palaciosauthor=T.+Benfieldauthor=G.+F%C3%A4tkenheuerauthor=M.+G.+Kortepeterauthor=R.+L.+Atmarauthor=C.+B.+Creechauthor=J.+Lundgrenauthor=A.+G.+Babikerauthor=S.+Pettauthor=J.+D.+Neatonauthor=T.+H.+Burgessauthor=T.+Bonnettauthor=M.+Greenauthor=M.+Makowskiauthor=A.+Osinusiauthor=S.+Nayakauthor=H.+C.+Laneauthor=for+the+ACTT-1+Study+Group+Members&title=Remdesivir+for+the+treatment+of+Covid-19%E2%80%93Final+report&doi=10.1056%2FNEJMoa2007764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir for the treatment of Covid-19 - Final Report</span></div><div class="casAuthors">Beigel, J. H.; Tomashek, K. M.; Dodd, L. E.; Mehta, A. K.; Zingman, B. S.; Kalil, A. C.; Hohmann, E.; Chu, H. Y.; Luetkemeyer, A.; Kline, S.; de Castilla, D. Lopez; Finberg, R. W.; Dierberg, K.; Tapson, V.; Hsieh, L.; Patterson, T. F.; Paredes, R.; Sweeney, D. A.; Short, W. R.; Touloumi, G.; Lye, D. C.; Ohmagari, N.; Oh, M.; Ruiz-Palacios, G. M.; Benfield, T.; Fatkenheuer, G.; Kortepeter, M. G.; Atmar, R. L.; Creech, C. B.; Lundgren, J.; Babiker, A. G.; Pett, S.; Neaton, J. D.; Burgess, T. H.; Bonnett, T.; Green, M.; Makowski, M.; Osinusi, A.; Nayak, S.; Lane, H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1813-1826</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. methods the authors conducted a double-blind, randomized, placebo-controlled trial of i.v. remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.  Patients were randomly assigned to receive either remdesivir (200 mg loading dose on day 1, followed by 100 mg daily for up to 9 addnl. days) or placebo for up to 10 days.  The primary outcome was the time to recovery, defined by either discharge from the hospital or hospitalization for infection-control purposes only. results A total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo).  Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).  In an anal. that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clin. improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity).  The Kaplan-Meier ests. of mortality were 6.7% with remdesivir and 11.9% with placebo by day 15 and 11.4% with remdesivir and 15.2% with placebo by day 29 (hazard ratio, 0.73; 95% CI, 0.52 to 1.03).  Serious adverse events were reported in 131 of the 532 patients who received remdesivir (24.6%) and in 163 of the 516 patients who received placebo (31.6%). conclusions the authors' data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotyQ9MMc8Xo7Vg90H21EOLACvtfcHk0lhnRcpcHKqQeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1yltL7O&md5=6824e8433486a105b147b1cf1bf222c9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2007764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2007764%26sid%3Dliteratum%253Aachs%26aulast%3DBeigel%26aufirst%3DJ.%2BH.%26aulast%3DTomashek%26aufirst%3DK.%2BM.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DMehta%26aufirst%3DA.%2BK.%26aulast%3DZingman%26aufirst%3DB.%2BS.%26aulast%3DKalil%26aufirst%3DA.%2BC.%26aulast%3DHohmann%26aufirst%3DE.%26aulast%3DChu%26aufirst%3DH.%2BY.%26aulast%3DLuetkemeyer%26aufirst%3DA.%26aulast%3DKline%26aufirst%3DS.%26aulast%3DLopez%2Bde%2BCastilla%26aufirst%3DD.%26aulast%3DFinberg%26aufirst%3DR.%2BW.%26aulast%3DDierberg%26aufirst%3DK.%26aulast%3DTapson%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26aulast%3DParedes%26aufirst%3DR.%26aulast%3DSweeney%26aufirst%3DD.%2BA.%26aulast%3DShort%26aufirst%3DW.%2BR.%26aulast%3DTouloumi%26aufirst%3DG.%26aulast%3DLye%26aufirst%3DD.%2BC.%26aulast%3DOhmagari%26aufirst%3DN.%26aulast%3DOh%26aufirst%3DM.%26aulast%3DRuiz-Palacios%26aufirst%3DG.%2BM.%26aulast%3DBenfield%26aufirst%3DT.%26aulast%3DF%25C3%25A4tkenheuer%26aufirst%3DG.%26aulast%3DKortepeter%26aufirst%3DM.%2BG.%26aulast%3DAtmar%26aufirst%3DR.%2BL.%26aulast%3DCreech%26aufirst%3DC.%2BB.%26aulast%3DLundgren%26aufirst%3DJ.%26aulast%3DBabiker%26aufirst%3DA.%2BG.%26aulast%3DPett%26aufirst%3DS.%26aulast%3DNeaton%26aufirst%3DJ.%2BD.%26aulast%3DBurgess%26aufirst%3DT.%2BH.%26aulast%3DBonnett%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DMakowski%26aufirst%3DM.%26aulast%3DOsinusi%26aufirst%3DA.%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3D%26atitle%3DRemdesivir%2520for%2520the%2520treatment%2520of%2520Covid-19%25E2%2580%2593Final%2520report%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D383%26spage%3D1813%26epage%3D1826%26doi%3D10.1056%2FNEJMoa2007764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoes, E. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polack, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsells, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acacio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alassani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awori, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azziz-Baumgartner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggett, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmaseda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barahona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassat, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basualdo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigogo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breiman, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carosone-Link, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipeta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Cuellar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash-yandag, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deloria-Knoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dherani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebruke, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echavarria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Lázaro Emediato, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feikin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halasa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirve, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homaira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howie, S. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jara, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jroundi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kartasasmita, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khuri-Bulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotloff, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucion, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupisan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcone, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munywoki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutyara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nokes, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nymadawa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa Oliveira, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paranhos-Baccalà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picot, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakoto-Andrianarivelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russomando, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salimi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawatwong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltema, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutanto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thamthitiwat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waicharoen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watthanaworawit, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, H.</span></span>; <span class="NLM_contrib-group">for RSV Global Epidemiology Network.</span> <span> </span><span class="NLM_article-title">Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)30938-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2FS0140-6736%2817%2930938-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=28689664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BC1cjlslKluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=946-958&author=T.+Shiauthor=D.+A.+McAllisterauthor=K.+L.+O%E2%80%99Brienauthor=E.+A.+F.+Simoesauthor=S.+A.+Madhiauthor=B.+D.+Gessnerauthor=F.+P.+Polackauthor=E.+Balsellsauthor=S.+Acacioauthor=C.+Aguayoauthor=I.+Alassaniauthor=A.+Aliauthor=M.+Antonioauthor=S.+Awasthiauthor=J.+O.+Aworiauthor=E.+Azziz-Baumgartnerauthor=H.+C.+Baggettauthor=V.+L.+Baillieauthor=A.+Balmasedaauthor=A.+Barahonaauthor=S.+Basnetauthor=Q.+Bassatauthor=W.+Basualdoauthor=G.+Bigogoauthor=L.+Bontauthor=R.+F.+Breimanauthor=W.+A.+Brooksauthor=S.+Broorauthor=N.+Bruceauthor=D.+Brudenauthor=P.+Buchyauthor=S.+Campbellauthor=P.+Carosone-Linkauthor=M.+Chadhaauthor=J.+Chipetaauthor=M.+Chouauthor=W.+Claraauthor=C.+Cohenauthor=E.+de+Cuellarauthor=D.-A.+Dangauthor=B.+Dash-yandagauthor=M.+Deloria-Knollauthor=M.+Dheraniauthor=T.+Eapauthor=B.+E.+Ebrukeauthor=M.+Echavarriaauthor=C.+C.+de+Freitas+L%C3%A1zaro+Emediatoauthor=R.+A.+Fasceauthor=D.+R.+Feikinauthor=L.+Fengauthor=A.+Gentileauthor=A.+Gordonauthor=D.+Goswamiauthor=S.+Goyetauthor=M.+Groomeauthor=N.+Halasaauthor=S.+Hirveauthor=N.+Homairaauthor=S.+R.+C.+Howieauthor=J.+Jaraauthor=I.+Jroundiauthor=C.+B.+Kartasasmitaauthor=N.+Khuri-Bulosauthor=K.+L.+Kotloffauthor=A.+Krishnanauthor=R.+Libsterauthor=O.+Lopezauthor=M.+G.+Luceroauthor=F.+Lucionauthor=S.+P.+Lupisanauthor=D.+N.+Marconeauthor=J.+P.+McCrackenauthor=M.+Mejiaauthor=J.+C.+Moisiauthor=J.+M.+Montgomeryauthor=D.+P.+Mooreauthor=C.+Moraledaauthor=J.+Moyesauthor=P.+Munywokiauthor=K.+Mutyaraauthor=M.+P.+Nicolauthor=D.+J.+Nokesauthor=P.+Nymadawaauthor=M.+T.+da+Costa+Oliveiraauthor=H.+Oshitaniauthor=N.+Pandeyauthor=G.+Paranhos-Baccal%C3%A0author=L.+N.+Phillipsauthor=V.+S.+Picotauthor=M.+Rahmanauthor=M.+Rakoto-Andrianariveloauthor=Z.+A.+Rasmussenauthor=B.+A.+Rathauthor=A.+Robinsonauthor=C.+Romeroauthor=G.+Russomandoauthor=V.+Salimiauthor=P.+Sawatwongauthor=N.+Scheltemaauthor=B.+Schweigerauthor=J.+A.+G.+Scottauthor=P.+Seidenbergauthor=K.+Shenauthor=R.+Singletonauthor=V.+Sotomayorauthor=T.+A.+Strandauthor=A.+Sutantoauthor=M.+Syllaauthor=M.+D.+Tapiaauthor=S.+Thamthitiwatauthor=E.+D.+Thomasauthor=R.+Tokarzauthor=C.+Turnerauthor=M.+Venterauthor=S.+Waicharoenauthor=J.+Wangauthor=W.+Watthanaworawitauthor=L.-M.+Yoshidaauthor=H.+Yuauthor=H.+J.+Zarauthor=H.+Campbellauthor=H.+Nairauthor=for+RSV+Global+Epidemiology+Network.&title=Global%2C+regional%2C+and+national+disease+burden+estimates+of+acute+lower+respiratory+infections+due+to+respiratory+syncytial+virus+in+young+children+in+2015%3A+A+systematic+review+and+modelling+study&doi=10.1016%2FS0140-6736%2817%2930938-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study</span></div><div class="casAuthors">Shi Ting; Balsells Evelyn; Campbell Stuart; Campbell Harry; McAllister David A; O'Brien Katherine L; Deloria-Knoll Maria; Simoes Eric A F; Madhi Shabir A; Groome Michelle; Moore David P; Gessner Bradford D; Moisi Jennifer C; Polack Fernando P; Acacio Sozinho; Aguayo Claudia; Sotomayor Viviana; Alassani Issifou; Ali Asad; Antonio Martin; Ebruke Bernard E; Awasthi Shally; Pandey Nitin; Awori Juliet O; Azziz-Baumgartner Eduardo; Baggett Henry C; Baillie Vicky L; Balmaseda Angel; Barahona Alfredo; Basnet Sudha; Bassat Quique; Basualdo Wilma; Bigogo Godfrey; Bont Louis; Scheltema Nienke; Breiman Robert F; Brooks W Abdullah; Goswami Doli; Broor Shobha; Krishnan Anand; Bruce Nigel; Dherani Mukesh; Bruden Dana; Buchy Philippe; Carosone-Link Phyllis; Chadha Mandeep; Chipeta James; Chou Monidarin; Clara Wilfrido; Cohen Cheryl; Moyes Jocelyn; de Cuellar Elizabeth; Dang Duc-Anh; Dash-Yandag Budragchaagiin; Eap Tekchheng; Echavarria Marcela; Marcone Debora N; de Freitas Lazaro Emediato Carla Cecilia; da Costa Oliveira Maria Tereza; Fasce Rodrigo A; Feikin Daniel R; Feng Luzhao; Yu Hongjie; Gentile Angela; Lucion Florencia; Gordon Aubree; Goyet Sophie; Halasa Natasha; Hirve Siddhivinayak; Homaira Nusrat; Howie Stephen R C; Jara Jorge; McCracken John P; Jroundi Imane; Kartasasmita Cissy B; Mutyara Kuswandewi; Khuri-Bulos Najwa; Kotloff Karen L; Tapia Milagritos D; Libster Romina; Lopez Olga; Lucero Marilla G; Lupisan Socorro P; Mejia Mario; Montgomery Joel M; Moraleda Cinta; Munywoki Patrick; Nicol Mark P; Nokes D James; Nymadawa Pagbajabyn; Oshitani Histoshi; Paranhos-Baccala Glaucia; Picot Valentina Sanchez; Phillips Lia N; Rahman Mustafizur; Rakoto-Andrianarivelo Mala; Rasmussen Zeba A; Thomas Elizabeth D; Rath Barbara A; Robinson Annick; Romero Candice; Russomando Graciela; Salimi Vahid; Sawatwong Pongpun; Thamthitiwat Somsak; Schweiger Brunhilde; Scott J Anthony G; Seidenberg Phil; Shen Kunling; Singleton Rosalyn; Strand Tor A; Sutanto Agustinus; Sylla Mariam; Tokarz Rafal; Turner Claudia; Watthanaworawit Wanitda; Venter Marietjie; Waicharoen Sunthareeya; Wang Jianwei; Yoshida Lay-Myint; Zar Heather J; Nair Harish</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10098</span>),
    <span class="NLM_cas:pages">946-958</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005.  In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries.  With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015.  METHODS:  We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies.  We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates.  We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies.  We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity.  FINDINGS:  We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years.  In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI.  We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400).  Incidence and mortality varied substantially from year to year in any given population.  INTERPRETATION:  Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services.  About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months.  An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group.  FUNDING:  The Bill & Melinda Gates Foundation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1wEfflojsmwxyojvcjibhfW6udTcc2eYKwrhe7j_-mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjlslKluw%253D%253D&md5=e31889022b79f89577df68e5c4fa2788</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2930938-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252930938-8%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DT.%26aulast%3DMcAllister%26aufirst%3DD.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DK.%2BL.%26aulast%3DSimoes%26aufirst%3DE.%2BA.%2BF.%26aulast%3DMadhi%26aufirst%3DS.%2BA.%26aulast%3DGessner%26aufirst%3DB.%2BD.%26aulast%3DPolack%26aufirst%3DF.%2BP.%26aulast%3DBalsells%26aufirst%3DE.%26aulast%3DAcacio%26aufirst%3DS.%26aulast%3DAguayo%26aufirst%3DC.%26aulast%3DAlassani%26aufirst%3DI.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DAntonio%26aufirst%3DM.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DAwori%26aufirst%3DJ.%2BO.%26aulast%3DAzziz-Baumgartner%26aufirst%3DE.%26aulast%3DBaggett%26aufirst%3DH.%2BC.%26aulast%3DBaillie%26aufirst%3DV.%2BL.%26aulast%3DBalmaseda%26aufirst%3DA.%26aulast%3DBarahona%26aufirst%3DA.%26aulast%3DBasnet%26aufirst%3DS.%26aulast%3DBassat%26aufirst%3DQ.%26aulast%3DBasualdo%26aufirst%3DW.%26aulast%3DBigogo%26aufirst%3DG.%26aulast%3DBont%26aufirst%3DL.%26aulast%3DBreiman%26aufirst%3DR.%2BF.%26aulast%3DBrooks%26aufirst%3DW.%2BA.%26aulast%3DBroor%26aufirst%3DS.%26aulast%3DBruce%26aufirst%3DN.%26aulast%3DBruden%26aufirst%3DD.%26aulast%3DBuchy%26aufirst%3DP.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DCarosone-Link%26aufirst%3DP.%26aulast%3DChadha%26aufirst%3DM.%26aulast%3DChipeta%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DM.%26aulast%3DClara%26aufirst%3DW.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3Dde%2BCuellar%26aufirst%3DE.%26aulast%3DDang%26aufirst%3DD.-A.%26aulast%3DDash-yandag%26aufirst%3DB.%26aulast%3DDeloria-Knoll%26aufirst%3DM.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DEap%26aufirst%3DT.%26aulast%3DEbruke%26aufirst%3DB.%2BE.%26aulast%3DEchavarria%26aufirst%3DM.%26aulast%3Dde%2BFreitas%2BL%25C3%25A1zaro%2BEmediato%26aufirst%3DC.%2BC.%26aulast%3DFasce%26aufirst%3DR.%2BA.%26aulast%3DFeikin%26aufirst%3DD.%2BR.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DGentile%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DGoswami%26aufirst%3DD.%26aulast%3DGoyet%26aufirst%3DS.%26aulast%3DGroome%26aufirst%3DM.%26aulast%3DHalasa%26aufirst%3DN.%26aulast%3DHirve%26aufirst%3DS.%26aulast%3DHomaira%26aufirst%3DN.%26aulast%3DHowie%26aufirst%3DS.%2BR.%2BC.%26aulast%3DJara%26aufirst%3DJ.%26aulast%3DJroundi%26aufirst%3DI.%26aulast%3DKartasasmita%26aufirst%3DC.%2BB.%26aulast%3DKhuri-Bulos%26aufirst%3DN.%26aulast%3DKotloff%26aufirst%3DK.%2BL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DLibster%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DO.%26aulast%3DLucero%26aufirst%3DM.%2BG.%26aulast%3DLucion%26aufirst%3DF.%26aulast%3DLupisan%26aufirst%3DS.%2BP.%26aulast%3DMarcone%26aufirst%3DD.%2BN.%26aulast%3DMcCracken%26aufirst%3DJ.%2BP.%26aulast%3DMejia%26aufirst%3DM.%26aulast%3DMoisi%26aufirst%3DJ.%2BC.%26aulast%3DMontgomery%26aufirst%3DJ.%2BM.%26aulast%3DMoore%26aufirst%3DD.%2BP.%26aulast%3DMoraleda%26aufirst%3DC.%26aulast%3DMoyes%26aufirst%3DJ.%26aulast%3DMunywoki%26aufirst%3DP.%26aulast%3DMutyara%26aufirst%3DK.%26aulast%3DNicol%26aufirst%3DM.%2BP.%26aulast%3DNokes%26aufirst%3DD.%2BJ.%26aulast%3DNymadawa%26aufirst%3DP.%26aulast%3Dda%2BCosta%2BOliveira%26aufirst%3DM.%2BT.%26aulast%3DOshitani%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DN.%26aulast%3DParanhos-Baccal%25C3%25A0%26aufirst%3DG.%26aulast%3DPhillips%26aufirst%3DL.%2BN.%26aulast%3DPicot%26aufirst%3DV.%2BS.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DRakoto-Andrianarivelo%26aufirst%3DM.%26aulast%3DRasmussen%26aufirst%3DZ.%2BA.%26aulast%3DRath%26aufirst%3DB.%2BA.%26aulast%3DRobinson%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DC.%26aulast%3DRussomando%26aufirst%3DG.%26aulast%3DSalimi%26aufirst%3DV.%26aulast%3DSawatwong%26aufirst%3DP.%26aulast%3DScheltema%26aufirst%3DN.%26aulast%3DSchweiger%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DSeidenberg%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DK.%26aulast%3DSingleton%26aufirst%3DR.%26aulast%3DSotomayor%26aufirst%3DV.%26aulast%3DStrand%26aufirst%3DT.%2BA.%26aulast%3DSutanto%26aufirst%3DA.%26aulast%3DSylla%26aufirst%3DM.%26aulast%3DTapia%26aufirst%3DM.%2BD.%26aulast%3DThamthitiwat%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DE.%2BD.%26aulast%3DTokarz%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DM.%26aulast%3DWaicharoen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWatthanaworawit%26aufirst%3DW.%26aulast%3DYoshida%26aufirst%3DL.-M.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZar%26aufirst%3DH.%2BJ.%26aulast%3DCampbell%26aufirst%3DH.%26aulast%3DNair%26aufirst%3DH.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520disease%2520burden%2520estimates%2520of%2520acute%2520lower%2520respiratory%2520infections%2520due%2520to%2520respiratory%2520syncytial%2520virus%2520in%2520young%2520children%2520in%25202015%253A%2520A%2520systematic%2520review%2520and%2520modelling%2520study%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D946%26epage%3D958%26doi%3D10.1016%2FS0140-6736%2817%2930938-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brammer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, K.</span></span> <span> </span><span class="NLM_article-title">Mortality associated with influenza and respiratory syncytial virus in the United States</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1001/jama.289.2.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1001%2Fjama.289.2.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=12517228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=179-186&author=W.+W.+Thompsonauthor=D.+K.+Shayauthor=E.+Weintraubauthor=L.+Brammerauthor=N.+Coxauthor=L.+J.+Andersonauthor=K.+Fukuda&title=Mortality+associated+with+influenza+and+respiratory+syncytial+virus+in+the+United+States&doi=10.1001%2Fjama.289.2.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality associated with influenza and respiratory syncytial virus in the United States</span></div><div class="casAuthors">Thompson William W; Shay David K; Weintraub Eric; Brammer Lynnette; Cox Nancy; Anderson Larry J; Fukuda Keiji</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality.  Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation.  OBJECTIVE:  To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype.  DESIGN, SETTING, AND POPULATION:  Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths.  Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons.  MAIN OUTCOME MEASURES:  Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes.  RESULTS:  Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category).  For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1).  Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36 155 (11 055) and 11 321 (668) underlying respiratory and circulatory deaths, and 51 203 (15 081) and 17 358 (1086) all-cause deaths.  For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older.  Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year.  On average, influenza was associated with 3 times as many deaths as RSV.  CONCLUSIONS:  Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons.  Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QBM7LTwlvHqj_yg7twvpfW6udTcc2eYrbIDyq53UILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D&md5=76dba2ff0597ae7dafd32c90820fa1f7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Fjama.289.2.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.289.2.179%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BW.%26aulast%3DShay%26aufirst%3DD.%2BK.%26aulast%3DWeintraub%26aufirst%3DE.%26aulast%3DBrammer%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DFukuda%26aufirst%3DK.%26atitle%3DMortality%2520associated%2520with%2520influenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D179%26epage%3D186%26doi%3D10.1001%2Fjama.289.2.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartert, T. V.</span></span> <span> </span><span class="NLM_article-title">Evidence for a causal relationship between respiratory syncytial virus infection and asthma</span>. <i>Expert Rev. Anti-infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1586/eri.11.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1586%2Feri.11.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=21905783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfislemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=731-745&author=P.+Wuauthor=T.+V.+Hartert&title=Evidence+for+a+causal+relationship+between+respiratory+syncytial+virus+infection+and+asthma&doi=10.1586%2Feri.11.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a causal relationship between respiratory syncytial virus infection and asthma</span></div><div class="casAuthors">Wu Pingsheng; Hartert Tina V</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of anti-infective therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">731-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) infects all children early in life, is the most common cause of infant lower respiratory tract infections, and causes disease exacerbations in children with asthma.  Episodes of lower respiratory tract infection in early life are associated with asthma development.  Whether RSV infection early in life directly causes asthma or simply identifies infants who are genetically predisposed to develop subsequent wheezing is debatable.  Recent studies suggest that these two explanations are not mutually exclusive, and are likely both important in asthma development.  An open-label study of RSV immunoprophylaxis administered to preterm infants reduced recurrent wheezing by 50%.  Clinical trials of infant RSV prevention, delay or severity reduction on the outcome of childhood asthma would confirm the causal relationship between RSV infection and asthma, and offer a primary prevention strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7ykLg-qbEDXtlzo9xastyfW6udTcc2eYrbIDyq53UILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfislemug%253D%253D&md5=441cea807a4e7c0e8cc585463b3c8c6e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1586%2Feri.11.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.11.92%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHartert%26aufirst%3DT.%2BV.%26atitle%3DEvidence%2520for%2520a%2520causal%2520relationship%2520between%2520respiratory%2520syncytial%2520virus%2520infection%2520and%2520asthma%26jtitle%3DExpert%2520Rev.%2520Anti-infect.%2520Ther.%26date%3D2011%26volume%3D9%26spage%3D731%26epage%3D745%26doi%3D10.1586%2Feri.11.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tin
Tin Htar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerramalla, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moïsi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, D. L.</span></span> <span> </span><span class="NLM_article-title">The burden of respiratory syncytial virus in adults: A systematic review and meta-analysis</span>. <i>Epidemiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>148</i></span>, <span class="NLM_elocation-id">e48</span> <span class="refDoi"> DOI: 10.1017/S0950268820000400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1017%2FS0950268820000400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32052719" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2020&author=M.+Tin%0ATin+Htarauthor=M.+S.+Yerramallaauthor=J.+C.+Mo%C3%AFsiauthor=D.+L.+Swerdlow&title=The+burden+of+respiratory+syncytial+virus+in+adults%3A+A+systematic+review+and+meta-analysis&doi=10.1017%2FS0950268820000400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1017%2FS0950268820000400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0950268820000400%26sid%3Dliteratum%253Aachs%26aulast%3DTin%2BTin%2BHtar%26aufirst%3DM.%26aulast%3DYerramalla%26aufirst%3DM.%2BS.%26aulast%3DMo%25C3%25AFsi%26aufirst%3DJ.%2BC.%26aulast%3DSwerdlow%26aufirst%3DD.%2BL.%26atitle%3DThe%2520burden%2520of%2520respiratory%2520syncytial%2520virus%2520in%2520adults%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DEpidemiol.%2520Infect.%26date%3D2020%26volume%3D148%26doi%3D10.1017%2FS0950268820000400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. K.</span></span> <span> </span><span class="NLM_article-title">High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections</span>. <i>Clin Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1077</span>, <span class="refDoi"> DOI: 10.1093/cid/cit471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Fcid%2Fcit471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=23876395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFygu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1069-1077&author=N.+Leeauthor=G.+C.+Luiauthor=K.+T.+Wongauthor=T.+C.+Liauthor=E.+C.+Tseauthor=J.+Y.+Chanauthor=J.+Yuauthor=S.+S.+Wongauthor=K.+W.+Choiauthor=R.+Y.+Wongauthor=K.+L.+Ngaiauthor=D.+S.+Huiauthor=P.+K.+Chan&title=High+morbidity+and+mortality+in+adults+hospitalized+for+respiratory+syncytial+virus+infections&doi=10.1093%2Fcid%2Fcit471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections</span></div><div class="casAuthors">Lee, N.; Lui, G. C. Y.; Wong, K. T.; Li, T. C. M.; Tse, E. C. M.; Chan, J. Y. C.; Yu, J.; Wong, S. S. M.; Choi, K. W.; Wong, R. Y. K.; Ngai, K. L. K.; Hui, D. S. C.; Chan, P. K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1069-1077</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In a large hospital cohort, older adults with respiratory syncytial virus infections were shown to have high rates of lower respiratory tract complications (72%) and respiratory failure requiring assisted ventilation (>10%), prolonged hospitalization, and high mortality (>10%).  Background. Better understanding of complications and outcomes of adults hospitalized with respiratory syncytial virus (RSV) infection is necessary.  Methods. A retrospective cohort study was conducted on all adults (≥18 years) admitted to 3 acute care general hospitals in Hong Kong with virol. confirmed RSV infection during 2009-2011 (N = 607).  Adults hospitalized for seasonal influenza during the period were used for comparison (n = 547).  Both infections were prospectively diagnosed following a std. protocol.  Independent reviews of chest radiographs were performed by radiologists.  Main outcome measures were all-cause death, respiratory failure requiring ventilatory support, and hospitalization duration.  Cox proportional hazards models were used for analyses.  Results. The mean age of RSV patients was 75 (SD, 16) years; 87% had underlying conditions.  Lower respiratory and cardiovascular complications were diagnosed in 71.9% (pneumonia, 42.3%; acute bronchitis, 21.9%; chronic obstructive pulmonary disease/asthma exacerbation, 27.3%) and 14.3% of patients, resp.; 12.5% had bacterial superinfections.  Supplemental oxygen and ventilatory support were required in 67.9% and 11.1%, resp.  Crude all-cause mortality was 9.1% and 11.9% within 30 days and 60 days, resp.; mean length of stay of survivors was 12 (SD, 13) days.  Advanced age, radiog. pneumonia, requirement for ventilation, bacterial superinfection, and elevated urea level and white blood cell count were independently assocd. with poorer survival.  Systemic corticosteroid use was assocd. with longer hospitalization and secondary infections.  The overall outcomes of survival and length of stay were not significantly different from those in influenza.  Conclusions. RSV can cause severe lower respiratory complications in older adults, resulting in respiratory failure, prolonged hospitalization, and high mortality similar to seasonal influenza.  Corticosteroids did not seem to improve outcomes.  The unmet need for antiviral therapy and vaccination against RSV in adults should be promptly addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Tm2SRrtGyrVg90H21EOLACvtfcHk0lg1iY16nGPkWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFygu7jK&md5=6876b479c6d8fbf2e1d1a73f12ae8e29</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit471%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.%26aulast%3DLui%26aufirst%3DG.%2BC.%26aulast%3DWong%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DT.%2BC.%26aulast%3DTse%26aufirst%3DE.%2BC.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DChoi%26aufirst%3DK.%2BW.%26aulast%3DWong%26aufirst%3DR.%2BY.%26aulast%3DNgai%26aufirst%3DK.%2BL.%26aulast%3DHui%26aufirst%3DD.%2BS.%26aulast%3DChan%26aufirst%3DP.%2BK.%26atitle%3DHigh%2520morbidity%2520and%2520mortality%2520in%2520adults%2520hospitalized%2520for%2520respiratory%2520syncytial%2520virus%2520infections%26jtitle%3DClin%2520Infect.%2520Dis.%26date%3D2013%26volume%3D57%26spage%3D1069%26epage%3D1077%26doi%3D10.1093%2Fcid%2Fcit471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falsey, A. R.</span></span> <span> </span><span class="NLM_article-title">Risk factors for severe respiratory syncytial virus infection in elderly persons</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1086/380907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1086%2F380907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=14722887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FitlCgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2004&pages=233-238&author=E.+E.+Walshauthor=D.+R.+Petersonauthor=A.+R.+Falsey&title=Risk+factors+for+severe+respiratory+syncytial+virus+infection+in+elderly+persons&doi=10.1086%2F380907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Risk factors for severe respiratory syncytial virus infection in elderly persons</span></div><div class="casAuthors">Walsh Edward E; Peterson Derick R; Falsey Ann R</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-8</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">Risk factors for severe respiratory syncytial virus (RSV) infection were determined in 3 cohorts of adults during 2 consecutive winters (1999-2000 and 2000-2001) in Rochester, New York.  Community-dwelling healthy persons > or =65 years old and persons >21 years old who had underlying symptomatic cardiopulmonary conditions were prospectively evaluated for RSV infection.  Evidence of infection was also sought in persons who were > or =65 years old or had underlying cardiopulmonary disease and who were hospitalized with acute respiratory symptoms.  Sixty-nine RSV infections were identified by culture, reverse-transcription polymerase chain reaction, or serologic testing in the prospective groups, and 61 were identified in the hospitalized group.  The presence of underlying chronic pulmonary disease (odds ratio [OR], 3.97), functional disability (OR, 1.67/integer increase in Instruments of Activities of Daily Living score), and low serum neutralizing antibody titer (OR, 5.89) were each independently associated with increased risk of severe disease, defined as "hospitalization with RSV infection." These data suggest that the induction of neutralizing serum antibody with an RSV vaccine may potentially reduce disease severity in adult populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1oqRk11s5o7P3FVUi_gf8fW6udTcc2eZl0O6ktGtIKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FitlCgsA%253D%253D&md5=e71db55d15f961f245b7f149cf7d9a3a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F380907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F380907%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DFalsey%26aufirst%3DA.%2BR.%26atitle%3DRisk%2520factors%2520for%2520severe%2520respiratory%2520syncytial%2520virus%2520infection%2520in%2520elderly%2520persons%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D189%26spage%3D233%26epage%3D238%26doi%3D10.1086%2F380907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falsey, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessey, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formica, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus infection in elderly and high-risk adults</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa043951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa043951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=15858184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1749-1759&author=A.+R.+Falseyauthor=P.+A.+Hennesseyauthor=M.+A.+Formicaauthor=C.+Coxauthor=E.+E.+Walsh&title=Respiratory+syncytial+virus+infection+in+elderly+and+high-risk+adults&doi=10.1056%2FNEJMoa043951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection in elderly and high-risk adults</span></div><div class="casAuthors">Falsey, Ann R.; Hennessey, Patricia A.; Formica, Maria A.; Cox, Christopher; Walsh, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1749-1759</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults.  Data on the epidemiol. and clin. effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development.  METHODS During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (≥65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions.  RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serol. studies.  RESULTS A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled.  A total of 2514 illnesses were evaluated.  RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients.  RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults.  Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups.  In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, resp.), and mortality (8 percent and 7 percent, resp.).  On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clin. Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma.  CONCLUSIONS RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high.  An effective RSV vaccine may offer benefits for these adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4DLnaPCjP7Vg90H21EOLACvtfcHk0lgGLUwYlERQ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsr8%253D&md5=84051565564c0794974fde0b28a0e887</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa043951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa043951%26sid%3Dliteratum%253Aachs%26aulast%3DFalsey%26aufirst%3DA.%2BR.%26aulast%3DHennessey%26aufirst%3DP.%2BA.%26aulast%3DFormica%26aufirst%3DM.%2BA.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%2520in%2520elderly%2520and%2520high-risk%2520adults%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1749%26epage%3D1759%26doi%3D10.1056%2FNEJMoa043951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boeckh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuypers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, R.</span></span> <span> </span><span class="NLM_article-title">Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1086/509930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1086%2F509930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=17173225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2007&pages=245-249&author=M.+Boeckhauthor=J.+Englundauthor=Y.+Liauthor=C.+Millerauthor=A.+Crossauthor=H.+Fernandezauthor=J.+Kuypersauthor=H.+Kimauthor=J.+Gnannauthor=R.+Whitley&title=Randomized+controlled+multicenter+trial+of+aerosolized+ribavirin+for+respiratory+syncytial+virus+upper+respiratory+tract+infection+in+hematopoietic+cell+transplant+recipients&doi=10.1086%2F509930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients</span></div><div class="casAuthors">Boeckh, Michael; Englund, Janet; Li, Yufeng; Miller, Carole; Cross, Alan; Fernandez, Humberto; Kuypers, Jane; Kim, Hyung; Gnann, John; Whitley, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus infection of the upper airways may progress to fatal pneumonia in hematopoietic cell transplant recipients.  The safety and efficacy of aerosolized ribavirin in preventing disease progression is unknown.  Methods: In a multicenter prospective trial, hematopoietic cell transplant recipients with respiratory syncytial virus infection of the upper airways were randomized to receive ribavirin (2g 3 times daily) or supportive care for 10 days.  The primary end point was progression to radiog. proven pneumonia.  Secondary end points included virol. proven respiratory syncytial virus pneumonia, viral load changes, and safety.  Results: Fourteen patients were randomized to 1 of 2 treatment arms.  The trial was discontinued after 5 years because of slow accrual.  Pneumonia at 1 mo after randomization occurred in 1 of 9 patients who received ribavirin and in 2 of 5 patients who received supportive care (P = .51); virol. proven respiratory syncytial virus pneumonia occurred in 0 of 9 and 2 of 5 patients, resp. (P = .11). At 10 days after randomization, the av. viral load decreased by 0.75 log10 copies/mL in ribavirin recipients, compared with a viral load increase of 1.26 log10 copies/mL in untreated patients (P = .07).  No discontinuations of ribavirin therapy because of adverse effects occurred during 84 drug administrations.  Rates of adverse events were similar in both groups.  Conclusions: Preemptive aerosolized ribavirin treatment appeared to be safe, and trends of decreasing viral load over time were obsd.  However, proof of efficacy remains elusive in hematopoietic cell transplant recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeJWblyEW72rVg90H21EOLACvtfcHk0lgGLUwYlERQ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKkt7s%253D&md5=98e0890e9a040091ec33dbe070559193</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1086%2F509930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F509930%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckh%26aufirst%3DM.%26aulast%3DEnglund%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%26aulast%3DKuypers%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DGnann%26aufirst%3DJ.%26aulast%3DWhitley%26aufirst%3DR.%26atitle%3DRandomized%2520controlled%2520multicenter%2520trial%2520of%2520aerosolized%2520ribavirin%2520for%2520respiratory%2520syncytial%2520virus%2520upper%2520respiratory%2520tract%2520infection%2520in%2520hematopoietic%2520cell%2520transplant%2520recipients%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2007%26volume%3D44%26spage%3D245%26epage%3D249%26doi%3D10.1086%2F509930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. R.</span></span> <span> </span><span class="NLM_article-title">Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: Results from four years of palivizumab usage</span>. <i>Pediatr. Infect. Dis. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">S46</span>– <span class="NLM_lpage">S54</span>, <span class="refDoi"> DOI: 10.1097/01.inf.0000053885.34703.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1097%2F01.inf.0000053885.34703.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=12671452" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=S46-S54&author=J.+R.+Romero&title=Palivizumab+prophylaxis+of+respiratory+syncytial+virus+disease+from+1998+to+2002%3A+Results+from+four+years+of+palivizumab+usage&doi=10.1097%2F01.inf.0000053885.34703.84"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2F01.inf.0000053885.34703.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.inf.0000053885.34703.84%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DJ.%2BR.%26atitle%3DPalivizumab%2520prophylaxis%2520of%2520respiratory%2520syncytial%2520virus%2520disease%2520from%25201998%2520to%25202002%253A%2520Results%2520from%2520four%2520years%2520of%2520palivizumab%2520usage%26jtitle%3DPediatr.%2520Infect.%2520Dis.%2520J.%26date%3D2003%26volume%3D22%26spage%3DS46%26epage%3DS54%26doi%3D10.1097%2F01.inf.0000053885.34703.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gala, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildreth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Eyck, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. J.</span></span> <span> </span><span class="NLM_article-title">Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1056/NEJM198306163082403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJM198306163082403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=6343860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADyaL3s3hvFSrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1983&pages=1443-1447&author=C.+B.+Hallauthor=J.+T.+McBrideauthor=E.+E.+Walshauthor=D.+M.+Bellauthor=C.+L.+Galaauthor=S.+Hildrethauthor=L.+G.+Ten+Eyckauthor=W.+J.+Hall&title=Aerosolized+ribavirin+treatment+of+infants+with+respiratory+syncytial+viral+infection.+A+randomized+double-blind+study&doi=10.1056%2FNEJM198306163082403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study</span></div><div class="casAuthors">Hall C B; McBride J T; Walsh E E; Bell D M; Gala C L; Hildreth S; Ten Eyck L G; Hall W J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1443-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus.  Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days.  Seventeen infants were treated with placebo, and 16 with ribavirin.  By the end of treatment, infants receiving ribavirin had significantly greater improvement in their overall score for severity of illness, in lower-respiratory-tract signs, and in arterial oxygen saturation.  Viral shedding was also diminished in the treated groups as compared with the placebo group.  No side effects or toxicity were associated with the aerosol therapy.  Isolates of respiratory syncytial virus obtained from the infants over the course of therapy showed no change in sensitivity to ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ9XKtcKu4OC-bLEOO4dYpfW6udTcc2eZEgY0moXpkjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s3hvFSrsA%253D%253D&md5=b1ed2d8c6c38451ac61b41369de5f8ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2FNEJM198306163082403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198306163082403%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DC.%2BB.%26aulast%3DMcBride%26aufirst%3DJ.%2BT.%26aulast%3DWalsh%26aufirst%3DE.%2BE.%26aulast%3DBell%26aufirst%3DD.%2BM.%26aulast%3DGala%26aufirst%3DC.%2BL.%26aulast%3DHildreth%26aufirst%3DS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BG.%26aulast%3DHall%26aufirst%3DW.%2BJ.%26atitle%3DAerosolized%2520ribavirin%2520treatment%2520of%2520infants%2520with%2520respiratory%2520syncytial%2520viral%2520infection.%2520A%2520randomized%2520double-blind%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1983%26volume%3D308%26spage%3D1443%26epage%3D1447%26doi%3D10.1056%2FNEJM198306163082403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taber, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaudt, W. R.</span></span> <span> </span><span class="NLM_article-title">Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=6356005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A280%3ADyaL2c%252FktFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1983&pages=613-618&author=L.+H.+Taberauthor=V.+Knightauthor=B.+E.+Gilbertauthor=H.+W.+McClungauthor=S.+Z.+Wilsonauthor=H.+J.+Nortonauthor=J.+M.+Thursonauthor=W.+H.+Gordonauthor=R.+L.+Atmarauthor=W.+R.+Schlaudt&title=Ribavirin+aerosol+treatment+of+bronchiolitis+associated+with+respiratory+syncytial+virus+infection+in+infants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants</span></div><div class="casAuthors">Taber L H; Knight V; Gilbert B E; McClung H W; Wilson S Z; Norton H J; Thurson J M; Gordon W H; Atmar R L; Schlaudt W R</div><div class="citationInfo"><span class="NLM_cas:title">Pediatrics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-8</span>
        ISSN:<span class="NLM_cas:issn">0031-4005</span>.
    </div><div class="casAbstract">In a double-blind study, bronchiolitis associated with respiratory syncytial virus infection in 12 randomly selected patients treated with ribavirin aerosol improved more rapidly than in 14 control patients given saline aerosol (P = .044, Wilcoxon rank sum test, two-tailed).  An estimated 10 mg of ribavirin per kilogram of body weight was administered in daily 12-hour treatments over a five-day period.  Respiratory syncytial virus disappeared from secretions at about the same rate in treated and control patients.  There was no local or systemic intolerance, and there was no evidence of hematologic or other organ toxicity in the ribavirin-treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBC8mxSsJG78zK395ZObgVfW6udTcc2ea_mLQOJJKqMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FktFamsg%253D%253D&md5=4f1345f8b9df6ef9281bcdd422979d58</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaber%26aufirst%3DL.%2BH.%26aulast%3DKnight%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DB.%2BE.%26aulast%3DMcClung%26aufirst%3DH.%2BW.%26aulast%3DWilson%26aufirst%3DS.%2BZ.%26aulast%3DNorton%26aufirst%3DH.%2BJ.%26aulast%3DThurson%26aufirst%3DJ.%2BM.%26aulast%3DGordon%26aufirst%3DW.%2BH.%26aulast%3DAtmar%26aufirst%3DR.%2BL.%26aulast%3DSchlaudt%26aufirst%3DW.%2BR.%26atitle%3DRibavirin%2520aerosol%2520treatment%2520of%2520bronchiolitis%2520associated%2520with%2520respiratory%2520syncytial%2520virus%2520infection%2520in%2520infants%26jtitle%3DPediatrics%26date%3D1983%26volume%3D72%26spage%3D613%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P. L.</span>; <span class="NLM_string-name">Fearns, R.</span>; <span class="NLM_string-name">Graham, B. S.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus: Virology, reverse genetics, and pathogenesis of disease</span>.  <i>Challenges and Opportunities for Respiratory Syncytial Virus Vaccines</i>; <span class="NLM_series">Current Topics in Microbiology and Immunology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">372</span>, pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">38</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1007%2F978-3-642-38919-1_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=3-38&author=P.+L.+Collins&author=R.+Fearns&author=B.+S.+Graham&title=Challenges+and+Opportunities+for+Respiratory+Syncytial+Virus+Vaccines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-38919-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-38919-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BL.%26atitle%3DRespiratory%2520syncytial%2520virus%253A%2520Virology%252C%2520reverse%2520genetics%252C%2520and%2520pathogenesis%2520of%2520disease%26btitle%3DChallenges%2520and%2520Opportunities%2520for%2520Respiratory%2520Syncytial%2520Virus%2520Vaccines%26pub%3DSpringer%26date%3D2013%26volume%3D372%26spage%3D3%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglioni-Weinlich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambkin-Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Riordan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toback, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, J. W.</span></span> <span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1401184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.-L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1401184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0lgLZOAVkKqaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.-L.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722%26doi%3D10.1056%2FNEJMoa1401184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meals, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fok-Seang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntjens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lounis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariën, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remmerie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roymans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verloes, R.</span></span> <span> </span><span class="NLM_article-title">Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: A placebo-controlled study</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiy227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Finfdis%2Fjiy227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=29684148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCnt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2018&pages=748-756&author=M.+Stevensauthor=S.+Ruschauthor=J.+DeVincenzoauthor=Y.-I.+Kimauthor=L.+Harrisonauthor=E.+A.+Mealsauthor=A.+Boyersauthor=J.+Fok-Seangauthor=D.+Huntjensauthor=N.+Lounisauthor=K.+Mari%C3%ABnauthor=B.+Remmerieauthor=D.+Roymansauthor=A.+Koulauthor=R.+Verloes&title=Antiviral+activity+of+oral+JNJ-53718678+in+healthy+adult+volunteers+challenged+with+respiratory+syncytial+virus%3A+A+placebo-controlled+study&doi=10.1093%2Finfdis%2Fjiy227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: a placebo-controlled study</span></div><div class="casAuthors">Stevens, Marita; Rusch, Sarah; DeVincenzo, John; Kim, Young-In; Harrison, Lisa; Meals, Elizabeth A.; Boyers, Alison; Fok-Seang, Juin; Huntjens, Dymphy; Lounis, Nacer; Marien, Kris; Remmerie, Bart; Roymans, Dirk; Koul, Anil; Verloes, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">748-756</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Respiratory syncytial virus (RSV) disease has no effective treatment.  JNJ-53718678 is a fusion inhibitor with selective activity against RSV.  After confirmation of RSV infection or 5 days after inoculation with RSV, participants (n = 69) were randomized to JNJ-53718678 75 mg (n = 15), 200 mg (n = 17), 500 mg (n = 18), or placebo (n = 17) orally once daily for 7 days.  Antiviral effects were evaluated by assessing RSV RNA viral load (VL) area under the curve (AUC) from baseline (before the first dose) until discharge, time-to-peak VL, duration of viral shedding, clin. symptoms, and quantity of nasal secretions.  Mean VL AUC was lower for individuals treated with different doses of JNJ-53718678 vs. placebo (203.8-253.8 vs 432.8 log10 PFUe.hour/mL).  Also, mean peak VL, time to peak VL, duration of viral shedding, mean overall symptom score, and nasal secretion wt. were lower in each JNJ-53718678-treated group vs. placebo.  No clear exposure-response relationship was obsd.  Three participants discontinued due to treatment-emergent adverse events of grade 2 and 1 ECG change (JNJ-53718678 75 mg and 200 mg, resp.) and grade 2 urticaria (placebo).  Conclusions.  JNJ-53718678 at all 3 doses substantially reduced VL and clin. disease severity, thus establishing clin. proof of concept and the compd.'s potential as a novel RSV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9lct-FnOIM7Vg90H21EOLACvtfcHk0lgLZOAVkKqaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCnt77J&md5=a7da58b73e29e9c06537292a14dc3408</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiy227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiy227%26sid%3Dliteratum%253Aachs%26aulast%3DStevens%26aufirst%3DM.%26aulast%3DRusch%26aufirst%3DS.%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-I.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DMeals%26aufirst%3DE.%2BA.%26aulast%3DBoyers%26aufirst%3DA.%26aulast%3DFok-Seang%26aufirst%3DJ.%26aulast%3DHuntjens%26aufirst%3DD.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DMari%25C3%25ABn%26aufirst%3DK.%26aulast%3DRemmerie%26aufirst%3DB.%26aulast%3DRoymans%26aufirst%3DD.%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DVerloes%26aufirst%3DR.%26atitle%3DAntiviral%2520activity%2520of%2520oral%2520JNJ-53718678%2520in%2520healthy%2520adult%2520volunteers%2520challenged%2520with%2520respiratory%2520syncytial%2520virus%253A%2520A%2520placebo-controlled%2520study%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2018%26volume%3D218%26spage%3D748%26epage%3D756%26doi%3D10.1093%2Finfdis%2Fjiy227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efthimiou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littler, E.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">e01884</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1128/AAC.01884-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1128%2FAAC.01884-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31712214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2020&pages=e01884-19&author=J.+DeVincenzoauthor=D.+Taitauthor=J.+Efthimiouauthor=J.+Moriauthor=Y.-I.+Kimauthor=E.+Thomasauthor=L.+Wilsonauthor=R.+Harlandauthor=N.+Mathewsauthor=S.+Cockerillauthor=K.+Powellauthor=E.+Littler&title=A+randomized%2C+placebo-controlled%2C+respiratory+syncytial+virus+human+challenge+study+of+the+antiviral+efficacy%2C+safety%2C+and+pharmacokinetics+of+RV521%2C+an+inhibitor+of+the+RSV-F+protein&doi=10.1128%2FAAC.01884-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein</span></div><div class="casAuthors">DeVincenzo, John; Tait, Dereck; Efthimiou, John; Mori, Julie; Kim, Young-In; Thomas, Elaine; Wilson, Lynn; Harland, Rachel; Mathews, Neil; Cockerill, Stuart; Powell, Kenneth; Littler, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e01884</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Effective treatments for respiratory syncytial virus (RSV) infection are lacking.  Here, we report a human proof-of-concept study for RV521, a small-mol. antiviral inhibitor of the RSV-F protein.  In this randomized, double-blind, placebo-controlled trial, healthy adults were challenged with RSV-A Memphis-37b.  After infection was confirmed (or 5 days after challenge virus inoculation), subjects received RV521 (350 mg or 200 mg) or placebo orally every 12 h for 5 days.  The primary endpoint was area under the curve (AUC) for viral load, as assessed by reverse transcriptase quant. PCR (RT-qPCR) of nasal wash samples.  The primary efficacy anal. set included subjects successfully infected with RSV who received ≥1 dose of study drug.  A total of 66 subjects were enrolled (n = 22 per group); 53 were included in the primary anal. set (RV521 350 mg: n = 16; 200 mg: n = 18; placebo: n = 19).  The mean AUC of RT-qPCR-assessed RSV viral load (log10 PFU equiv. [PFUe]/mL.h) was significantly lower with RV521 350 mg (185.26; std. error [SE], 31.17; P = 0.002) and 200 mg (224.35; SE, 37.60; P = 0.007) vs. placebo (501.39; SE, 86.57).  Disease severity improved with RV521 350 mg and 200 mg vs. placebo (P = 0.002 and P = 0.009, resp., for AUC total symptom score [score × hours]).  Daily nasal mucus wt. was significantly reduced (P = 0.010 and P = 0.038 for RV521 350 mg and 200 mg, resp., vs. placebo).  All treatment-emergent adverse events were grade 1 or 2.  No subjects discontinued due to adverse events.  There was no evidence of clin. significant viral resistance, and only three variants were detected.  RV521 effectively reduced RSV viral load and disease severity in humans and was well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVsGp1QWwVrVg90H21EOLACvtfcHk0liD6FxvUn5Y8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFygs7g%253D&md5=9e3b634f6cca773406727b57776eea0d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.01884-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01884-19%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DTait%26aufirst%3DD.%26aulast%3DEfthimiou%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-I.%26aulast%3DThomas%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DHarland%26aufirst%3DR.%26aulast%3DMathews%26aufirst%3DN.%26aulast%3DCockerill%26aufirst%3DS.%26aulast%3DPowell%26aufirst%3DK.%26aulast%3DLittler%26aufirst%3DE.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%252C%2520respiratory%2520syncytial%2520virus%2520human%2520challenge%2520study%2520of%2520the%2520antiviral%2520efficacy%252C%2520safety%252C%2520and%2520pharmacokinetics%2520of%2520RV521%252C%2520an%2520inhibitor%2520of%2520the%2520RSV-F%2520protein%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2020%26volume%3D64%26spage%3De01884%26epage%3D19%26doi%3D10.1128%2FAAC.01884-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coakley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenhoor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noulin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvathova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adda, N.</span></span> <span> </span><span class="NLM_article-title">LB6. EDP-938, a novel RSV N-inhibitor, administered once or twice daily was safe and demonstrated robust antiviral and clinical efficacy in a healthy volunteer challenge study</span>. <i>Open Forum Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S995</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofz415.2489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1093%2Fofid%2Fofz415.2489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=S995&author=E.+Coakleyauthor=A.+Ahmadauthor=K.+Larsonauthor=T.+McClureauthor=K.+Linauthor=K.+Linauthor=K.+Tenhoorauthor=K.+Ezeauthor=N.+Noulinauthor=V.+Horvathovaauthor=B.+Murrayauthor=M.+Bailletauthor=J.+Moriauthor=N.+Adda&title=LB6.+EDP-938%2C+a+novel+RSV+N-inhibitor%2C+administered+once+or+twice+daily+was+safe+and+demonstrated+robust+antiviral+and+clinical+efficacy+in+a+healthy+volunteer+challenge+study&doi=10.1093%2Fofid%2Fofz415.2489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofz415.2489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofz415.2489%26sid%3Dliteratum%253Aachs%26aulast%3DCoakley%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DLarson%26aufirst%3DK.%26aulast%3DMcClure%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DTenhoor%26aufirst%3DK.%26aulast%3DEze%26aufirst%3DK.%26aulast%3DNoulin%26aufirst%3DN.%26aulast%3DHorvathova%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DBaillet%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DAdda%26aufirst%3DN.%26atitle%3DLB6.%2520EDP-938%252C%2520a%2520novel%2520RSV%2520N-inhibitor%252C%2520administered%2520once%2520or%2520twice%2520daily%2520was%2520safe%2520and%2520demonstrated%2520robust%2520antiviral%2520and%2520clinical%2520efficacy%2520in%2520a%2520healthy%2520volunteer%2520challenge%2520study%26jtitle%3DOpen%2520Forum%2520Infect.%2520Dis.%26date%3D2019%26volume%3D6%26spage%3DS995%26doi%3D10.1093%2Fofid%2Fofz415.2489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeVincenzo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambkin-Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, J.</span></span> <span> </span><span class="NLM_article-title">Activity of oral ALS-008176 in a respiratory syncytial virus challenge study</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2058</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1413275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1056%2FNEJMoa1413275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26580997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVSrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2048-2058&author=J.+P.+DeVincenzoauthor=M.+W.+McClureauthor=J.+A.+Symonsauthor=H.+Fathiauthor=C.+Westlandauthor=S.+Chandaauthor=R.+Lambkin-Williamsauthor=P.+Smithauthor=Q.+Zhangauthor=L.+Beigelmanauthor=L.+M.+Blattauthor=J.+Fry&title=Activity+of+oral+ALS-008176+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1413275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of oral ALS-008176 in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; McClure, Matthew W.; Symons, Julian A.; Fathi, Hosnieh; Westland, Christopher; Chanda, Sushmita; Lambkin-Williams, Rob; Smith, Patrick; Zhang, Qingling; Beigelman, Leo; Blatt, Lawrence M.; Fry, John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2048-2058</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality.  There is no known effective therapy.  We conducted a randomized, double-blind, clin. trial in healthy adults inoculated with RSV.  Participants received the oral nucleoside analog ALS-008176 or placebo 12 h after confirmation of RSV infection or 6 days after inoculation.  Treatment was administered every 12 h for 5 days.  Viral load, disease severity, resistance, and safety were measured throughout the 28-day study period, with measurement beginning before inoculation.  The primary end point was the area under the curve (AUC) for viral load, which was assessed immediately before administration of the first dose through the 12th day after inoculation in participants infected with RSV.  A total of 62 participants received placebo or one of three ALS-008176 dosing regimens: 1 loading dose of 750 mg followed by 9 maintenance doses of 500 mg (group 1), 1 loading dose of 750 mg followed by 9 maintenance doses of 150 mg (group 2), or 10 doses of 375 mg (group 3).  In the 35 infected participants (23 of whom were treated with ALS-008176), the AUCs for viral load for groups 1, 2, and 3 and the placebo group were 59.9, 73.7, 133.4, and 500.9 log10 plaque-forming-unit equiv. × hours per mL, resp. (P≤0.001).  The time to nondetectability on polymerase-chain-reaction assay (P<0.001), the peak viral load (P≤0.001), the AUC for symptom score (P<0.05), and the AUC for mucus wt. were lower in all groups receiving ALS-008176 than in the placebo group.  Antiviral activity was greatest in the two groups that received a loading dose - viral clearance was accelerated (P≤0.05), and the AUC for viral load decreased by 85 to 88% as compared with the placebo group.  Within this small trial, no viral rebound or resistance was identified.  There were no serious adverse events, and there was no need for premature discontinuation of the study drug.  In this RSV challenge study, more rapid RSV clearance and a greater redn. of viral load, with accompanying improvements in the severity of clin. disease, were obsd. in the groups treated with ALS-008176 than in the placebo group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVhsAaDKW-4bVg90H21EOLACvtfcHk0lgYvaIzKIMshg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVSrsro%253D&md5=e1cac2ef1b91f47abf768403cb072ec0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1413275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1413275%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DMcClure%26aufirst%3DM.%2BW.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DFathi%26aufirst%3DH.%26aulast%3DWestland%26aufirst%3DC.%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DFry%26aufirst%3DJ.%26atitle%3DActivity%2520of%2520oral%2520ALS-008176%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2048%26epage%3D2058%26doi%3D10.1056%2FNEJMoa1413275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span> <span> </span><span class="NLM_article-title">Nucleosides for the treatment of respiratory RNA virus infections</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">2040206618764483</span> <span class="refDoi"> DOI: 10.1177/2040206618764483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1177%2F2040206618764483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&author=P.+C.+Jordanauthor=S.+K.+Stevensauthor=J.+Deval&title=Nucleosides+for+the+treatment+of+respiratory+RNA+virus+infections&doi=10.1177%2F2040206618764483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F2040206618764483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040206618764483%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DP.%2BC.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DNucleosides%2520for%2520the%2520treatment%2520of%2520respiratory%2520RNA%2520virus%2520infections%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2018%26volume%3D26%26doi%3D10.1177%2F2040206618764483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boojamra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piedra, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinkade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theodore, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1021/jm5017768</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1yltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1630-1643&author=R.+L.+Mackmanauthor=M.+Sangiauthor=D.+Sperandioauthor=J.+P.+Parrishauthor=E.+Eisenbergauthor=M.+Perronauthor=H.+Huiauthor=L.+Zhangauthor=D.+Siegelauthor=H.+Yangauthor=O.+Saundersauthor=C.+Boojamraauthor=G.+Leeauthor=D.+Samuelauthor=K.+Babaogluauthor=A.+Careyauthor=B.+E.+Gilbertauthor=P.+A.+Piedraauthor=R.+Strickleyauthor=Q.+Iwataauthor=J.+Hayesauthor=K.+Strayauthor=A.+Kinkadeauthor=D.+Theodoreauthor=R.+Jordanauthor=M.+Desaiauthor=T.+Cihlar&title=Discovery+of+an+oral+respiratory+syncytial+virus+%28RSV%29+fusion+inhibitor+%28GS-5806%29+and+clinical+proof+of+concept+in+a+human+RSV+challenge+study&doi=10.1021%2Fjm5017768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study</span></div><div class="casAuthors">Mackman, Richard L.; Sangi, Michael; Sperandio, David; Parrish, Jay P.; Eisenberg, Eugene; Perron, Michel; Hui, Hon; Zhang, Lijun; Siegel, Dustin; Yang, Hai; Saunders, Oliver; Boojamra, Constantine; Lee, Gary; Samuel, Dharmaraj; Babaoglu, Kerim; Carey, Anne; Gilbert, Brian E.; Piedra, Pedro A.; Strickley, Robert; Iwata, Quynh; Hayes, Jaclyn; Stray, Kirsten; Kinkade, April; Theodore, Dorothy; Jordan, Robert; Desai, Manoj; Cihlar, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1630-1643</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GS-5806 I is a novel, orally bioavailable RSV fusion inhibitor discovered following a lead optimization campaign on a screening hit.  The oral absorption properties were optimized by converting to the pyrazolo[1,5-a]-pyrimidine heterocycle, while potency, metabolic, and physicochem. properties were optimized by introducing the para-chloro and aminopyrrolidine groups.  A mean EC50 = 0.43 nM was found toward a panel of 75 RSV A and B clin. isolates and dose-dependent antiviral efficacy in the cotton rat model of RSV infection.  Oral bioavailability in preclin. species ranged from 46 to 100%, with evidence of efficient penetration into lung tissue.  In healthy human volunteers exptl. infected with RSV, a potent antiviral effect was obsd. with a mean 4.2 log10 redn. in peak viral load and a significant redn. in disease severity compared to placebo.  In conclusion, a potent, once daily, oral RSV fusion inhibitor with the potential to treat RSV infection in infants and adults is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL4lY74Xv7GbVg90H21EOLACvtfcHk0lgYvaIzKIMshg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1yltw%253D%253D&md5=5a723ce1defe717da8cb7985ee297811</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm5017768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017768%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSangi%26aufirst%3DM.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DParrish%26aufirst%3DJ.%2BP.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSaunders%26aufirst%3DO.%26aulast%3DBoojamra%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DCarey%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DB.%2BE.%26aulast%3DPiedra%26aufirst%3DP.%2BA.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DQ.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DStray%26aufirst%3DK.%26aulast%3DKinkade%26aufirst%3DA.%26aulast%3DTheodore%26aufirst%3DD.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DCihlar%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520oral%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520fusion%2520inhibitor%2520%2528GS-5806%2529%2520and%2520clinical%2520proof%2520of%2520concept%2520in%2520a%2520human%2520RSV%2520challenge%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1630%26epage%3D1643%26doi%3D10.1021%2Fjm5017768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Kim, C.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">1′-Substituted Carba-Nucleoside Analogs for Antiviral Treatment</span>. <span class="NLM_patent">WO2009/132135</span>, Gilead Sciences, April 22, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Butler&author=A.+Cho&author=C.+Kim&author=O.+L.+Saunders&author=L.+Zhang&title=1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs+for+Antiviral+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3D1%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%2520for%2520Antiviral%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suanders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.bmcl.2012.02.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=22446091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2705-2707&author=A.+Choauthor=O.+L.+Suandersauthor=T.+Butlerauthor=L.+Zhangauthor=J.+Xuauthor=J.+E.+Velaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+and+antiviral+activity+of+a+series+of+1%E2%80%B2-substituted+4-aza-7%2C9-dideazaadenosine+C-nucleosides&doi=10.1016%2Fj.bmcl.2012.02.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span></div><div class="casAuthors">Cho, Aesop; Saunders, Oliver L.; Butler, Thomas; Zhang, Lijun; Xu, Jie; Vela, Jennifer E.; Feng, Joy Y.; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2705-2707</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1'-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside, e.g. I, were prepd. and evaluated for the potential as antiviral agents.  These compds. showed a broad range of inhibitory activity against various RNA viruses.  In particular, the whole cell potency against HCV when R = CN was attributed to inhibition of HCV NS5B polymerase and intracellular concn. of the corresponding nucleoside triphosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAj_ComFGJ9LVg90H21EOLACvtfcHk0lgYvaIzKIMshg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D&md5=b7576da7b34ae7b3862d80b52645465a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.105%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DSuanders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520a%2520series%2520of%25201%25E2%2580%25B2-substituted%25204-aza-7%252C9-dideazaadenosine%2520C-nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2705%26epage%3D2707%26doi%3D10.1016%2Fj.bmcl.2012.02.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHutchison, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1021/jm400201a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400201a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1812-1825&author=A.+Choauthor=L.+Zhangauthor=J.+Xuauthor=R.+Leeauthor=T.+Butlerauthor=S.+Metoboauthor=V.+Aktoudianakisauthor=W.+Lewauthor=H.+Yeauthor=M.+Clarkeauthor=E.+Doerfflerauthor=D.+Byunauthor=T.+Wangauthor=D.+Babusisauthor=A.+C.+Careyauthor=P.+Bermanauthor=D.+Sauerauthor=W.+Zhongauthor=S.+Rossiauthor=M.+Fenauxauthor=J.+G.+McHutchisonauthor=J.+Perryauthor=J.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Discovery+of+the+first+C-nucleoside+HCV+polymerase+inhibitor+%28GS-6620%29+with+demonstrated+antiviral+response+in+HCV+infected+patients&doi=10.1021%2Fjm400201a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span></div><div class="casAuthors">Cho, Aesop; Zhang, Lijun; Xu, Jie; Lee, Rick; Butler, Thomas; Metobo, Sammy; Aktoudianakis, Vangelis; Lew, Willard; Ye, Hong; Clarke, Michael; Doerffler, Edward; Byun, Daniel; Wang, Ting; Babusis, Darius; Carey, Anne C.; German, Polina; Sauer, Dorothea; Zhong, Weidong; Rossi, Stephen; Fenaux, Martijn; McHutchison, John G.; Perry, Jason; Feng, Joy; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1812-1825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection presents an unmet medical need requiring more effective treatment options.  Nucleoside inhibitors (NI) of HCV polymerase (NS5B) have demonstrated pan-genotypic activity and durable antiviral response in the clinic, and they are likely to become a key component of future treatment regimens.  NI candidates that have entered clin. development thus far have all been N-nucleoside derivs.  Herein, we report the discovery of a C-nucleoside class of NS5B inhibitors.  Exploration of adenosine analogs in this class identified 1'-cyano-2'-C-Me 4-aza-7,9-dideaza adenosine as a potent and selective inhibitor of NS5B.  A monophosphate prodrug approach afforded a series of compds. showing submicromolar activity in HCV replicon assays.  Further pharmacokinetic optimization for sufficient oral absorption and liver triphosphate loading led to identification of a clin. development candidate GS-6620 (I).  In a phase I clin. study, the potential for potent activity was demonstrated but with high intra- and interpatient pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0DWejYRAB7Vg90H21EOLACvtfcHk0ljTsWZk5GAD4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D&md5=60cb14dcd3d500933bcf4e55e9257fc6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400201a%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DV.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DA.%2BC.%26aulast%3DBerman%26aufirst%3DP.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DRossi%26aufirst%3DS.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520the%2520first%2520C-nucleoside%2520HCV%2520polymerase%2520inhibitor%2520%2528GS-6620%2529%2520with%2520demonstrated%2520antiviral%2520response%2520in%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1812%26epage%3D1825%26doi%3D10.1021%2Fjm400201a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyatkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4′-chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1878</span>, <span class="refDoi"> DOI: 10.1021/jm5017279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1862-1878&author=G.+Wangauthor=J.+Devalauthor=J.+Hongauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=J.+Taylorauthor=A.+Fungauthor=Z.+Jinauthor=S.+K.+Stevensauthor=V.+Serebryanyauthor=J.+Liuauthor=Q.+Zhangauthor=Y.+Tamauthor=S.+M.+Chandaauthor=D.+B.+Smithauthor=J.+A.+Symonsauthor=L.+M.+Blattauthor=L.+Beigelman&title=Discovery+of+4%E2%80%B2-chloromethyl-2%E2%80%B2-deoxy-3%E2%80%B2%2C5%E2%80%B2-di-O-isobutyryl-2%E2%80%B2-fluorocytidine+%28ALS-8176%29%2C+a+first-in-class+RSV+polymerase+inhibitor+for+treatment+of+human+respiratory+syncytial+virus+infection&doi=10.1021%2Fjm5017279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4'-Chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection</span></div><div class="casAuthors">Wang, Guangyi; Deval, Jerome; Hong, Jin; Dyatkina, Natalia; Prhavc, Marija; Taylor, Joshua; Fung, Amy; Jin, Zhinan; Stevens, Sarah K.; Serebryany, Vladimir; Liu, Jyanwei; Zhang, Qingling; Tam, Yuen; Chanda, Sushmita M.; Smith, David B.; Symons, Julian A.; Blatt, Lawrence M.; Beigelman, Leo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1862-1878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is assocd. with significant morbidity and mortality.  To date, ribavirin is the only approved small mol. drug, which has limited use.  The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis.  Clearly, there is an urgent need for small mol. RSV drugs.  This article reports the design, synthesis, anti-RSV activity, metab., and pharmacokinetics of a series of 4'-substituted cytidine nucleosides.  Among tested compds. 4'-chloromethyl-2'-deoxy-2'-fluorocytidine I exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM.  The 5'-triphosphate of I (I-TP)inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM.  ALS-8176 II, the 3',5'-di-O-isobutyryl prodrug of I, demonstrated good oral bioavailability and a high level of I-TP in vivo.  Compd. II is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clin. RSV challenge study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaKHh4AhV9drVg90H21EOLACvtfcHk0ljTsWZk5GAD4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D&md5=da9e883eb67f20ca259dec06a6a05367</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm5017279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017279%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-O-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2520%2528ALS-8176%2529%252C%2520a%2520first-in-class%2520RSV%2520polymerase%2520inhibitor%2520for%2520treatment%2520of%2520human%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1862%26epage%3D1878%26doi%3D10.1021%2Fjm5017279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalayanov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sund, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winqvist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltseva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leveque, V. J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajyaguru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkestock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span> <span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: The discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′,2′-difluorocytidine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2971</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm801595c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=C.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+4%E2%80%B2-azidocytidine+against+hepatitis+C+virus+replication%3A+The+discovery+of+4%E2%80%B2-azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine&doi=10.1021%2Fjm801595c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4'-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4'-Azido-2'-deoxy-2'-fluorocytidine and 4'-Azido-2'-dideoxy-2',2'-difluorocytidine</span></div><div class="casAuthors">Smith, David B.; Kalayanov, Genadiy; Sund, Christian; Winqvist, Anna; Maltseva, Tatiana; Leveque, Vincent J.-P.; Rajyaguru, Sonal; Le Pogam, Sophie; Najera, Isabel; Benkestock, Kurt; Zhou, Xiao-Xiong; Kaiser, Ann C.; Maag, Hans; Cammack, Nick; Martin, Joseph A.; Swallow, Steven; Johansson, Nils Gunnar; Klumpp, Klaus; Smith, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2971-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 4'-azidocytidine (R1479) (J. Biol. Chem.2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 μM), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the synthesis and biol. evaluation of several monofluoro and difluoro derivs. of 4'-azidocytidine.  The most potent compds. in this series were 4'-azido-2'-deoxy-2',2'-difluorocytidine I (R = F) and 4'-azido-2'-deoxy-2'-fluoroarabinocytidine I (R = H) with antiviral EC50 of 66 nM and 24 nM in the HCV replicon system, resp.  The structure-activity relationships within this series were discussed, which led to the discovery of these novel nucleoside analogs with the most potent compd., showing more than a 50-fold increase in antiviral potency as compared to 4'-azidocytidine (R1479).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWf69k-wQED7Vg90H21EOLACvtfcHk0lgNUKM7PpK9_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKrtbc%253D&md5=c9d96b25d6d3247580087a5d657a9c1f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%25204%25E2%2580%25B2-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520The%2520discovery%2520of%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978%26doi%3D10.1021%2Fjm801595c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7202</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.1021/jm100863x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Micolochick+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus&doi=10.1021%2Fjm100863x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0lgNUKM7PpK9_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218%26doi%3D10.1021%2Fjm100863x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span> <span> </span><span class="NLM_article-title">Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1006889</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1006889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1371%2Fjournal.ppat.1006889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=29425244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsleltrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=P.+C.+Jordanauthor=C.+Liuauthor=P.+Raynaudauthor=M.+K.+Loauthor=C.+F.+Spiropoulouauthor=J.+A.+Symonsauthor=L.+Beigelmanauthor=J.+Deval&title=Initiation%2C+extension%2C+and+termination+of+RNA+synthesis+by+a+paramyxovirus+polymerase&doi=10.1371%2Fjournal.ppat.1006889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase</span></div><div class="casAuthors">Jordan, Paul C.; Liu, Cheng; Raynaud, Pauline; Lo, Michael K.; Spiropoulou, Christina F.; Symons, Julian A.; Beigelman, Leo; Deval, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006889/1-e1006889/23</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Paramyxoviruses represent a family of RNA viruses causing significant human diseases.  These include measles virus, the most infectious virus ever reported, in addn. to parainfluenza virus, and other emerging viruses.  Paramyxoviruses likely share common replication machinery but their mechanisms of RNA biosynthesis activities and details of their complex polymerase structures are unknown.  Mechanistic and functional details of a paramyxovirus polymerase would have sweeping implications for understanding RNA virus replication and for the development of new antiviral medicines.  To study paramyxovirus polymerase structure and function, we expressed an active recombinant Nipah virus (NiV) polymerase complex assembled from the multifunctional NiV L protein bound to its phosphoprotein cofactor.  NiV is an emerging highly pathogenic virus that causes severe encephalitis and has been declared a global public health concern due to its high mortality rate.  Using neg.-stain electron microscopy, we demonstrated NiV polymerase forms ring-like particles resembling related RNA polymerases.  We identified conserved sequence elements driving recognition of the 3'- terminal genomic promoter by NiV polymerase, and leading to initiation of RNA synthesis, primer extension, and transition to elongation mode.  Polyadenylation resulting from NiV polymerase stuttering provides a mechanistic basis for transcription termination.  It also suggests a divergent adaptation in promoter recognition between pneumo- and paramyxoviruses.  The lack of available antiviral therapy for NiV prompted us to identify the triphosphate forms of R1479 and GS-5734, two clin. relevant nucleotide analogs, as substrates and inhibitors of NiV polymerase activity by delayed chain termination.  Overall, these findings provide low-resoln. structural details and the mechanism of an RNA polymerase from a previously uncharacterized virus family.  This work illustrates important functional differences yet remarkable similarities between the polymerases of nonsegmented neg.-strand RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SobNcmdy9rVg90H21EOLACvtfcHk0lgNUKM7PpK9_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsleltrvM&md5=c4e11dad7faf0fb43d2dfff9f3dc202a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006889%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DP.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DP.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DInitiation%252C%2520extension%252C%2520and%2520termination%2520of%2520RNA%2520synthesis%2520by%2520a%2520paramyxovirus%2520polymerase%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1006889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyatkina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoycheva, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span> <span> </span><span class="NLM_article-title">Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2′-fluoro-4′-chloromethyl-cytidine triphosphate</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004995</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1371%2Fjournal.ppat.1004995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=26098424" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=J.+Devalauthor=J.+Hongauthor=G.+Wangauthor=J.+Taylorauthor=L.+K.+Smithauthor=A.+Fungauthor=S.+K.+Stevensauthor=H.+Liuauthor=Z.+Jinauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=A.+D.+Stoychevaauthor=V.+Serebryanyauthor=J.+Liuauthor=D.+B.+Smithauthor=Y.+Tamauthor=Q.+Zhangauthor=M.+L.+Mooreauthor=R.+Fearnsauthor=S.+M.+Chandaauthor=L.+M.+Blattauthor=J.+A.+Symonsauthor=L.+Beigelman&title=Molecular+basis+for+the+selective+inhibition+of+respiratory+syncytial+virus+RNA+polymerase+by+2%E2%80%B2-fluoro-4%E2%80%B2-chloromethyl-cytidine+triphosphate&doi=10.1371%2Fjournal.ppat.1004995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004995%26sid%3Dliteratum%253Aachs%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DL.%2BK.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DStoycheva%26aufirst%3DA.%2BD.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520selective%2520inhibition%2520of%2520respiratory%2520syncytial%2520virus%2520RNA%2520polymerase%2520by%25202%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-chloromethyl-cytidine%2520triphosphate%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.ppat.1004995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchesnokov, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span> <span> </span><span class="NLM_article-title">Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">6785</span>– <span class="NLM_lpage">6797</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA120.013679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1074%2Fjbc.RA120.013679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32284326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Wqt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=6785-6797&author=C.+J.+Gordonauthor=E.+P.+Tchesnokovauthor=E.+Woolnerauthor=J.+K.+Perryauthor=J.+Y.+Fengauthor=D.+P.+Porterauthor=M.+G%C3%B6tte&title=Remdesivir+is+a+direct-acting+antiviral+that+inhibits+RNA-dependent+RNA+polymerase+from+severe+acute+respiratory+syndrome+coronavirus+2+with+high+potency&doi=10.1074%2Fjbc.RA120.013679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency</span></div><div class="casAuthors">Gordon, Calvin J.; Tchesnokov, Egor P.; Woolner, Emma; Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6785-6797</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to control this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Replication of SARS-CoV-2 depends on the viral RNA-dependent RNA polymerase (RdRp), which is the likely target of the investigational nucleotide analog remdesivir (RDV).  RDV shows broad-spectrum antiviral activity against RNA viruses, and previous studies with RdRps from Ebola virus and Middle East respiratory syndrome coronavirus (MERS-CoV) have revealed that delayed chain termination is RDV's plausible mechanism of action.  Here, we expressed and purified active SARS-CoV-2 RdRp composed of the nonstructural proteins nsp8 and nsp12.  Enzyme kinetics indicated that this RdRp efficiently incorporates the active triphosphate form of RDV (RDV-TP) into RNA.  Incorporation of RDV-TP at position i caused termination of RNA synthesis at position i + 3.  We obtained almost identical results with SARS-CoV, MERS-CoV, and SARS-CoV-2 RdRps.  A unique property of RDV-TP is its high selectivity over incorporation of its natural nucleotide counterpart ATP.  In this regard, the triphosphate forms of 2'-C-methylated compds., including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits.  Furthermore, we provide evidence for the target specificity of RDV, as RDV-TP was less efficiently incorporated by the distantly related Lassa virus RdRp, and termination of RNA synthesis was not obsd.  These results collectively provide a unifying, refined mechanism of RDV-mediated RNA synthesis inhibition in coronaviruses and define this nucleotide analog as a direct-acting antiviral.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHbFv_ESm2rVg90H21EOLACvtfcHk0li6SzETrYBifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Wqt7bN&md5=10cbcacce46953727591712e0edebed8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013679%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BJ.%26aulast%3DTchesnokov%26aufirst%3DE.%2BP.%26aulast%3DWoolner%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26atitle%3DRemdesivir%2520is%2520a%2520direct-acting%2520antiviral%2520that%2520inhibits%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%25202%2520with%2520high%2520potency%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D6785%26epage%3D6797%26doi%3D10.1074%2Fjbc.RA120.013679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick
Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">34337</span>– <span class="NLM_lpage">34347</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1074%2Fjbc.M110.161802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=20801890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34337-34347&author=E.+Murakamiauthor=T.+Tolstykhauthor=H.+Baoauthor=C.+Niuauthor=H.+M.+Micolochick%0ASteuerauthor=D.+Baoauthor=W.+Changauthor=C.+Espirituauthor=S.+Bansalauthor=A.+M.+Lamauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furman&title=Mechanism+of+activation+of+PSI-7851+and+its+diastereoisomer+PSI-7977&doi=10.1074%2Fjbc.M110.161802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977</span></div><div class="casAuthors">Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34337-34347</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A phosphoramidate prodrug of 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo.  PSI-7851 is a mixt. of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay.  To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form.  The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction.  Western blot anal. showed that CatA and CES1 are both expressed in primary human hepatocytes.  However, expression of CES1 is undetectable in clone A replicon cells.  Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis.  Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the prodn. of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers.  The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411.  SiRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411.  PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SPaB9Whp17Vg90H21EOLACvtfcHk0li6SzETrYBifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O&md5=28287a5f7547ab85158f594cd5fb1cd0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161802%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520activation%2520of%2520PSI-7851%2520and%2520its%2520diastereoisomer%2520PSI-7977%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34337%26epage%3D34347%26doi%3D10.1074%2Fjbc.M110.161802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klena, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span> <span> </span><span class="NLM_article-title">Remdesivir (GS-5734) protects African Green monkeys from Nipah virus challenge</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">eaau9242</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aau9242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1126%2Fscitranslmed.aau9242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=31142680" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&author=M.+K.+Loauthor=F.+Feldmannauthor=J.+M.+Garyauthor=R.+Jordanauthor=R.+Bannisterauthor=J.+Croninauthor=N.+R.+Patelauthor=J.+D.+Klenaauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+R.+Zakiauthor=H.+Feldmannauthor=C.+F.+Spiropoulouauthor=E.+de+Wit&title=Remdesivir+%28GS-5734%29+protects+African+Green+monkeys+from+Nipah+virus+challenge&doi=10.1126%2Fscitranslmed.aau9242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aau9242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aau9242%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DGary%26aufirst%3DJ.%2BM.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DCronin%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKlena%26aufirst%3DJ.%2BD.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DZaki%26aufirst%3DS.%2BR.%26aulast%3DFeldmann%26aufirst%3DH.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3Dde%2BWit%26aufirst%3DE.%26atitle%3DRemdesivir%2520%2528GS-5734%2529%2520protects%2520African%2520Green%2520monkeys%2520from%2520Nipah%2520virus%2520challenge%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2019%26volume%3D11%26doi%3D10.1126%2Fscitranslmed.aau9242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span> <span> </span><span class="NLM_article-title">Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6771</span>– <span class="NLM_lpage">6776</span>, <span class="refDoi"> DOI: 10.1073/pnas.1922083117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1073%2Fpnas.1922083117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32054787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsl2jtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=6771-6776&author=E.+de%0AWitauthor=F.+Feldmannauthor=J.+Croninauthor=R.+Jordanauthor=A.+Okumuraauthor=T.+Thomasauthor=D.+Scottauthor=T.+Cihlarauthor=H.+Feldmann&title=Prophylactic+and+therapeutic+remdesivir+%28GS-5734%29+treatment+in+the+rhesus+macaque+model+of+MERS-CoV+infection&doi=10.1073%2Fpnas.1922083117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection</span></div><div class="casAuthors">de Wit, Emmie; Feldmann, Friederike; Cronin, Jacqueline; Jordan, Robert; Okumura, Atsushi; Thomas, Tina; Scott, Dana; Cihlar, Tomas; Feldmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6771-6776</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of effective antiviral treatments.  Remdesivir (GS-5734) effectively inhibited MERS coronavirus (MERS-CoV) replication in vitro, and showed efficacy against Severe Acute Respiratory Syndrome (SARS)-CoV in a mouse model.  Here, we tested the efficacy of prophylactic and therapeutic remdesivir treatment in a nonhuman primate model of MERS-CoV infection, the rhesus macaque.  Prophylactic remdesivir treatment initiated 24 h prior to inoculation completely prevented MERS-CoV-induced clin. disease, strongly inhibited MERS-CoV replication in respiratory tissues, and prevented the formation of lung lesions.  Therapeutic remdesivir treatment initiated 12 h postinoculation also provided a clear clin. benefit, with a redn. in clin. signs, reduced virus replication in the lungs, and decreased presence and severity of lung lesions.  The data presented here support testing of the efficacy of remdesivir treatment in the context of a MERS clin. trial.  It may also be considered for a wider range of coronaviruses, including the currently emerging novel coronavirus 2019-nCoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCmXVnq9TNnLVg90H21EOLACvtfcHk0ljZyJIYtKpd7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsl2jtLw%253D&md5=42bcd1ccac323048b1d67893af237a99</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1922083117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1922083117%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DCronin%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DFeldmann%26aufirst%3DH.%26atitle%3DProphylactic%2520and%2520therapeutic%2520remdesivir%2520%2528GS-5734%2529%2520treatment%2520in%2520the%2520rhesus%2520macaque%2520model%2520of%2520MERS-CoV%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2020%26volume%3D117%26spage%3D6771%26epage%3D6776%26doi%3D10.1073%2Fpnas.1922083117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrc, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trantcheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaal3653</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aal3653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1126%2Fscitranslmed.aal3653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=28659436" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=T.+P.+Sheahanauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=V.+D.+Menacheryauthor=L.+E.+Gralinskiauthor=J.+B.+Caseauthor=S.+R.+Leistauthor=K.+Pyrcauthor=J.+Y.+Fengauthor=I.+Trantchevaauthor=R.+Bannisterauthor=Y.+Parkauthor=D.+Babusisauthor=M.+O.+Clarkeauthor=R.+L.+Mackmanauthor=J.+E.+Spahnauthor=C.+A.+Palmiottiauthor=D.+Siegelauthor=A.+S.+Rayauthor=T.+C.+Cihlarauthor=R.+Jordanauthor=M.+R.+Denisonauthor=R.+S.+Baric&title=Broad-spectrum+antiviral+GS-5734+inhibits+both+epidemic+and+zoonotic+coronaviruses&doi=10.1126%2Fscitranslmed.aal3653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal3653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal3653%26sid%3Dliteratum%253Aachs%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26aulast%3DGralinski%26aufirst%3DL.%2BE.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DPyrc%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DTrantcheva%26aufirst%3DI.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSpahn%26aufirst%3DJ.%2BE.%26aulast%3DPalmiotti%26aufirst%3DC.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%2BC.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26atitle%3DBroad-spectrum%2520antiviral%2520GS-5734%2520inhibits%2520both%2520epidemic%2520and%2520zoonotic%2520coronaviruses%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aal3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade-White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doremalen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yinda, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovaglio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturday, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span> <span> </span><span class="NLM_article-title">Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2423-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1038%2Fs41586-020-2423-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32516797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslelu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2020&pages=273-276&author=B.+N.+Williamsonauthor=F.+Feldmannauthor=B.+Schwarzauthor=K.+Meade-Whiteauthor=D.+P.+Porterauthor=J.+Schulzauthor=N.+van+Doremalenauthor=I.+Leightonauthor=C.+K.+Yindaauthor=L.+P%C3%A9rez-P%C3%A9rezauthor=A.+Okumuraauthor=J.+Lovaglioauthor=P.+W.+Hanleyauthor=G.+Saturdayauthor=C.+M.+Bosioauthor=S.+Anzickauthor=K.+Barbianauthor=T.+Cihlarauthor=C.+Martensauthor=D.+P.+Scottauthor=V.+J.+Munsterauthor=E.+de+Wit&title=Clinical+benefit+of+remdesivir+in+rhesus+macaques+infected+with+SARS-CoV-2&doi=10.1038%2Fs41586-020-2423-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2</span></div><div class="casAuthors">Williamson, Brandi N.; Feldmann, Friederike; Schwarz, Benjamin; Meade-White, Kimberly; Porter, Danielle P.; Schulz, Jonathan; van Doremalen, Neeltje; Leighton, Ian; Yinda, Claude Kwe; Perez-Perez, Lizzette; Okumura, Atsushi; Lovaglio, Jamie; Hanley, Patrick W.; Saturday, Greg; Bosio, Catharine M.; Anzick, Sarah; Barbian, Kent; Cihlar, Tomas; Martens, Craig; Scott, Dana P.; Munster, Vincent J.; de Wit, Emmie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">7824</span>),
    <span class="NLM_cas:pages">273-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed.  While many investigational, approved, and repurposed drugs have been suggested as potential treatments, preclin. data from animal models can guide the search for effective treatments by ruling out those that lack efficacy in vivo.  Remdesivir (GS-5734) is a nucleotide analog prodrug with broad antiviral activity1,2 that is currently being investigated in COVID-19 clin. trials and recently received Emergency Use Authorization from the US Food and Drug Administration3,4.  In animal models, remdesivir was effective against infection with Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)2,5,6.  In vitro, remdesivir inhibited replication of SARS-CoV-27,8.  Here we investigate the efficacy of remdesivir in a rhesus macaque model of SARS-CoV-2 infection9.  Unlike vehicle-treated animals, macaques treated with remdesivir did not show signs of respiratory disease; they also showed reduced pulmonary infiltrates on radiographs and reduced virus titers in bronchoalveolar lavages twelve hours after the first dose.  Virus shedding from the upper respiratory tract was not reduced by remdesivir treatment.  At necropsy, remdesivir-treated animals had lower lung viral loads and reduced lung damage.  Thus, treatment with remdesivir initiated early during infection had a clin. benefit in rhesus macaques infected with SARS-CoV-2.  Although the rhesus macaque model does not represent the severe disease obsd. in some patients with COVID-19, our data support the early initiation of remdesivir treatment in patients with COVID-19 to prevent progression to pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fZodXTdabLVg90H21EOLACvtfcHk0lhYAKqAS1j_FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslelu7rJ&md5=68d6cbbababc8d7b3d005285528b896e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2423-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2423-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DB.%2BN.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DSchwarz%26aufirst%3DB.%26aulast%3DMeade-White%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DSchulz%26aufirst%3DJ.%26aulast%3Dvan%2BDoremalen%26aufirst%3DN.%26aulast%3DLeighton%26aufirst%3DI.%26aulast%3DYinda%26aufirst%3DC.%2BK.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DL.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DLovaglio%26aufirst%3DJ.%26aulast%3DHanley%26aufirst%3DP.%2BW.%26aulast%3DSaturday%26aufirst%3DG.%26aulast%3DBosio%26aufirst%3DC.%2BM.%26aulast%3DAnzick%26aufirst%3DS.%26aulast%3DBarbian%26aufirst%3DK.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DMartens%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BP.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3Dde%2BWit%26aufirst%3DE.%26atitle%3DClinical%2520benefit%2520of%2520remdesivir%2520in%2520rhesus%2520macaques%2520infected%2520with%2520SARS-CoV-2%26jtitle%3DNature%26date%3D2020%26volume%3D585%26spage%3D273%26epage%3D276%26doi%3D10.1038%2Fs41586-020-2423-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pruijssers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinksi, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinnon, K. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gully, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Pont, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilello, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span> <span> </span><span class="NLM_article-title">Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span>, <span class="NLM_elocation-id">107940</span> <span class="refDoi"> DOI: 10.1016/j.celrep.2020.107940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.celrep.2020.107940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32668216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2isrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&author=A.+J.+Pruijssersauthor=A.+S.+Georgeauthor=A.+Sch%C3%A4ferauthor=S.+R.+Leistauthor=L.+E.+Gralinksiauthor=K.+H.+Dinnonauthor=B.+L.+Yountauthor=M.+L.+Agostiniauthor=L.+J.+Stevensauthor=J.+D.+Chappellauthor=X.+Luauthor=T.+M.+Hughesauthor=K.+Gullyauthor=D.+R.+Martinezauthor=A.+J.+Brownauthor=R.+L.+Grahamauthor=J.+K.+Perryauthor=V.+Du+Pontauthor=J.+Pittsauthor=B.+Maauthor=D.+Babusisauthor=E.+Murakamiauthor=J.+Y.+Fengauthor=J.+P.+Bilelloauthor=D.+P.+Porterauthor=T.+Tomas+Cihlarauthor=R.+S.+Baricauthor=M.+R.+Denisonauthor=T.+P.+Sheahan&title=Remdesivir+inhibits+SARS-CoV-2+in+human+lung+cells+and+chimeric+SARS-CoV+expressing+the+SARS-CoV-2+RNA+polymerase+in+mice&doi=10.1016%2Fj.celrep.2020.107940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice</span></div><div class="casAuthors">Pruijssers, Andrea J.; George, Amelia S.; Schafer, Alexandra; Leist, Sarah R.; Gralinksi, Lisa E.; Dinnon, Kenneth H.; Yount, Boyd L.; Agostini, Maria L.; Stevens, Laura J.; Chappell, James D.; Lu, Xiaotao; Hughes, Tia M.; Gully, Kendra; Martinez, David R.; Brown, Ariane J.; Graham, Rachel L.; Perry, Jason K.; Du Pont, Venice; Pitts, Jared; Ma, Bin; Babusis, Darius; Murakami, Eisuke; Feng, Joy Y.; Bilello, John P.; Porter, Danielle P.; Cihlar, Tomas; Baric, Ralph S.; Denison, Mark R.; Sheahan, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107940</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the novel viral disease COVID-19.  With no approved therapies, this pandemic illustrates the urgent need for broad-spectrum antiviral countermeasures against SARS-CoV-2 and future emerging CoVs.  We report that remdesivir (RDV) potently inhibits SARS-CoV-2 replication in human lung cells and primary human airway epithelial cultures (EC50 = 0.01μM).  Weaker activity is obsd. in Vero E6 cells (EC50 = 1.65μM) because of their low capacity to metabolize RDV.  To rapidly evaluate in vivo efficacy, we engineered a chimeric SARS-CoV encoding the viral target of RDV, the RNA-dependent RNA polymerase of SARS-CoV-2.  In mice infected with the chimeric virus, therapeutic RDV administration diminishes lung viral load and improves pulmonary function compared with vehicle-treated animals.  These data demonstrate that RDV is potently active against SARS-CoV-2 in vitro and in vivo, supporting its further clin. testing for treatment of COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUzmxM5ARME7Vg90H21EOLACvtfcHk0lhYAKqAS1j_FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2isrzL&md5=d869e7d9f406848283f0a92d14e8f9ed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107940%26sid%3Dliteratum%253Aachs%26aulast%3DPruijssers%26aufirst%3DA.%2BJ.%26aulast%3DGeorge%26aufirst%3DA.%2BS.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DA.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DGralinksi%26aufirst%3DL.%2BE.%26aulast%3DDinnon%26aufirst%3DK.%2BH.%26aulast%3DYount%26aufirst%3DB.%2BL.%26aulast%3DAgostini%26aufirst%3DM.%2BL.%26aulast%3DStevens%26aufirst%3DL.%2BJ.%26aulast%3DChappell%26aufirst%3DJ.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DHughes%26aufirst%3DT.%2BM.%26aulast%3DGully%26aufirst%3DK.%26aulast%3DMartinez%26aufirst%3DD.%2BR.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DDu%2BPont%26aufirst%3DV.%26aulast%3DPitts%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBilello%26aufirst%3DJ.%2BP.%26aulast%3DPorter%26aufirst%3DD.%2BP.%26aulast%3DTomas%2BCihlar%26aufirst%3DT.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26atitle%3DRemdesivir%2520inhibits%2520SARS-CoV-2%2520in%2520human%2520lung%2520cells%2520and%2520chimeric%2520SARS-CoV%2520expressing%2520the%2520SARS-CoV-2%2520RNA%2520polymerase%2520in%2520mice%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D32%26doi%3D10.1016%2Fj.celrep.2020.107940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosserman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getty, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prhavc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/jm030424e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030424e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVygtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2283-2295&author=A.+B.+Eldrupauthor=C.+R.+Allersonauthor=C.+F.+Bennettauthor=S.+Beraauthor=B.+Bhatauthor=N.+Bhatauthor=M.+R.+Bossermanauthor=J.+Brooksauthor=C.+Burleinauthor=S.+S.+Carrollauthor=P.+D.+Cookauthor=K.+L.+Gettyauthor=M.+MacCossauthor=D.+R.+McMastersauthor=D.+B.+Olsenauthor=T.+P.+Prakashauthor=M.+Prhavcauthor=Q.+Songauthor=J.+E.+Tomassiniauthor=J.+Xia&title=Structure-activity+relationship+of+purine+ribonucleosides+for+inhibition+of+hepatitis+C+virus+RNA-dependent+RNA+polymerase&doi=10.1021%2Fjm030424e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase</span></div><div class="casAuthors">Eldrup, Anne B.; Allerson, Charles R.; Bennett, C. Frank; Bera, Sanjib; Bhat, Balkrishen; Bhat, Neelima; Bosserman, Michele R.; Brooks, Jennifer; Burlein, Christine; Carroll, Steven S.; Cook, P. Dan; Getty, Krista L.; MacCoss, Malcolm; McMasters, Daniel R.; Olsen, David B.; Prakash, Thazha P.; Prhavc, Marija; Song, Quanlai; Tomassini, Joanne E.; Xia, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2283-2295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of a continued effort to identify inhibitors of hepatitis C viral (HCV) replication, we report here the synthesis and evaluation of a series of nucleoside analogs and their corresponding triphosphates.  Nucleosides were evaluated for their ability to inhibit HCV RNA replication in a cell-based, subgenomic replicon system, while nucleoside triphosphates were evaluated for their ability to inhibit in vitro RNA synthesis mediated by the HCV RNA-dependent RNA polymerase, NS5B.  2'-C-Methyladenosine and 2'-C-methylguanosine were identified as potent inhibitors of HCV RNA replication, and the corresponding triphosphates were found to be potent inhibitors of HCV NS5B-mediated RNA synthesis.  The data generated in the cell-based assay demonstrated a fairly stringent structure-activity relationship around the active nucleosides.  Increase in steric bulk beyond Me on C2, change in the stereo- or regiochem. of the Me substituent, or change of identity of the heterobase beyond that of the endogenous adenine or guanine was found to lead to loss of inhibitory activity.  The results highlight the importance of the ribo configuration 2'- and 3'-hydroxy pharmacophores for inhibition of HCV RNA replication in the cell-based assay and demonstrate that inclusion of the 2'-C-methylribonucleoside pharmacophore leads to increased resistance to adenosine deaminase and purine nucleoside phosphorylase mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN5TEtkVswmbVg90H21EOLACvtfcHk0lhYAKqAS1j_FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVygtrg%253D&md5=a932a7398e472269f75c7ab029e8630f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm030424e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030424e%26sid%3Dliteratum%253Aachs%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DAllerson%26aufirst%3DC.%2BR.%26aulast%3DBennett%26aufirst%3DC.%2BF.%26aulast%3DBera%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBhat%26aufirst%3DN.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DCook%26aufirst%3DP.%2BD.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DPrakash%26aufirst%3DT.%2BP.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DXia%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520purine%2520ribonucleosides%2520for%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2283%26epage%3D2295%26doi%3D10.1021%2Fjm030424e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of β-D-2′-deoxy-2′-α-fluoro-4′-α-cyano-5-aza-7,9-dideazaadenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1016%2Fj.bmcl.2015.04.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=25978965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2484-2487&author=M.+O.+Clarkeauthor=R.+Mackmanauthor=D.+Byunauthor=H.+Huiauthor=O.+Barauskasauthor=G.+Birkusauthor=B.-K.+Chunauthor=E.+Doerfflerauthor=J.+Fengauthor=K.+Karkiauthor=G.+Leeauthor=M.+Perronauthor=D.+Siegelauthor=S.+Swaminathanauthor=W.+Lee&title=Discovery+of+%CE%B2-D-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-4%E2%80%B2-%CE%B1-cyano-5-aza-7%2C9-dideazaadenosine+as+a+potent+nucleoside+inhibitor+of+respiratory+syncytial+virus+with+excellent+selectivity+over+mitochondrial+RNA+and+DNA+polymerases&doi=10.1016%2Fj.bmcl.2015.04.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-D-2'-deoxy-2'-α-fluoro-4'-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span></div><div class="casAuthors">Clarke, Michael O.; Mackman, Richard; Byun, Daniel; Hui, Hon; Barauskas, Ona; Birkus, Gabriel; Chun, Byoung-Kwon; Doerffler, Edward; Feng, Joy; Karki, Kapil; Lee, Gary; Perron, Michel; Siegel, Dustin; Swaminathan, Swami; Lee, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2484-2487</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 4'-substituted β-D-2'-deoxy-2'-α-fluoro (2'd2'F) nucleoside inhibitors of respiratory syncytial virus (RSV) are reported.  The introduction of 4'-substitution onto 2'd2'F nucleoside analogs resulted in compds. demonstrating potent cell based RSV inhibition, improved inhibition of the RSV polymerase by the nucleoside triphosphate metabolites, and enhanced selectivity over incorporation by mitochondrial RNA and DNA polymerases.  Selectivity over the mitochondrial polymerases was found to be extremely sensitive to the specific 4'-substitution and not readily predictable.  Combining the most potent and selective 4'-groups from N-nucleoside analogs onto a 2'd2'F C-nucleoside analog resulted in the identification of I as a promising nucleoside lead for RSV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr67PvLBml7Vg90H21EOLACvtfcHk0liGxhNtFaeeFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D&md5=744a3a2680ef899fcd84258c386471d2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.073%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-4%25E2%2580%25B2-%25CE%25B1-cyano-5-aza-7%252C9-dideazaadenosine%2520as%2520a%2520potent%2520nucleoside%2520inhibitor%2520of%2520respiratory%2520syncytial%2520virus%2520with%2520excellent%2520selectivity%2520over%2520mitochondrial%2520RNA%2520and%2520DNA%2520polymerases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2484%26epage%3D2487%26doi%3D10.1016%2Fj.bmcl.2015.04.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warhurst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gifford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastmond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and <span class="smallcaps smallerCapital">d</span>-peptides</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1021/js970120d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1021%2Fjs970120d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=9572915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADyaK1cXivVeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1998&pages=626-633&author=Y.-L.+Heauthor=S.+Murbyauthor=G.+Warhurstauthor=L.+Giffordauthor=D.+Walkerauthor=J.+Ayrtonauthor=R.+Eastmondauthor=M.+Rowland&title=Species+differences+in+size+discrimination+in+the+paracellular+pathway+reflected+by+oral+bioavailability+of+poly%28ethylene+glycol%29+and+d-peptides&doi=10.1021%2Fjs970120d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of polyethylene glycol and D-peptides</span></div><div class="casAuthors">He, Yan-Ling; Murby, Susan; Warhurst, Geoffrey; Gifford, Larry; Walker, David; Ayrton, John; Eastmond, Richard; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">626-633</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Animal models are frequently used to aid prediction of intestinal absorption in humans.  However, there is little comparative quant. information on species differences in paracellular permeation, which is an important route for oral absorption of small to medium-sized hydrophilic drug mols.  This study addresses this issue by comparing the mol. mass (MM) dependency in oral bioavailability between rat and dog of PEG, a polydispersed model mixt. commonly used to characterize paracellular absorption, and of a series of 8 D-peptides (based on D-phenylalanine).  Fasted rats and dogs received PEG (400/900) and the D-peptides (MM 236-406 Da), orally and i.v., with total 24-48 h urine collection to est. oral bioavailability.  After HPLC sepn., the individual PEG oligomers and D-peptides were detd. by using radiometric detection, for radiolabeled material, and LC-MS, for unlabeled (PEG) material.  All compds. were predominantly excreted unchanged following i.v. administration.  After oral administration, the predominant peak in the radio chromatogram was unchanged material, indicating stability of the compds. in the gastrointestinal tract.  A clear mol. mass dependency in oral bioavailability was seen with both series, but with absorption much greater in dog than rat.  Thus, for PEG in rat, bioavailability decreased sharply from 79 to around 2% with increasing MM between 282 and 591 Da, and then tapered to around 1.5% up to 1295 Da. .  Whereas in dog, bioavailability remained around 100% for oligomers up to 600 Da and then decreased quite sharply with increasing MM, tending to plateau around 13% beyond 900 Da.  Likewise, for the D-peptides in rat, bioavailability decreased from 30 to 1% with increasing MM between 236 and 406 Da, whereas in dog it was 100%, declining to 16% over the same mol. range.  This species difference appears to be due to a larger pore size and greater frequency of pores in the paracellular pathway of dog compared to rat.  Furthermore, on the basis of comparison with literature data for PEG and selected drugs, rat would appear to be a better predictor than dog of absorption of hydrophilic compds. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeYs7HYKui57Vg90H21EOLACvtfcHk0liGxhNtFaeeFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVeltLs%253D&md5=76f94525ac770ea72fa1584477e29dd1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjs970120d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs970120d%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.-L.%26aulast%3DMurby%26aufirst%3DS.%26aulast%3DWarhurst%26aufirst%3DG.%26aulast%3DGifford%26aufirst%3DL.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DAyrton%26aufirst%3DJ.%26aulast%3DEastmond%26aufirst%3DR.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DSpecies%2520differences%2520in%2520size%2520discrimination%2520in%2520the%2520paracellular%2520pathway%2520reflected%2520by%2520oral%2520bioavailability%2520of%2520poly%2528ethylene%2520glycol%2529%2520and%2520d-peptides%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1998%26volume%3D87%26spage%3D626%26epage%3D633%26doi%3D10.1021%2Fjs970120d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibach, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapathy, M. E.</span></span> <span> </span><span class="NLM_article-title">Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10824137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1artbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2000&pages=781-789&author=M.+Sugawaraauthor=W.+Huangauthor=Y.-J.+Feiauthor=F.+H.+Leibachauthor=V.+Ganapathyauthor=M.+E.+Ganapathy&title=Transport+of+valganciclovir%2C+a+ganciclovir+prodrug%2C+via+peptide+transporters+PEPT1+and+PEPT2&doi=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2</span></div><div class="casAuthors">Sugawara, Mitsuru; Huang, Wei; Fei, You-Jun; Leibach, Frederick H.; Ganapathy, Vadivel; Ganapathy, Malliga E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In clin. trials, valganciclovir, the valyl ester of ganciclovir, has been shown to enhance the bioavailability of ganciclovir when taken orally by patients with cytomegalovirus infection.  We investigated the role of the intestinal peptide transporter PEPT1 in this process by comparing the interaction of ganciclovir and valganciclovir with the transporter in different exptl. systems.  We also studied the interaction of these two compds. with the renal peptide transporter PEPT2.  In cell culture model systems using Caco-2 cells for PEPT1 and SKPT cells for PEPT2, valganciclovir inhibited glycylsarcosine transport mediated by PEPT1 and PEPT2 with Ki values (inhibition const.) of 1.68 ± 0.30 and 0.043 ± 0.005 mM, resp.  The inhibition by valganciclovir was competitive in both cases.  Ganciclovir did not interact with either transporter.  Similar studies done with cloned PEPT1 and PEPT2 in heterologous expression systems yielded comparable results.  The transport of valganciclovir via PEPT1 was investigated directly in PEPT1-expressing Xenopus laevis oocytes with an electrophysiol. approach.  Valganciclovir, but not ganciclovir, induced inward currents in PEPT1-expressing oocytes.  These results demonstrate that the increased bioavailability of valganciclovir is related to its recognition as a substrate by the intestinal peptide transporter PEPT1.  This prodrug is also recognized by the renal peptide transporter PEPT2 with high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBcbDYOSpJvrVg90H21EOLACvtfcHk0lgZNSZccSej4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1artbY%253D&md5=bff73ba55562df124b08ecdaebcaa8b6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291520-6017%2528200006%252989%253A6%253C781%253A%253AAID-JPS10%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSugawara%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DFei%26aufirst%3DY.-J.%26aulast%3DLeibach%26aufirst%3DF.%2BH.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DGanapathy%26aufirst%3DM.%2BE.%26atitle%3DTransport%2520of%2520valganciclovir%252C%2520a%2520ganciclovir%2520prodrug%252C%2520via%2520peptide%2520transporters%2520PEPT1%2520and%2520PEPT2%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D89%26spage%3D781%26epage%3D789%26doi%3D10.1002%2F%28SICI%291520-6017%28200006%2989%3A6%3C781%3A%3AAID-JPS10%3E3.0.CO%3B2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisa, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for repurpose and design of nucleoside drugs for treating COVID-19</span>. <i>bioRxiv</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">11.01.363812</span> <span class="refDoi"> DOI: 10.1101/2020.11.01.363812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1101%2F2020.11.01.363812" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=W.+Yinauthor=X.+Luanauthor=Z.+Liauthor=Y.+Xieauthor=Z.+Zhouauthor=J.+Liuauthor=M.+Gaoauthor=X.+Wangauthor=F.+Zhouauthor=Q.+Wangauthor=Q.+Wangauthor=D.+Shenauthor=Y.+Zhangauthor=G.+Tianauthor=H.+A.+Aisaauthor=T.+Huauthor=D.+Weiauthor=Y.+Jiangauthor=G.+Xiaoauthor=H.+Jiangauthor=L.+Zhangauthor=X.+Yuauthor=J.+Shenauthor=S.+Zhangauthor=H.+E.+Xu&title=Structural+basis+for+repurpose+and+design+of+nucleoside+drugs+for+treating+COVID-19&doi=10.1101%2F2020.11.01.363812"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1101%2F2020.11.01.363812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.11.01.363812%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DAisa%26aufirst%3DH.%2BA.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520repurpose%2520and%2520design%2520of%2520nucleoside%2520drugs%2520for%2520treating%2520COVID-19%26jtitle%3DbioRxiv%26date%3D2020%26doi%3D10.1101%2F2020.11.01.363812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Périgaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubertin, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbach, J.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, decomposition pathways and “In Vitro” evaluation of bioreversible phosphotriesters of Azt</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1080/15257779508012467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1080%2F15257779508012467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=763-766&author=I.+Lefebvreauthor=A.+Pomponauthor=C.+P%C3%A9rigaudauthor=J.-L.+Girardetauthor=G.+Gosselinauthor=A.-M.+Aubertinauthor=A.+Kirnauthor=J.-L.+Imbach&title=Synthesis%2C+decomposition+pathways+and+%E2%80%9CIn+Vitro%E2%80%9D+evaluation+of+bioreversible+phosphotriesters+of+Azt&doi=10.1080%2F15257779508012467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1080%2F15257779508012467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257779508012467%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DI.%26aulast%3DPompon%26aufirst%3DA.%26aulast%3DP%25C3%25A9rigaud%26aufirst%3DC.%26aulast%3DGirardet%26aufirst%3DJ.-L.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DAubertin%26aufirst%3DA.-M.%26aulast%3DKirn%26aufirst%3DA.%26aulast%3DImbach%26aufirst%3DJ.-L.%26atitle%3DSynthesis%252C%2520decomposition%2520pathways%2520and%2520%25E2%2580%259CIn%2520Vitro%25E2%2580%259D%2520evaluation%2520of%2520bioreversible%2520phosphotriesters%2520of%2520Azt%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1995%26volume%3D14%26spage%3D763%26epage%3D766%26doi%3D10.1080%2F15257779508012467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Axt, S. D.</span>; <span class="NLM_string-name">Badalov, P. R.</span>; <span class="NLM_string-name">Brak, K.</span>; <span class="NLM_string-name">Campagna, S.</span>; <span class="NLM_string-name">Chtchemelinine, A.</span>; <span class="NLM_string-name">Doerffler, E.</span>; <span class="NLM_string-name">Frick, M. M.</span>; <span class="NLM_string-name">Gao, D.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Hoang, B.</span>; <span class="NLM_string-name">Lew, W.</span>; <span class="NLM_string-name">Milburn, R. R.</span>; <span class="NLM_string-name">Neville, S. T.</span>; <span class="NLM_string-name">Ross, B.</span>; <span class="NLM_string-name">Rueden, E.</span>; <span class="NLM_string-name">Scott, R. W.</span>; <span class="NLM_string-name">Siegel, D.</span>; <span class="NLM_string-name">Stevens, A. C.</span>; <span class="NLM_string-name">Tadeus, C.</span>; <span class="NLM_string-name">Vieira, T.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Whitcomb, M. C.</span>; <span class="NLM_string-name">Wolfe, L.</span>; <span class="NLM_string-name">Yu, C.-Y.</span></span> <span> </span><span class="NLM_article-title">Methods for the Preparation of Ribosides</span>. <span class="NLM_patent">WO2016069825A1</span>, Gilead Sciences, May 6, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+D.+Axt&author=P.+R.+Badalov&author=K.+Brak&author=S.+Campagna&author=A.+Chtchemelinine&author=E.+Doerffler&author=M.+M.+Frick&author=D.+Gao&author=L.+V.+Heumann&author=B.+Hoang&author=W.+Lew&author=R.+R.+Milburn&author=S.+T.+Neville&author=B.+Ross&author=E.+Rueden&author=R.+W.+Scott&author=D.+Siegel&author=A.+C.+Stevens&author=C.+Tadeus&author=T.+Vieira&author=A.+W.+Waltman&author=X.+Wang&author=M.+C.+Whitcomb&author=L.+Wolfe&author=C.-Y.+Yu&title=Methods+for+the+Preparation+of+Ribosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAxt%26aufirst%3DS.%2BD.%26atitle%3DMethods%2520for%2520the%2520Preparation%2520of%2520Ribosides%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, A. J.</span>; <span class="NLM_string-name">Wiemer, D. F.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of phosphonates and phosphates: Crossing the membrane barrier</span>.  <i>Phosphorus Chemistry I. Topics in Current Chemistry</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">360</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=115-160&author=A.+J.+Wiemer&author=D.+F.+Wiemer&title=Phosphorus+Chemistry+I.+Topics+in+Current+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWiemer%26aufirst%3DA.%2BJ.%26atitle%3DProdrugs%2520of%2520phosphonates%2520and%2520phosphates%253A%2520Crossing%2520the%2520membrane%2520barrier%26btitle%3DPhosphorus%2520Chemistry%2520I.%2520Topics%2520in%2520Current%2520Chemistry%26pub%3DSpringer%26date%3D2015%26volume%3D360%26spage%3D115%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serpi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertusati, F.</span></span> <span> </span><span class="NLM_article-title">Phosphoramidates and phosphonamidates (ProTides) with antiviral activity</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">2040206618775243</span> <span class="refDoi"> DOI: 10.1177/2040206618775243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1177%2F2040206618775243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&author=M.+Slusarczykauthor=M.+Serpiauthor=F.+Pertusati&title=Phosphoramidates+and+phosphonamidates+%28ProTides%29+with+antiviral+activity&doi=10.1177%2F2040206618775243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1177%2F2040206618775243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040206618775243%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarczyk%26aufirst%3DM.%26aulast%3DSerpi%26aufirst%3DM.%26aulast%3DPertusati%26aufirst%3DF.%26atitle%3DPhosphoramidates%2520and%2520phosphonamidates%2520%2528ProTides%2529%2520with%2520antiviral%2520activity%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2018%26volume%3D26%26doi%3D10.1177%2F2040206618775243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kernan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisbe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohloff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparacino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terhorst, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1081/NCN-100002338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1081%2FNCN-100002338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=11563079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=621-628&author=H.+Chapmanauthor=M.+Kernanauthor=E.+Prisbeauthor=J.+Rohloffauthor=M.+Sparacinoauthor=T.+Terhorstauthor=R.+Yu&title=Practical+synthesis%2C+separation%2C+and+stereochemical+assignment+of+the+PMPA+pro-drug+GS-7340&doi=10.1081%2FNCN-100002338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340</span></div><div class="casAuthors">Chapman, H.; Kernan, M.; Prisbe, E.; Rohloff, J.; Sparacino, M.; Terhorst, T.; Yu, R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4-7</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The practical synthesis of a mixed phenoxy-amidate deriv. of PMPA with high oral bioavailability and favorable pharmacokinetics is described.  The non-stereoselective synthetic route produces a 1:1 mixt. of two diastereomers at phosphorous.  Simulated moving bed chromatog. using Chiral pak AS enabled kilo-scale isolation of the more potent diastereomer I (GS-7340).  The GS-7340 phosphorous chiral center was found to be (S) by X-ray crystallog.  I was tested in vitro as antiviral agent (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrje-dv-gsW4rVg90H21EOLACvtfcHk0lhsXU5mpRpvxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslCqtr4%253D&md5=cd6f353bdf365a1f3dd2fdb2288bff21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1081%2FNCN-100002338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-100002338%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DH.%26aulast%3DKernan%26aufirst%3DM.%26aulast%3DPrisbe%26aufirst%3DE.%26aulast%3DRohloff%26aufirst%3DJ.%26aulast%3DSparacino%26aufirst%3DM.%26aulast%3DTerhorst%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DR.%26atitle%3DPractical%2520synthesis%252C%2520separation%252C%2520and%2520stereochemical%2520assignment%2520of%2520the%2520PMPA%2520pro-drug%2520GS-7340%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2001%26volume%3D20%26spage%3D621%26epage%3D628%26doi%3D10.1081%2FNCN-100002338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeples, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickles, R. J.</span></span> <span> </span><span class="NLM_article-title">Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">5654</span>– <span class="NLM_lpage">5666</span>, <span class="refDoi"> DOI: 10.1128/JVI.76.11.5654-5666.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1128%2FJVI.76.11.5654-5666.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=11991994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BD38XjslGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=5654-5666&author=L.+Zhangauthor=M.+E.+Peeplesauthor=R.+C.+Boucherauthor=P.+L.+Collinsauthor=R.+J.+Pickles&title=Respiratory+syncytial+virus+infection+of+human+airway+epithelial+cells+is+polarized%2C+specific+to+ciliated+cells%2C+and+without+obvious+cytopathology&doi=10.1128%2FJVI.76.11.5654-5666.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology</span></div><div class="casAuthors">Zhang, Liqun; Peeples, Mark E.; Boucher, Richard C.; Collins, Peter L.; Pickles, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5654-5666</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gene therapy for cystic fibrosis (CF) lung disease requires efficient gene transfer to airway epithelial cells after intralumenal delivery.  Most gene transfer vectors so far tested have not provided the efficiency required.  Although human respiratory syncytial virus (RSV), a common respiratory virus, is known to infect the respiratory epithelium, the mechanism of infection and the epithelial cell type targeted by RSV have not been detd.  We have utilized human primary airway epithelial cell cultures that generate a well-differentiated pseudostratified mucociliary epithelium to investigate whether RSV infects airway epithelium via the lumenal (apical) surface.  A recombinant RSV expressing green fluorescent protein (rgRSV) infected epithelial cell cultures with high gene transfer efficiency when applied to the apical surface but not after basolateral inoculation.  Analyses of the cell types infected by RSV revealed that lumenal columnar cells, specifically ciliated epithelial cells, were targeted by RSV and that cultures became susceptible to infection as they differentiated into a ciliated phenotype.  In addn. to infection of ciliated cells via the apical membrane, RSV was shed exclusively from the apical surface and spread to neighboring ciliated cells by the motion of the cilial beat.  Gross histol. examn. of cultures infected with RSV revealed no evidence of obvious cytopathol., suggesting that RSV infection in the absence of an immune response can be tolerated for >3 mo.  Therefore, rgRSV efficiently transduced the airway epithelium via the lumenal surface and specifically targeted ciliated airway epithelial cells.  Since rgRSV appears to breach the lumenal barriers encountered by other gene transfer vectors in the airway, this virus may be a good candidate for the development of a gene transfer vector for CF lung disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdM4PYqfjIs7Vg90H21EOLACvtfcHk0liQ5r1xN49Ufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjslGnurg%253D&md5=b2438d0048b474f84513b89547c28f91</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FJVI.76.11.5654-5666.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.76.11.5654-5666.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DPickles%26aufirst%3DR.%2BJ.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%2520of%2520human%2520airway%2520epithelial%2520cells%2520is%2520polarized%252C%2520specific%2520to%2520ciliated%2520cells%252C%2520and%2520without%2520obvious%2520cytopathology%26jtitle%3DJ.%2520Virol.%26date%3D2002%26volume%3D76%26spage%3D5654%26epage%3D5666%26doi%3D10.1128%2FJVI.76.11.5654-5666.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humeniuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinusi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1111/cts.12840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=10.1111%2Fcts.12840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=32589775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVant7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=896-906&author=R.+Humeniukauthor=A.+Mathiasauthor=H.+Caoauthor=A.+Osinusiauthor=G.+Shenauthor=E.+Chngauthor=J.+Lingauthor=A.+Vuauthor=P.+German&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+remdesivir%2C+an+antiviral+for+treatment+of+COVID-19%2C+in+healthy+subjects&doi=10.1111%2Fcts.12840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects</span></div><div class="casAuthors">Humeniuk, Rita; Mathias, Anita; Cao, Huyen; Osinusi, Anu; Shen, Gong; Chng, Estelle; Ling, John; Vu, Amanda; German, Polina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">896-906</span>CODEN:
                <span class="NLM_cas:coden">CTSLCA</span>;
        ISSN:<span class="NLM_cas:issn">1752-8062</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Remdesivir (RDV), a single diastereomeric monophosphoramidate prodrug that inhibits viral RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).  RDV received the US Food and Drug Administration (FDA)'s emergency use authorization in the United States and approval in Japan for treatment of patients with severe coronavirus disease 2019 (COVID-19).  This report describes two phase I studies that evaluated the safety and pharmacokinetics (PKs) of single escalating and multiple i.v. doses of RDV (soln. or lyophilized formulation) in healthy subjects.  Lyophilized formulation was evaluated for potential future use in clin. trials due to its storage stability in resource-limited settings.  All adverse events were grade 1 or 2 in severity.  Overall, RDV exhibited a linear profile following single-dose i.v. administration over 2 h of RDV soln. formulation across the dose range of 3-225 mg.  Both lyophilized and soln. formulations provided comparable PK parameters.  High intracellular concns. of the active triphosphate (∼ 220-fold to 370-fold higher than the in vitro half-maximal effective concn. against SARS-CoV-2 clin. isolate) were achieved following infusion of 75 mg or 150 mg lyophilized formulation over 30 min or 2 h.  Following multiple-doses of RDV 150 mg once daily for 7 or 14 days, RDV exhibited a PK profile similar to single-dose administration.  Metabolite GS-441524 accumulated ∼ 1.9-fold after daily dosing.  Overall, RDV exhibited favorable safety and PK profiles that supported once-daily dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-fP8Z8aWbbVg90H21EOLACvtfcHk0liQ5r1xN49Ufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVant7nF&md5=55f4dd660988005ffaf9b9c921c71bec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fcts.12840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12840%26sid%3Dliteratum%253Aachs%26aulast%3DHumeniuk%26aufirst%3DR.%26aulast%3DMathias%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DOsinusi%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DChng%26aufirst%3DE.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DA.%26aulast%3DGerman%26aufirst%3DP.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520remdesivir%252C%2520an%2520antiviral%2520for%2520treatment%2520of%2520COVID-19%252C%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D13%26spage%3D896%26epage%3D906%26doi%3D10.1111%2Fcts.12840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-6"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00071">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58832"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00071?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00071</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Amino acid ester synthesis, cell line sources, HCV 1b replicon assay, tabulated RSV HAE PCR data, in vitro pharmacokinetics, in vitro <b>1-NTP</b> metabolism methods, AGM efficacy study RT-qPCR method, and appendix of final compounds NMR and HPLC spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular Formula Strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_001.pdf">jm1c00071_si_001.pdf (1.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00071/suppl_file/jm1c00071_si_002.csv">jm1c00071_si_002.csv (3.71 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00071&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00071%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00071" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ba184d833d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
